QUARTERLY REPORT

Q2 2021 — Form 6-K results report

Q2 2021PDF · 125 pages658 KB
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
July 28, 2021
Commission File Number: 001-09246
Barclays PLC
(Name of Registrant)
1 Churchill Place
London E14 5HP
England
(Address of Principal Executive Office)
Interim Results Announcement
Indicate by check mark whether the registrant files or will file annual reports under cover of
Form 20-F or Form 40-F.
Form 20-F X Form 40-F
Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule
101(b)(1): ____
Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule
101(b)(7): ____
This report on Form 6-K shall be deemed to be incorporated by reference in the registration statements on Form S-8 (No.
333-153723, 333-167232, 333-173899, 333-183110, 333-195098, 333-216361, 333-225082, 333-236905, 333-236904
and 333-254570) and Form F-3 (333-253693) of Barclays PLC and to be a part thereof from the date on which this report
is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.

-- 1 of 125 --

The Report comprises the following:
Exhibit 99.1 Results of Barclays PLC Group as of, and for the six months ended, 30 June 2021.
Exhibit 99.2 A table setting forth the issued share capital of Barclays PLC and the Barclays PLC Group’s total shareholders’
equity, indebtedness and contingent liabilities as at 30 June 2021, the most recent reported statement of
position, and updated for any significant or material items since that reporting date.
101.INS XBRL Instance Document
101.SCH XBRL Taxonomy Extension Schema
101.CAL XBRL Taxonomy Extension Schema Calculation Linkbase
101.DEF XBRL Taxonomy Extension Schema Definition Linkbase
101.LAB XBRL Taxonomy Extension Schema Label Linkbase
101.PRE XBRL Taxonomy Extension Schema Presentation Linkbase
1

-- 2 of 125 --

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned, thereunto duly authorised.
BARCLAYS PLC
(Registrant)
Date: Date: July 28, 2021 By: /s/ Garth Wright
Name: Garth Wright
Title: Assistant Secretary
2

-- 3 of 125 --

Exhibit 99.1
Barclays PLC
This exhibit includes portions from the previously published Results Announcement of Barclays PLC relating to the six
months ended 30 June 2021, as amended in part to comply with the requirements of Regulation G and Item 10(e) of
Regulation S-K promulgated by the US Securities and Exchange Commission (SEC), including the reconciliation of
certain financial information to comparable measures prepared in accordance with International Financial Reporting
Standards (IFRS). The purpose of this document is to provide such additional disclosure as required by Regulation G and
Regulation S-K item 10(e), to delete certain information not in compliance with SEC regulations and to include
reconciliations of certain non-IFRS figures to the most directly equivalent IFRS figures for the periods presented. This
document does not update or otherwise supplement the information contained in the previously published Results
Announcement. Any reference to a website in this document is made for informational purposes only, and information
found at such websites is not incorporated by reference into this document.
An audit opinion has not been rendered in respect of this document.
1

-- 4 of 125 --

Results Announcement Page
Notes 3
Performance Highlights 5
Group Finance Director’s Review 8
Results by Business
• Barclays UK 10
• Barclays International 13
• Head Office 18
Quarterly Results Summary 19
Quarterly Results by Business 20
Performance Management 25
• Margins and Balances 25
Risk Management
• Risk Management and Principal Risks 26
• Credit Risk 28
• Market Risk 49
• Treasury and Capital Risk 50
Condensed Consolidated Financial Statements 63
Financial Statement Notes 69
Appendix: Non-IFRS Performance Measures 95
Shareholder Information 101
Glossary of Terms 102
Capitalisation and Indebtedness 122
BARCLAYS PLC, 1 CHURCHILL PLACE, LONDON, E14 5HP, UNITED KINGDOM. TELEPHONE: +44 (0) 20 7116 1000. COMPANY NO. 48839.
Table of Contents
2

-- 5 of 125 --

The terms Barclays or Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income
statement analysis compares the six months ended 30 June 2021 to the corresponding six months of 2020 and balance
sheet analysis as at 30 June 2021 with comparatives relating to 31 December 2020 and 30 June 2020. The abbreviations
‘£m’ and ‘£bn’ represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations ‘$m’ and
‘$bn’ represent millions and thousands of millions of US Dollars respectively; and the abbreviations ‘€m’ and ‘€bn’
represent millions and thousands of millions of Euros respectively.
There are a number of key judgement areas, for example impairment calculations, which are based on models and which
are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the
given point in time.
Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International
Financial Reporting Standards (IFRS) are explained in the results glossary, attached hereto.
The information in this announcement, which was approved by the Board of Directors on 27 July 2021, does not comprise
statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended
31 December 2020, which contained an unmodified audit report under Section 495 of the Companies Act 2006 (which did
not make any statements under Section 498 of the Companies Act 2006) have been delivered to the Registrar of
Companies in accordance with Section 441 of the Companies Act 2006.
Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal road-shows and
other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter
it will meet with investors globally to discuss these results and other matters relating to the Group.
Non-IFRS performance measures
Barclays management believes that the non-IFRS performance measures included in this document provide valuable
information to the readers of the financial statements as they enable the reader to identify a more consistent basis for
comparing the businesses’ performance between financial periods and provide more detail concerning the elements of
performance which the managers of these businesses are most directly able to influence or are relevant for an
assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and
performance is monitored by Barclays management. However, any non-IFRS performance measures in this document are
not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix on
pages 96 to 100 for further information and calculations of non-IFRS performance measures included throughout this
document, and the most directly comparable IFRS measures.
Key non-IFRS measures included in this document, and the most directly comparable IFRS measures, are:
– Average allocated equity represents the average shareholders’ equity that is allocated to the businesses. The
comparable IFRS measure is average equity. A reconciliation is provided on pages 97 to 99;
– Average allocated tangible equity is calculated as the average of the previous month’s period end allocated tangible
equity and the current month’s period end allocated tangible equity. The average allocated tangible equity for the period is
the average of the monthly averages within that period. Period end allocated tangible equity is calculated as 13.5% (2020:
13.0%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting
the assumptions the Group uses for capital planning purposes. Head Office allocated tangible equity represents the
difference between the Group’s tangible shareholders’ equity and the amounts allocated to businesses. The comparable
IFRS measure is average equity. A reconciliation is provided on pages 97 to 99;
– Average tangible shareholders’ equity is calculated as the average of the previous month’s period end tangible equity
and the current month’s period end tangible equity. The average tangible shareholders’ equity for the period is the
average of the monthly averages within that period. The comparable IFRS measure is average equity. A reconciliation is
provided on pages 97 to 99;
– Return on average allocated equity represents the return on shareholders’ equity that is allocated to the businesses.
The comparable IFRS measure is return on equity. A reconciliation is provided on page 100;
– Return on average allocated tangible equity is calculated as the annualised profit after tax attributable to ordinary equity
holders of the parent, as a proportion of average allocated tangible equity. The comparable IFRS measure is return on
equity. A reconciliation is provided on pages 97 to 99;
– Return on average tangible shareholders’ equity is calculated as the annualised profit after tax attributable to ordinary
equity holders of the parent, as a proportion of average shareholders’ equity excluding non-controlling interests and other
Notes
3

-- 6 of 125 --

equity instruments adjusted for the deduction of intangible assets and goodwill. The comparable IFRS measure is return
on equity. A reconciliation is provided on page 96; and
– Tangible net asset value per share is calculated by dividing shareholders’ equity, excluding non-controlling interests and
other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The comparable
IFRS measure is net asset value per share. A reconciliation is provided on page 99.
Forward-looking statements
This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities
Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the
Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual
results or other financial condition or performance measures could differ materially from those contained in the forward-
looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical
or current facts. Forward-looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’,
‘anticipate’, ‘target’, ‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar
meaning. Forward-looking statements can be made in writing but also may be made verbally by members of the
management of the Group (including, without limitation, during management presentations to financial analysts) in
connection with this document. Examples of forward-looking statements include, among others, statements or guidance
regarding or relating to the Group’s future financial position, income growth, assets, impairment charges, provisions,
business strategy, capital, leverage and other regulatory ratios, capital distributions (including dividend pay-out ratios and
expected payment strategies), projected levels of growth in the banking and financial markets, projected costs or savings,
any commitments and targets, estimates of capital expenditures, plans and objectives for future operations, projected
employee numbers, IFRS impacts and other statements that are not historical fact. By their nature, forward-looking
statements involve risk and uncertainty because they relate to future events and circumstances. The forward-looking
statements speak only as at the date on which they are made. Forward-looking statements may be affected by changes in
legislation, the development of standards and interpretations under IFRS, including evolving practices with regard to the
interpretation and application of accounting and regulatory standards, the outcome of current and future legal proceedings
and regulatory investigations, future levels of conduct provisions, the policies and actions of governmental and regulatory
authorities, the Group’s ability along with governments and other stakeholders to measure, manage and mitigate the
impacts of climate change effectively, geopolitical risks and the impact of competition. In addition, factors including (but
not limited to) the following may have an effect: capital, leverage and other regulatory rules applicable to past, current and
future periods; UK, US, Eurozone and global macroeconomic and business conditions; the effects of any volatility in credit
markets; market related risks such as changes in interest rates and foreign exchange rates; effects of changes in
valuation of credit market exposures; changes in valuation of issued securities; volatility in capital markets; changes in
credit ratings of any entity within the Group or any securities issued by such entities; direct and indirect impacts of the
coronavirus (COVID-19) pandemic; instability as a result of the UK’s exit from the European Union (“EU”), the effects of
the EU-UK Trade and Cooperation Agreement and the disruption that may subsequently result in the UK and globally; the
risk of cyber-attacks, information or security breaches or technology failures on the Group’s reputation, business or
operations; and the success of future acquisitions, disposals and other strategic transactions. A number of these
influences and factors are beyond the Group’s control. As a result, the Group’s actual financial position, future results,
capital distributions, capital, leverage or other regulatory ratios or other financial and non-financial metrics or performance
measures may differ materially from the statements or guidance set forth in the Group’s forward-looking statements.
Additional risks and factors which may impact the Group’s future financial condition and performance are identified in
Barclays PLC’s filings with the SEC (including, without limitation, Barclays PLC’s Annual Report on Form 20-F for the
fiscal year ended 31 December 2020), which are available on the SEC’s website at www.sec.gov.
Subject to Barclays’ obligations under the applicable laws and regulations of any relevant jurisdiction, (including, without
limitation, the UK and the US), in relation to disclosure and ongoing information, we undertake no obligation to update
publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Notes
4

-- 7 of 125 --

Group return on equity (RoE) of 14.0% for H121. Group return on tangible equity
(RoTE) of 16.4% for H121. Announced increased capital distributions, with half year
dividend of 2.0p per share and intend to initiate a further share buyback of up to
£500m
Barclays delivered a strong Group profit before tax in H121 of £5.0bn (H120: £1.3bn) and attributable profit of
£3.8bn (H120: £0.7bn). This delivered a RoE of 14.0% (H120: 2.5%) and a RoTE of 16.4% (H120: 2.9%) and
earnings per share (EPS) of 22.2p (H120: 4.0p)
Income Group income of £11.3bn down 3% versus prior year reflecting currency
headwinds
• Barclays International income of £8.2bn, down 5% versus prior year
Resilient income as the
Group continues to benefit
from diversified income
streams
– Corporate and Investment Bank (CIB) income of £6.6bn, down 5% with strong
Equities and Investment Banking fees performance, up 38% and 27%
respectively, whilst FICC was down 37% versus a strong H120
– Consumer, Cards and Payments (CC&P) income of £1.6bn, down 4% primarily
reflecting lower interest earning US cards balances
• Barclays UK income of £3.2bn increased 1% reflecting strong mortgages
performance with record net balance growth of £6.9bn, partially offset by lower
interest earning UK cards balances and the effect of lower interest rates
• Excluding the impact of the 10% depreciation of average USD against GBP, Group
income was up versus prior year
Credit impairment Group credit impairment net release of £0.7bn (H120: £3.7bn charge)
Improved macroeconomic
outlook and benign credit
environment
• The net release included a reversal of £1.1bn in non-default charges, primarily
reflecting the improved macroeconomic outlook. Excluding this reversal, the charge
was £0.4bn, reflecting reduced unsecured lending balances and the benign credit
environment
Costs Group total operating expenses of £7.2bn up 10% versus prior year, resulting in a
cost: income ratio of 64% (H120: 57%)
Investing for income growth
whilst taking structural cost
actions
• Total operating expenses included structural cost actions of £321m (H120: £78m),
primarily related to the real estate review in Q221, higher performance costs
reflective of improved returns, and continued investment and business growth,
partially offset by the benefit from the depreciation of average USD against GBP and
efficiency savings
Capital / capital
distributions
Common equity tier 1 (CET1) ratio of 15.1%, in line with December 2020
Announced increased capital
distributions
• Half year dividend of 2.0p (H120: 0p) per share to be paid on 17 September 2021
• Completed £700m share buyback in April
• Intend to initiate a further share buyback of up to £500m, which would have an effect
of 17bps on the CET1 ratio
Performance Highlights
5

-- 8 of 125 --

Q221 performance
Robust performance,
with profitability
benefiting from a credit
impairment net release
and the upwards re-
measurement of UK
DTAs
Q221 Group profit before tax of £2.6bn (Q220: £0.4bn), RoE of 15.5% (Q220: 0.6%), RoTE
of 18.1% (Q220: 0.7%) and EPS of 12.3p (Q220: 0.5p)
• Q221 Group income of £5.4bn, up 1% versus prior year despite currency headwinds.
Barclays International income of £3.8bn was down 5% versus prior year, reflecting CIB
income of £3.0bn, down 10% versus prior year and CC&P income of £0.8bn, up 21% versus
prior year driven by a valuation loss in 2020. Barclays UK income of £1.6bn was up 11%
versus prior year
• Q221 Group credit impairment net release of £0.8bn (Q220: £1.6bn charge), reflecting a
reversal of £1.0bn in non-default charges, primarily reflecting the improved macroeconomic
outlook. Excluding this reversal, the charge was £0.2bn, which is broadly aligned with prior
quarter
• Q221 Group total operating expenses of £3.7bn, up £0.3bn versus prior year, reflecting
structural cost actions
• Q221 attributable profit of £2.1bn (Q220: £0.1bn), which included an income statement tax
benefit of £0.4bn on the upwards re-measurement of UK deferred tax assets (DTAs)
• The CET1 ratio as at June 2021 was 15.1%, up 50bps in the quarter, driven by profits and
lower Risk Weighted Assets (RWAs)
Group outlook and targets
Outlook
Whilst the
macroeconomic
environment has
improved, the outlook
remains uncertain and
subject to change
depending on the
evolution and
persistence of the
COVID-19 pandemic
Returns
• Expect to deliver a RoTE above 10% in 2021
Impairment
• The quarterly impairment run rate is expected to remain below historical levels in coming
quarters given reduced unsecured lending balances and the improved macroeconomic
outlook, acknowledging the continuing uncertainty
Costs
• FY21 costs, excluding structural cost actions and performance costs, are expected to be
broadly in line with FY201
• Total full year 2021 costs are expected to be above 2020, due to higher structural cost
actions, including a real estate charge in Q221, and higher performance costs, reflecting
improved returns
Capital
• FY21 CET1 ratio is expected to remain above the target range of 13-14%, given the
economic environment remains uncertain and capital headwinds in 2022, including the
c.40bps impact from the reversal of software amortisation benefit from 1 January 2022
Capital returns
• Barclays’ capital returns policy incorporates a progressive ordinary dividend, supplemented
by additional cash returns, including share buybacks as and when appropriate
• Dividends will continue to be paid semi-annually, with the half year dividend expected to
represent, under normal circumstances, around one-third of the total dividend for the year
Targets
Continue to target the following over the medium term:
• Returns: RoTE of greater than 10%
• Cost efficiency: Cost: income ratio below 60%
• Capital adequacy: CET1 ratio in the range of 13-14%
1 Group cost outlook is based on an average rate of 1.38 (USD/GBP) in H221 and subject to foreign currency movements.
Performance Highlights
6

-- 9 of 125 --

Barclays Group results
for the half year ended 30.06.21 30.06.20
£m £m % Change
Net interest income 3,903 4,223 (8)
Net fee, commission and other income 7,412 7,398 —
Total income 11,315 11,621 (3)
Credit impairment releases/(charges) 742 (3,738)
Net operating income 12,057 7,883 53
Operating expenses (7,132) (6,563) (9)
Litigation and conduct (99) (30)
Total operating expenses (7,231) (6,593) (10)
Other net income/expenses 153 (18)
Profit before tax 4,979 1,272
Tax charge (759) (113)
Profit after tax 4,220 1,159
Non-controlling interests (19) (37) 49
Other equity instrument holders (389) (427) 9
Attributable profit 3,812 695
Performance measures
Return on average shareholders' equity 14.0% 2.5%
Return on average tangible shareholders' equity 16.4% 2.9%
Average shareholders' equity (£bn) 54.4 56.8
Average tangible shareholders' equity (£bn) 46.5 48.6
Cost: income ratio 64% 57%
Loan loss rate (bps) — 207
Basic earnings per share 22.2p 4.0p
Dividend per share 2.0p —
Basic weighted average number of shares (m) 17,140 17,294
Period end number of shares (m) 16,998 17,345
Share buyback announced (£m) 500 —
Total payout equivalent per share 4.9p —
As at
30.06.21
As at
31.12.20
As at
30.06.20
Balance sheet and capital management1 £bn £bn £bn
Loans and advances at amortised cost 348.5 342.6 354.9
Loans and advances at amortised cost impairment coverage ratio 1.8% 2.4% 2.5%
Deposits at amortised cost 500.9 481.0 466.9
Net asset value per share 329p 315p 331p
Tangible net asset value per share 281p 269p 284p
Common equity tier 1 ratio 15.1% 15.1% 14.2%
Common equity tier 1 capital 46.2 46.3 45.4
Risk weighted assets 306.4 306.2 319.0
Average UK leverage ratio 4.8% 5.0% 4.7%
UK leverage ratio 5.0% 5.3% 5.2%
Funding and liquidity
Group liquidity pool (£bn) 291 266 298
Liquidity coverage ratio 162% 162% 186%
Loan: deposit ratio 70% 71% 76%
1 Refer to pages 54 to 61 for further information on how capital, RWAs and leverage are calculated.
Performance Highlights
7

-- 10 of 125 --

Group performance
• Barclays delivered a profit before tax of £4,979m (H120: £1,272m), RoE of 14.0% (H120: 2.5%), RoTE of 16.4%
(H120: 2.9%), and EPS of 22.2p (H120: 4.0p). Profitability benefitted from a credit impairment net release and the
upwards re-measurement of UK DTAs. The 10% depreciation of average USD against GBP adversely impacted
income and profits and positively impacted total operating expenses
• Total income decreased to £11,315m (H120: £11,621m). Barclays UK income increased 1%. Barclays International
income decreased 5%, with CIB income down 5% and CC&P income down 4%. Excluding the impact of the 10%
depreciation of average USD against GBP, total income was up, reflecting the Group’s diversified income streams
• Credit impairment net release of £742m (H120: £3,738m charge) driven by an improved macroeconomic outlook used
in the Q221 scenario refresh, lower unsecured lending balances and a benign credit environment. Barclays has
maintained and refined management judgements in respect of customers and clients considered to be potentially more
vulnerable as government and other support schemes start to reduce. The reduction in unsecured lending balances
and growth in secured balances, with the mix impact contributing to a decrease in the Group’s loan coverage ratio to
1.8% (December 2020: 2.4%), with an unsecured loan coverage ratio at 10.2% (December 2020: 12.3%) and
wholesale loan coverage ratio at 1.1% (December 2020: 1.5%)
• Total operating expenses increased 10% to £7,231m, due to structural cost actions of £321m primarily relating to the
real estate review, higher performance costs that reflect improvement in returns, and continued investment and
business growth, partially offset by efficiency savings. This resulted in a cost: income ratio of 64% (H120: 57%)
• The effective tax rate was 15.2% (H120: 8.9%). This reflects the £392m tax benefit recognised for the re-measurement
of the Group’s UK DTAs as a result of the UK corporation tax rate increase from 19% to 25% from 1 April 2023
• Attributable profit was £3,812m (H120: £695m)
• As a result of the share buyback completed in April, the period end number of shares was 16,998m (December 2020:
17,359m)
• Total assets increased to £1,376bn (December 2020: £1,350bn) primarily due to a £26bn increase in cash at central
banks, a £19bn increase in trading portfolio assets due to increased activity and a £19bn increase in financial assets
at fair value due to an increase in secured lending, partially offset by a £46bn decrease in derivative assets driven by
an increase in major interest rate curves
• Net asset value (NAV) increased to 329p (December 2020: 315p). Tangible net asset value (TNAV) per share
increased to 281p (December 2020: 269p) primarily reflecting 22.2p of EPS, partially offset by negative reserve
movements
Group capital and leverage
• The CET1 ratio remained stable at 15.1% (December 2020: 15.1%)
– CET1 capital reduced by £0.1bn to £46.2bn (December 2020: £46.3bn) as profit before tax of £5.0bn was offset by
the removal of temporary regulatory supporting measures introduced in 2020, dividends paid and foreseen and
pensions deficit contribution payments. The £1.1bn release of non-defaulted credit impairment was more than
offset by a reduction in IFRS 9 transitional relief which also decreased due to impairment migrations from stage 2
to stage 3 and the relief on the pre-2020 impairment charge reducing from 70% to 50% in 2021
– RWAs remained broadly stable at £306.4bn (December 2020: £306.2bn) primarily due to increased client and
trading activity within CIB and growth in mortgages within Barclays UK, partially offset by lower consumer lending
• The average UK leverage ratio decreased to 4.8% (December 2020: 5.0%). The average leverage exposure increased
by £45.1bn to £1,192.0bn (December 2020: £1,146.9bn) largely driven by an increase in securities financing
transactions (SFTs), trading portfolio assets (TPAs) and potential future exposure (PFE) on derivatives
Group Performance Review
8

-- 11 of 125 --

Group funding and liquidity
• The liquidity pool was £291bn (December 2020: £266bn) and the liquidity coverage ratio remained significantly above
the 100% regulatory requirement at 162% (December 2020: 162%), equivalent to a surplus of £108bn (December
2020: £99bn). The increase in the pool is driven by continued deposit growth, further borrowing from the Bank of
England’s Term Funding Scheme with additional incentives for SMEs and a seasonal increase in short-term wholesale
funding, which were partly offset by an increase in business funding consumption
• Wholesale funding outstanding, excluding repurchase agreements, was £158.7bn (December 2020: £145.0bn). The
Group issued £5.9bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments from
Barclays PLC (the Parent company) during the year. The Group is well advanced in its MREL issuance plans relative
to the estimated 1 January 2022 requirement
Capital distributions
• Barclays understands the importance of delivering attractive total cash returns to shareholders. Barclays is therefore
committed to maintaining an appropriate balance between total cash returns to shareholders, investment in the
business and maintaining a strong capital position. Going forward, Barclays intends to pay a progressive ordinary
dividend, taking into account these objectives and the earnings outlook of the Group. It is also the Board’s intention to
continue to supplement the ordinary dividends with additional cash returns, including share buybacks, to shareholders
as and when appropriate
• Barclays will pay a half year dividend per share of 2.0p on 17 September 2021, and intends to initiate a share buyback
of up to £500m which is expected to commence in Q321. This is in addition to the £700m share buyback completed in
April
• The Board will assess the appropriate level and form of capital distributions as the year progresses
• Dividends will continue to be paid semi-annually, with the half year dividend expected to represent, under normal
circumstances, around one-third of the total dividend for the year
Tushar Morzaria, Group Finance Director
Group Performance Review
9

-- 12 of 125 --

Barclays UK Half year ended Half year ended
30.06.21 30.06.20
Income statement information £m £m % Change
Net interest income 2,586 2,637 (2)
Net fee, commission and other income 613 534 15
Total income 3,199 3,171 1
Credit impairment releases/(charges) 443 (1,064)
Net operating income 3,642 2,107 73
Operating expenses (2,114) (2,041) (4)
Litigation and conduct (22) (11)
Total operating expenses (2,136) (2,052) (4)
Other net income — 13
Profit before tax 1,506 68
Attributable profit 1,019 52
As at 30.06.21 As at 31.12.20 As at 30.06.20
Balance sheet information £bn £bn £bn
Loans and advances to customers at amortised cost 207.8 205.4 202.0
Total assets 311.2 289.1 287.6
Customer deposits at amortised cost 255.5 240.5 225.7
Loan: deposit ratio 87% 89% 92%
Risk weighted assets 72.2 73.7 77.9
Half year ended Half year ended
Key facts 30.06.21 30.06.20
Average loan to value of mortgage portfolio1 51% 52%
Average loan to value of new mortgage lending1 69% 68%
Number of branches 755 904
Mobile banking active customers 9.4m 8.7m
30 day arrears rate - Barclaycard Consumer UK 1.4% 2.0%
Performance measures
Return on average allocated equity 15.1% 0.8%
Return on average allocated tangible equity 20.6% 1.0%
Average allocated equity (£bn) 13.5 13.8
Average allocated tangible equity (£bn) 9.9 10.2
Cost: income ratio 67% 65%
Loan loss rate (bps) — 101
Net interest margin 2.54% 2.69%
1 Average loan to value of mortgages is balance weighted and reflects both residential and buy-to-let (BTL) mortgage portfolios within the Home Loans
portfolio.
Results by Business
10

-- 13 of 125 --

Analysis of Barclays UK Half year ended Half year ended
30.06.21 30.06.20
Analysis of total income £m £m % Change
Personal Banking 1,910 1,794 6
Barclaycard Consumer UK 605 803 (25)
Business Banking 684 574 19
Total income 3,199 3,171 1
Analysis of credit impairment releases/(charges)
Personal Banking 50 (264)
Barclaycard Consumer UK 398 (697)
Business Banking (5) (103)
Total credit impairment releases/(charges) 443 (1,064)
As at 30.06.21 As at 31.12.20 As at 30.06.20
Analysis of loans and advances to customers at amortised cost £bn £bn £bn
Personal Banking 162.4 157.3 154.9
Barclaycard Consumer UK 8.8 9.9 11.5
Business Banking 36.6 38.2 35.6
Total loans and advances to customers at amortised cost 207.8 205.4 202.0
Analysis of customer deposits at amortised cost
Personal Banking 191.0 179.7 169.6
Barclaycard Consumer UK 0.1 0.1 0.1
Business Banking 64.4 60.7 56.0
Total customer deposits at amortised cost 255.5 240.5 225.7
Results by Business
11

-- 14 of 125 --

Barclays UK delivered a RoE of 15.1% and a RoTE of 20.6% including the benefit from a net impairment release following
an improved UK macroeconomic outlook. Income increased 1% reflecting strong growth in mortgage balances of £6.9bn
at improved margins, despite a £1.5bn reduction in unsecured lending balances. Barclays UK grew deposits by £15.0bn,
further strengthening the liquidity position reflected in the loan: deposit ratio of 87%, 2% lower than FY20.
Income statement – H121 compared to H120
• Profit before tax increased to £1,506m (H120: £68m). RoE was 15.1% (H120: 0.8%). RoTE was 20.6% (H120: 1.0%)
reflecting materially lower credit impairment charges
• Total income increased 1% to £3,199m. Net interest income reduced 2% to £2,586m with a net interest margin (NIM)
of 2.54% (H120: 2.69%). Net fee, commission and other income increased 15% to £613m
– Personal Banking income increased 6% to £1,910m, reflecting strong growth in mortgages alongside improved
margins, balance growth in deposits and the non-recurrence of COVID-19 customer support actions, partially offset
by deposit margin compression from lower interest rates and lower unsecured lending balances
– Barclaycard Consumer UK income decreased 25% to £605m as reduced borrowing and continued payments by
customers resulted in a lower level of interest earning lending (IEL) balances
– Business Banking income increased 19% to £684m due to lending and deposit balance growth from £12.1bn of
government scheme lending and the non-recurrence of COVID-19 and related customer support actions, partially
offset by deposit margin compression from lower interest rates
• Credit impairment net release of £443m (H120: £1,064m charge) was driven by an improved macroeconomic outlook
used in the Q221 scenario refresh. The primary driver is a reduction in the anticipated peak of UK unemployment with
the majority of this provision release in UK cards and personal loans. As at 30 June 2021, 30 and 90 day arrears rates
in UK cards were 1.4% (H120: 2.0%) and 0.6% (H120: 1.0%) respectively
• Total operating expenses increased 4% to £2,136m reflecting investment spend and higher operational and customer
service costs, including ongoing financial assistance, partially offset by efficiency savings
Balance sheet – 30 June 2021 compared to 31 December 2020
• Loans and advances to customers at amortised cost increased 1% to £207.8bn predominantly from £6.9bn of
mortgage growth following continued strong flow of new applications as well as strong customer retention, offset by a
£1.8bn decrease in the Education, Social Housing and Local Authority (ESHLA) portfolio and £1.5bn lower unsecured
lending balances, albeit loans and advances in Barclaycard Consumer UK stabilised in Q221
• Customer deposits at amortised cost increased 6% to £255.5bn reflecting an increase of £11.3bn and £3.7bn in
Personal Banking and Business Banking respectively, further strengthening the liquidity position and contributing to a
loan: deposit ratio of 87% (December 2020: 89%)
• RWAs decreased to £72.2bn (December 2020: £73.7bn) driven by a reduction in unsecured lending and ESHLA,
partially offset by growth in mortgages
Results by Business
12

-- 15 of 125 --

Barclays International Half year ended Half year ended
30.06.21 30.06.20
Income statement information £m £m % Change
Net interest income 1,559 1,845 (16)
Net trading income 3,389 4,020 (16)
Net fee, commission and other income 3,270 2,789 17
Total income 8,218 8,654 (5)
Credit impairment releases/(charges) 293 (2,619)
Net operating income 8,511 6,035 41
Operating expenses (4,606) (4,405) (5)
Litigation and conduct (84) (11)
Total operating expenses (4,690) (4,416) (6)
Other net income 22 10
Profit before tax 3,843 1,629
Attributable profit 2,698 997
As at 30.06.21 As at 31.12.20 As at 30.06.20
Balance sheet information £bn £bn £bn
Loans and advances at amortised cost 121.9 122.7 138.1
Trading portfolio assets 147.1 127.7 109.5
Derivative financial instrument assets 255.4 301.8 306.8
Financial assets at fair value through the income statement 190.4 170.7 154.3
Cash collateral and settlement balances 108.5 97.5 130.8
Other assets 223.5 221.4 236.3
Total assets 1,046.8 1,041.8 1,075.8
Deposits at amortised cost 245.4 240.5 241.2
Derivative financial instrument liabilities 246.9 300.4 307.6
Loan: deposit ratio 50% 51% 57%
Risk weighted assets 223.2 222.3 231.2
Half year ended Half year ended
Performance measures 30.06.21 30.06.20
Return on average allocated equity 16.4% 6.0%
Return on average allocated tangible equity 16.7% 6.2%
Average allocated equity (£bn) 32.9 33.1
Average allocated tangible equity (£bn) 32.3 32.4
Cost: income ratio 57% 51%
Loan loss rate (bps) — 368
Net interest margin 3.95% 3.67%
Results by Business
13

-- 16 of 125 --

Analysis of Barclays International
Corporate and Investment Bank Half year ended Half year ended
30.06.21 30.06.20
Income statement information £m £m % Change
Net interest income 640 669 (4)
Net trading income 3,411 4,043 (16)
Net fee, commission and other income 2,522 2,221 14
Total income 6,573 6,933 (5)
Credit impairment releases/(charges) 272 (1,320)
Net operating income 6,845 5,613 22
Operating expenses (3,509) (3,370) (4)
Litigation and conduct (2) (3) 33
Total operating expenses (3,511) (3,373) (4)
Other net income 1 3 (67)
Profit before tax 3,335 2,243 49
Attributable profit 2,312 1,514 53
As at 30.06.21 As at 31.12.20 As at 30.06.20
Balance sheet information £bn £bn £bn
Loans and advances at amortised cost 91.0 92.4 104.9
Trading portfolio assets 147.0 127.5 109.3
Derivative financial instrument assets 255.3 301.7 306.7
Financial assets at fair value through the income statement 190.3 170.4 153.7
Cash collateral and settlement balances 107.7 96.7 129.7
Other assets 192.5 194.9 205.5
Total assets 983.8 983.6 1,009.8
Deposits at amortised cost 178.2 175.2 173.9
Derivative financial instrument liabilities 246.8 300.3 307.6
Risk weighted assets 194.3 192.2 198.3
Half year ended Half year ended
Performance measures 30.06.21 30.06.20
Return on average allocated equity 16.3% 10.9%
Return on average allocated tangible equity 16.3% 11.0%
Average allocated equity (£bn) 28.3 27.7
Average allocated tangible equity (£bn) 28.3 27.7
Cost: income ratio 53% 49%
Analysis of total income £m £m % Change
FICC 2,099 3,326 (37)
Equities 1,709 1,238 38
Global Markets1 3,808 4,564 (17)
Advisory 381 239 59
Equity capital markets 469 247 90
Debt capital markets 882 881
Investment Banking fees1 1,732 1,367 27
Corporate lending 244 172 42
Transaction banking 789 830 (5)
Corporate 1,033 1,002 3
Total income 6,573 6,933 (5)
1 Previously labelled as “Markets” and “Banking fees”.
Results by Business
14

-- 17 of 125 --

Analysis of Barclays International
Consumer, Cards and Payments Half year ended Half year ended
30.06.21 30.06.20
Income statement information £m £m % Change
Net interest income 919 1,176 (22)
Net fee, commission, trading and other income 726 545 33
Total income 1,645 1,721 (4)
Credit impairment releases/(charges) 21 (1,299)
Net operating income 1,666 422
Operating expenses (1,097) (1,035) (6)
Litigation and conduct (82) (8)
Total operating expenses (1,179) (1,043) (13)
Other net income 21 7
Profit/(loss) before tax 508 (614)
Attributable profit/(loss) 386 (517)
As at 30.06.21 As at 31.12.20 As at 30.06.20
Balance sheet information £bn £bn £bn
Loans and advances at amortised cost 30.9 30.3 33.2
Total assets 63.0 58.2 66.0
Deposits at amortised cost 67.2 65.3 67.3
Risk weighted assets 29.0 30.1 32.9
Half year ended Half year ended
Key facts 30.06.21 30.06.20
30 day arrears rate – Barclaycard US 1.6% 2.4%
US cards customer FICO score distribution
<660 10% 14%
>660 90% 86%
Total number of Barclaycard payments clients c.372,000 c.368,000
Value of payments processed (£bn)1 160 156
Performance measures
Return on average allocated equity 16.8% (19.3)%
Return on average allocated tangible equity 19.1% (21.9)%
Average allocated equity (£bn) 4.6 5.4
Average allocated tangible equity (£bn) 4.0 4.7
Cost: income ratio 72% 61%
Loan loss rate (bps) — 714
Half year ended Half year ended
30.06.21 30.06.20
Analysis of total income £m £m % Change
International Cards and Consumer Bank 1,050 1,257 (16)
Private Bank 393 362 9
Unified Payments 202 102 98
Total income 1,645 1,721 (4)
1 Includes £129bn (H120: £124bn) of merchant acquiring payments.
Results by Business
15

-- 18 of 125 --

Barclays International delivered a RoE of 16.4% and a RoTE of 16.7% reflecting the benefits of a diversified business.
CIB delivered a RoE of 16.3% and a RoTE of 16.3% reflecting a strong performance in Equities and Investment Banking
fees, offset by a decrease in FICC against a very strong H120 comparative. CC&P delivered a RoE of 16.8%. CC&P
RoTE improved significantly to 19.1% as a decline in income, reflecting lower cards balances, was more than offset by an
improvement in impairment.
Income statement – H121 compared to H120
• Profit before tax increased 136% to £3,843m with a RoE of 16.4% and a RoTE of 16.7% (H120: 6.2%), reflecting a
RoE of 16.3% (H120: 10.9%) and a RoTE of 16.3% (H120: 11.0%) in CIB and a RoE of 16.8% (H120: (19.3%) and a
RoTE 19.1% (H120: (21.9)%) in CC&P
• The 10% depreciation of average USD against GBP adversely impacted income and profits and positively impacted
total operating expenses
• Total income decreased to £8,218m (H120: £8,654m)
– CIB income decreased 5% to £6,573m
– Global Markets income decreased 17% to £3,808m as a strong performance in Equities, representing the best
ever first half of the year on a comparable basis1, was more than offset by FICC. Equities income increased 38%
to £1,709m driven by derivatives, reflecting strong client activity, and financing through increased client balances.
FICC income decreased 37% to £2,099m due to tighter spreads and the non-recurrence of H120 client activity
levels
– Investment Banking fees income, representing the best ever first half of the year on a comparable basis1,
increased 27% to £1,732m driven by a strong performance in Equity capital markets and Advisory reflecting an
increase in the fee pool and an increased market share2
– Within Corporate, Transaction banking income decreased 5% to £789m as deposit balance growth was more than
offset by margin compression. Corporate lending income increased by 42% to £244m driven by the non-recurrence
of losses on the mark-to-market of lending and related hedge positions partially offset by a current year write-off on
a single name
– CC&P income decreased 4% to £1,645m
– International Cards and Consumer Bank income decreased 16% to £1,050m reflecting lower cards balances
– Private Bank income increased 9% to £393m, which included a gain on a property sale
– Unified Payments income increased 98% to £202m driven by the non-recurrence of a c.£100m valuation loss on
Barclays’ preference shares in Visa Inc. resulting from the Q220 Supreme Court ruling concerning charges paid by
merchants
• Credit impairment net release of £293m (H120: £2,619m charge) was driven by an improved macroeconomic outlook
used in the Q221 scenario refresh
– CIB credit impairment net release of £272m (H120: £1,320m charge), supported by a benign credit risk
environment and limited single name wholesale loan charges
– CC&P credit impairment net release of £21m (H120: £1,299m charge) partially driven by lower delinquencies and
customer repayments. As at 30 June 2021, 30 and 90 day arrears in US cards were 1.6% (H120: 2.4%) and 0.9%
(H120: 1.4%) respectively
• Total operating expenses increased 6% to £4,690m
– CIB total operating expenses increased 4% to £3,511m due to higher performance costs that reflected an
improvement in returns
– CC&P total operating expenses increased 13% to £1,179m driven by the impact of higher investment spend,
including marketing, and customer remediation costs related to a legacy portfolio
Balance sheet – 30 June 2021 compared to 31 December 2020
• Trading portfolio assets increased £19.4bn to £147.1bn due to increased activity
• Derivative financial instruments assets decreased £46.4bn and liabilities decreased £53.5bn to £255.4bn and
£246.9bn respectively, driven by an increase in major interest rate curves
Results by Business
16

-- 19 of 125 --

• Financial assets at fair value through the income statement increased £19.7bn to £190.4bn driven by increased
secured lending
• Cash collateral and settlement balances increased £11.0bn to £108.5bn due to increased client activity
• Deposits at amortised cost increased £4.9bn to £245.4bn due to clients increasing liquidity
• RWAs increased to £223.2bn (December 2020: £222.3bn) primarily due to increased client and trading activity within
CIB, partially offset by the depreciation of period end EUR and USD against GBP
1 Period covering Q114 – Q221. Pre 2014 financials were not restated following re-segmentation in Q116.
2 Data source: Dealogic for the period covering 1 January to 30 June 2021.
Results by Business
17

-- 20 of 125 --

Head Office Half year ended Half year ended
30.06.21 30.06.20
Income statement information £m £m % Change
Net interest income (242) (259) 7
Net fee, commission and other income 140 55
Total income (102) (204) 50
Credit impairment releases/(charges) 6 (55)
Net operating income (96) (259) 63
Operating expenses (412) (117)
Litigation and conduct 7 (8)
Total operating expenses (405) (125)
Other net income/(expenses) 131 (41)
Loss before tax (370) (425) 13
Attributable profit/(loss) 95 (354)
As at 30.06.21 As at 31.12.20 As at 30.06.20
Balance sheet information £bn £bn £bn
Total assets 18.3 18.6 21.7
Risk weighted assets 11.1 10.2 9.9
Half year ended Half year ended
Performance measures 30.06.21 30.06.20
Average allocated equity (£bn) 8.0 9.9
Average allocated tangible equity (£bn) 4.3 6.0
Income statement – H121 compared to H120
• Loss before tax was £370m (H120: £425m)
• Total income was an expense of £102m (H120: £204m), which primarily reflected hedge accounting, funding costs on
legacy capital instruments and treasury items, partially offset by mark-to-market gains on legacy investments
• Credit impairment net release of £6m (H120: £55m charge) was driven by an improved macroeconomic outlook used
in the Q221 scenario refresh, resulting in a provision release for the Italian home loan portfolio
• Total operating expenses were £405m (H120: £125m), which included a charge of £266m relating to structural cost
actions taken as part of the real estate review
• Other net income was £131m (H120: £41m expense) driven by a fair value gain in Barclays’ associate investment
holding in the Business Growth Fund
Balance sheet – 30 June 2021 compared to 31 December 2020
• RWAs were £11.1bn (December 2020: £10.2bn)
Results by Business
18

-- 21 of 125 --

Barclays Group
Q221 Q121 Q420 Q320 Q220 Q120 Q419 Q319
Income statement information £m £m £m £m £m £m £m £m
Net interest income 2,052 1,851 1,845 2,055 1,892 2,331 2,344 2,445
Net fee, commission and other income 3,363 4,049 3,096 3,149 3,446 3,952 2,957 3,096
Total income 5,415 5,900 4,941 5,204 5,338 6,283 5,301 5,541
Credit impairment releases/(charges) 797 (55) (492) (608) (1,623) (2,115) (523) (461)
Net operating income 6,212 5,845 4,449 4,596 3,715 4,168 4,778 5,080
Operating costs (3,587) (3,545) (3,480) (3,391) (3,310) (3,253) (3,308) (3,293)
UK bank levy — — (299) — — — (226) —
Litigation and conduct (66) (33) (47) (76) (20) (10) (167) (1,568)
Total operating expenses (3,653) (3,578) (3,826) (3,467) (3,330) (3,263) (3,701) (4,861)
Other net income/(expenses) 21 132 23 18 (26) 8 20 27
Profit before tax 2,580 2,399 646 1,147 359 913 1,097 246
Tax charge (263) (496) (163) (328) (42) (71) (189) (269)
Profit/(loss) after tax 2,317 1,903 483 819 317 842 908 (23)
Non-controlling interests (15) (4) (37) (4) (21) (16) (42) (4)
Other equity instrument holders (194) (195) (226) (204) (206) (221) (185) (265)
Attributable profit/(loss) 2,108 1,704 220 611 90 605 681 (292)
Performance measures
Return on average shareholders' equity 15.5% 12.5% 1.6% 4.3% 0.6% 4.4% 5.0% (2.1)%
Return on average tangible shareholders' equity 18.1% 14.7% 1.8% 5.1% 0.7% 5.1% 5.9% (2.4)%
Average shareholders' equity 54.4 54.4 55.7 56.4 58.4 55.2 54.5 56.4
Average tangible shareholders' equity (£bn) 46.5 46.5 47.6 48.3 50.2 47.0 46.4 48.4
Cost: income ratio 67% 61% 77% 67% 62% 52% 70% 88%
Loan loss rate (bps) — 6 56 69 179 223 60 52
Basic earnings/(loss) per share 12.3p 9.9p 1.3p 3.5p 0.5p 3.5p 3.9p (1.7)p
Basic weighted average number of shares (m) 17,140 17,293 17,300 17,298 17,294 17,278 17,200 17,192
Period end number of shares (m) 16,998 17,223 17,359 17,353 17,345 17,332 17,322 17,269
Balance sheet and capital management1 £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances at amortised cost 348.5 345.8 342.6 344.4 354.9 374.1 339.1 345.1
Loans and advances at amortised cost impairment
coverage ratio 1.8% 2.2% 2.4% 2.5% 2.5% 2.1% 1.8% 1.9%
Total assets 1,376.3 1,379.7 1,349.5 1,421.7 1,385.1 1,444.3 1,140.2 1,290.4
Deposits at amortised cost 500.9 498.8 481.0 494.6 466.9 470.7 415.8 420.6
Net asset value per share 329p 312p 315p 322p 331p 332p 309p 320p
Tangible net asset value per share 281p 267p 269p 275p 284p 284p 262p 274p
Common equity tier 1 ratio 15.1% 14.6% 15.1% 14.6% 14.2% 13.1% 13.8% 13.4%
Common equity tier 1 capital 46.2 45.9 46.3 45.5 45.4 42.5 40.8 41.9
Risk weighted assets 306.4 313.4 306.2 310.7 319.0 325.6 295.1 313.3
Average UK leverage ratio 4.8% 4.9% 5.0% 5.1% 4.7% 4.5% 4.5% 4.6%
Average UK leverage exposure 1,192.0 1,174.9 1,146.9 1,111.1 1,148.7 1,176.2 1,142.8 1,171.2
UK leverage ratio 5.0% 5.0% 5.3% 5.2% 5.2% 4.5% 5.1% 4.8%
UK leverage exposure 1,153.6 1,145.4 1,090.9 1,095.1 1,071.1 1,178.7 1,007.7 1,099.8
Funding and liquidity
Group liquidity pool (£bn) 291 290 266 327 298 237 211 226
Liquidity coverage ratio 162% 161% 162% 181% 186% 155% 160% 151%
Loan: deposit ratio 70% 69% 71% 70% 76% 79% 82% 82%
1 Refer to pages 54 to 61 for further information on how capital, RWAs and leverage are calculated.
Quarterly Results by Business
19

-- 22 of 125 --

Barclays UK
Q221 Q121 Q420 Q320 Q220 Q120 Q419 Q319
Income statement information £m £m £m £m £m £m £m £m
Net interest income 1,305 1,281 1,317 1,280 1,225 1,412 1,478 1,503
Net fee, commission and other income 318 295 309 270 242 292 481 343
Total income 1,623 1,576 1,626 1,550 1,467 1,704 1,959 1,846
Credit impairment releases/(charges) 520 (77) (170) (233) (583) (481) (190) (101)
Net operating income 2,143 1,499 1,456 1,317 884 1,223 1,769 1,745
Operating costs (1,078) (1,036) (1,134) (1,095) (1,018) (1,023) (1,023) (952)
UK bank levy — — (50) — — — (41) —
Litigation and conduct (19) (3) 4 (25) (6) (5) (58) (1,480)
Total operating expenses (1,097) (1,039) (1,180) (1,120) (1,024) (1,028) (1,122) (2,432)
Other net income/(expenses) — — 6 (1) 13 — — —
Profit/(loss) before tax 1,046 460 282 196 (127) 195 647 (687)
Attributable profit/(loss) 721 298 160 113 (123) 175 438 (907)
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances to customers at amortised cost 207.8 205.7 205.4 203.9 202.0 195.7 193.7 193.2
Total assets 311.2 309.1 289.1 294.5 287.6 267.5 257.8 257.9
Customer deposits at amortised cost 255.5 247.5 240.5 232.0 225.7 207.5 205.5 203.3
Loan: deposit ratio 87% 88% 89% 91% 92% 96% 96% 97%
Risk weighted assets 72.2 72.7 73.7 76.2 77.9 77.7 74.9 76.8
Performance measures
Return on average allocated equity 21.4% 8.8% 4.8% 3.3% (3.6)% 5.1% 12.7% (26.1)%
Return on average allocated tangible equity 29.1% 12.0% 6.5% 4.5% (4.8)% 6.9% 17.0% (34.9)%
Average allocated equity (£bn) 13.5 13.5 13.4 13.7 13.9 13.7 13.8 13.9
Average allocated tangible equity (£bn) 9.9 9.9 9.8 10.1 10.3 10.1 10.3 10.4
Cost: income ratio 68% 66% 73% 72% 70% 60% 57% 132%
Loan loss rate (bps) — 14 31 43 111 96 38 20
Net interest margin 2.55% 2.54% 2.56% 2.51% 2.48% 2.91% 3.03% 3.10%
Quarterly Results by Business
20

-- 23 of 125 --

Analysis of Barclays UK Q221 Q121 Q420 Q320 Q220 Q120 Q419 Q319
Analysis of total income £m £m £m £m £m £m £m £m
Personal Banking 987 923 895 833 826 968 1,064 1,035
Barclaycard Consumer UK 290 315 354 362 367 436 533 472
Business Banking 346 338 377 355 274 300 362 339
Total income 1,623 1,576 1,626 1,550 1,467 1,704 1,959 1,846
Analysis of credit impairment releases/(charges)
Personal Banking 72 (22) (68) (48) (130) (134) (71) (36)
Barclaycard Consumer UK 434 (36) (78) (106) (396) (301) (108) (49)
Business Banking 14 (19) (24) (79) (57) (46) (11) (16)
Total credit impairment releases/(charges) 520 (77) (170) (233) (583) (481) (190) (101)
Analysis of loans and advances to customers at
amortised cost £bn £bn £bn £bn £bn £bn £bn £bn
Personal Banking 162.4 160.4 157.3 155.7 154.9 153.4 151.9 150.1
Barclaycard Consumer UK 8.8 8.7 9.9 10.7 11.5 13.6 14.7 14.9
Business Banking 36.6 36.6 38.2 37.5 35.6 28.7 27.1 28.2
Total loans and advances to customers at
amortised cost 207.8 205.7 205.4 203.9 202.0 195.7 193.7 193.2
Analysis of customer deposits at amortised cost
Personal Banking 191.0 186.0 179.7 173.2 169.6 161.4 159.2 157.9
Barclaycard Consumer UK 0.1 0.1 0.1 0.1 0.1 — — —
Business Banking 64.4 61.4 60.7 58.7 56.0 46.1 46.3 45.4
Total customer deposits at amortised cost 255.5 247.5 240.5 232.0 225.7 207.5 205.5 203.3
Quarterly Results by Business
21

-- 24 of 125 --

Barclays International
Q221 Q121 Q420 Q320 Q220 Q120 Q419 Q319
Income statement information £m £m £m £m £m £m £m £m
Net interest income 811 748 614 823 847 998 965 1,059
Net trading income 1,455 1,934 1,372 1,528 1,660 2,360 929 1,110
Net fee, commission and other income 1,553 1,717 1,500 1,430 1,503 1,286 1,558 1,581
Total income 3,819 4,399 3,486 3,781 4,010 4,644 3,452 3,750
Credit impairment releases/(charges) 271 22 (291) (370) (1,010) (1,609) (329) (352)
Net operating income 4,090 4,421 3,195 3,411 3,000 3,035 3,123 3,398
Operating costs (2,168) (2,438) (2,133) (2,227) (2,186) (2,219) (2,240) (2,282)
UK bank levy — — (240) — — — (174) —
Litigation and conduct (63) (21) (9) (28) (11) — (86) —
Total operating expenses (2,231) (2,459) (2,382) (2,255) (2,197) (2,219) (2,500) (2,282)
Other net income 13 9 9 9 4 6 17 21
Profit before tax 1,872 1,971 822 1,165 807 822 640 1,137
Attributable profit 1,267 1,431 441 782 468 529 397 799
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances at amortised cost 121.9 123.5 122.7 128.0 138.1 167.0 132.8 138.1
Trading portfolio assets 147.1 131.1 127.7 122.3 109.5 101.6 113.3 119.4
Derivative financial instrument assets 255.4 269.4 301.8 295.9 306.8 341.5 228.9 286.0
Financial assets at fair value through the income
statement 190.4 197.5 170.7 178.2 154.3 188.4 128.4 158.0
Cash collateral and settlement balances 108.5 109.7 97.5 121.8 130.8 153.2 79.4 112.5
Other assets 223.5 221.7 221.4 261.7 236.3 201.5 178.6 195.6
Total assets 1,046.8 1,052.9 1,041.8 1,107.9 1,075.8 1,153.2 861.4 1,009.6
Deposits at amortised cost 245.4 251.2 240.5 262.4 241.2 263.3 210.0 217.6
Derivative financial instrument liabilities 246.9 260.2 300.4 293.3 307.6 338.8 228.9 283.3
Loan: deposit ratio 50% 49% 51% 49% 57% 63% 63% 63%
Risk weighted assets 223.2 230.0 222.3 224.7 231.2 237.9 209.2 223.1
Performance measures
Return on average allocated equity 15.4% 17.4% 5.7% 10.0% 5.5% 6.6% 5.0% 9.6%
Return on average allocated tangible equity 15.6% 17.7% 5.8% 10.2% 5.6% 6.8% 5.1% 9.9%
Average allocated equity (£bn) 33.0 32.8 31.1 31.2 34.2 31.9 31.9 33.3
Average allocated tangible equity (£bn) 32.4 32.3 30.5 30.6 33.5 31.2 30.9 32.2
Cost: income ratio 58% 56% 68% 60% 55% 48% 72% 61%
Loan loss rate (bps) — (7) 90 112 284 377 96 99
Net interest margin 3.96% 3.92% 3.41% 3.79% 3.43% 3.93% 4.29% 4.10%
Quarterly Results by Business
22

-- 25 of 125 --

Analysis of Barclays International
Corporate and Investment Bank Q221 Q121 Q420 Q320 Q220 Q120 Q419 Q319
Income statement information £m £m £m £m £m £m £m £m
Net interest income 370 270 110 305 334 335 248 339
Net trading income 1,494 1,917 1,397 1,535 1,812 2,231 951 1,126
Net fee, commission and other income 1,115 1,407 1,131 1,065 1,170 1,051 1,115 1,152
Total income 2,979 3,594 2,638 2,905 3,316 3,617 2,314 2,617
Credit impairment releases/(charges) 229 43 (52) (187) (596) (724) (30) (31)
Net operating income 3,208 3,637 2,586 2,718 2,720 2,893 2,284 2,586
Operating costs (1,623) (1,886) (1,603) (1,716) (1,680) (1,690) (1,691) (1,712)
UK bank levy — — (226) — — — (156) —
Litigation and conduct (1) (1) 2 (3) (3) — (79) (4)
Total operating expenses (1,624) (1,887) (1,827) (1,719) (1,683) (1,690) (1,926) (1,716)
Other net income — 1 2 1 3 — 1 12
Profit before tax 1,584 1,751 761 1,000 1,040 1,203 359 882
Attributable profit 1,049 1,263 413 627 694 820 193 609
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances at amortised cost 91.0 94.3 92.4 96.8 104.9 128.2 92.0 95.8
Trading portfolio assets 147.0 130.9 127.5 122.2 109.3 101.5 113.3 119.3
Derivative financial instruments assets 255.3 269.4 301.7 295.9 306.7 341.4 228.8 286.0
Financial assets at fair value through the income
statement 190.3 197.3 170.4 177.9 153.7 187.8 127.7 157.3
Cash collateral and settlement balances 107.7 108.8 96.7 121.0 129.7 152.2 78.5 111.6
Other assets 192.5 190.8 194.9 228.9 205.5 171.4 155.3 171.5
Total assets 983.8 991.5 983.6 1,042.7 1,009.8 1,082.5 795.6 941.5
Deposits at amortised cost 178.2 185.2 175.2 195.6 173.9 198.4 146.2 152.1
Derivative financial instrument liabilities 246.8 260.2 300.3 293.2 307.6 338.7 228.9 283.2
Risk weighted assets 194.3 201.3 192.2 193.3 198.3 201.7 171.5 184.9
Performance measures
Return on average allocated equity 14.8% 17.9% 6.3% 9.5% 9.5% 12.5% 3.0% 9.1%
Return on average allocated tangible equity 14.8% 17.9% 6.3% 9.5% 9.6% 12.5% 3.0% 9.1%
Average allocated equity (£bn) 28.4 28.2 26.3 26.4 29.1 26.2 25.9 26.9
Average allocated tangible equity (£bn) 28.4 28.2 26.3 26.4 29.0 26.2 25.8 26.9
Cost: income ratio 55% 53% 69% 59% 51% 47% 83% 66%
Analysis of total income £m £m £m £m £m £m £m £m
FICC 895 1,204 812 1,000 1,468 1,858 726 816
Equities 777 932 542 691 674 564 409 494
Global Markets1 1,672 2,136 1,354 1,691 2,142 2,422 1,135 1,310
Advisory 218 163 232 90 84 155 202 221
Equity capital markets 226 243 104 122 185 62 56 86
Debt capital markets 429 453 418 398 463 418 322 381
Investment Banking fees1 873 859 754 610 732 635 580 688
Corporate lending 38 206 186 232 61 111 202 195
Transaction banking 396 393 344 372 381 449 397 424
Corporate 434 599 530 604 442 560 599 619
Total income 2,979 3,594 2,638 2,905 3,316 3,617 2,314 2,617
1 Previously labelled as “Markets” and “Banking fees”.
Quarterly Results by Business
23

-- 26 of 125 --

Analysis of Barclays International
Consumer, Cards and Payments Q221 Q121 Q420 Q320 Q220 Q120 Q419 Q319
Income statement information £m £m £m £m £m £m £m £m
Net interest income 441 478 504 518 513 663 717 720
Net fee, commission, trading and other income 399 327 344 358 181 364 421 413
Total income 840 805 848 876 694 1,027 1,138 1,133
Credit impairment releases/(charges) 42 (21) (239) (183) (414) (885) (299) (321)
Net operating income 882 784 609 693 280 142 839 812
Operating costs (545) (552) (530) (511) (506) (529) (549) (570)
UK bank levy — — (14) — — — (18) —
Litigation and conduct (62) (20) (11) (25) (8) — (7) 4
Total operating expenses (607) (572) (555) (536) (514) (529) (574) (566)
Other net income 13 8 7 8 1 6 16 9
Profit/(loss) before tax 288 220 61 165 (233) (381) 281 255
Attributable profit/(loss) 218 168 28 155 (226) (291) 204 190
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances at amortised cost 30.9 29.2 30.3 31.2 33.2 38.8 40.8 42.3
Total assets 63.0 61.4 58.2 65.2 66.0 70.7 65.8 68.1
Deposits at amortised cost 67.2 66.0 65.3 66.8 67.3 64.9 63.8 65.5
Risk weighted assets 29.0 28.8 30.1 31.4 32.9 36.2 37.7 38.2
Performance measures
Return on average allocated equity 19.0% 14.6% 2.4% 12.9% (17.7)% (20.7)% 13.6% 11.8%
Return on average allocated tangible equity 21.8% 16.5% 2.7% 14.7% (20.2)% (23.5)% 15.9% 14.2%
Average allocated equity (£bn) 4.6 4.6 4.8 4.8 5.1 5.7 6.0 6.4
Average allocated tangible equity (£bn) 4.0 4.1 4.2 4.2 4.5 5.0 5.1 5.3
Cost: income ratio 72% 71% 65% 61% 74% 52% 50% 50%
Loan loss rate (bps) — 27 286 211 455 846 273 283
Head Office
Q221 Q121 Q420 Q320 Q220 Q120 Q419 Q319
Income statement information £m £m £m £m £m £m £m £m
Net interest income (64) (178) (86) (48) (180) (79) (99) (117)
Net fee, commission and other income 37 103 (85) (79) 41 14 (11) 62
Total income (27) (75) (171) (127) (139) (65) (110) (55)
Credit impairment releases/(charges) 6 — (31) (5) (30) (25) (4) (8)
Net operating expenses (21) (75) (202) (132) (169) (90) (114) (63)
Operating costs (341) (71) (213) (69) (106) (11) (45) (59)
UK bank levy — — (9) — — — (11) —
Litigation and conduct 16 (9) (42) (23) (3) (5) (23) (88)
Total operating expenses (325) (80) (264) (92) (109) (16) (79) (147)
Other net income/(expenses) 8 123 8 10 (43) 2 3 6
Loss before tax (338) (32) (458) (214) (321) (104) (190) (204)
Attributable profit/(loss) 120 (25) (381) (284) (255) (99) (154) (184)
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Total assets 18.3 17.7 18.6 19.3 21.7 23.6 21.0 22.9
Risk weighted assets 11.1 10.7 10.2 9.8 9.9 10.0 11.0 13.4
Performance measures
Average allocated equity (£bn) 7.9 8.1 11.2 11.5 10.3 9.6 8.8 9.2
Average allocated tangible equity (£bn) 4.2 4.3 7.3 7.6 6.4 5.6 5.2 5.8
Quarterly Results by Business
24

-- 27 of 125 --

Margins and balances
Half year ended 30.06.21 Half year ended 30.06.20
Net interest
income
Average
customer
assets
Net interest
margin
Net interest
income
Average
customer
assets
Net interest
margin
£m £m % £m £m %
Barclays UK 2,586 204,930 2.54 2,637 197,023 2.69
Barclays International1,2 1,518 77,413 3.95 1,848 101,286 3.67
Total Barclays UK and Barclays International 4,104 282,343 2.93 4,485 298,309 3.02
Other3 (201) (262)
Total Barclays Group 3,903 4,223
1 Barclays International margins include IEL balances within the investment banking business.
2 Barclays amended the presentation of the premium paid for purchased financial guarantees which are embedded in notes it issues directly to the market
in Q420 from net investment income to interest expense within net interest income. Had the equivalent H120 interest expense been recognised in net
interest income, the Barclays International and Total Barclays UK and Barclays International NIMs would have been 3.57% and 2.99% respectively.
3 Other includes Head Office and non-lending related investment banking businesses not included in Barclays International margins.
The Group’s combined product and equity structural hedge notional as at 30 June 2021 was £198bn (June 2020:
£174bn), with an average duration of close to 3 years (2020: average duration 2.5 to 3 years). Group net interest income
includes gross structural hedge contributions of £689m (H120: £866m) and net structural hedge contributions of £592m
(H120: £555m). Gross structural hedge contributions represent the absolute level of interest earned from the fixed
receipts on the basket of swaps in the structural hedge, while the net structural hedge contributions represent the net
interest earned on the difference between the structural hedge rate and prevailing floating rates.
The Group net interest margin decreased 9bps to 2.93%. Barclays UK net interest margin decreased 15bps to 2.54%
reflecting lower unsecured lending balances and lower UK rates, partially offset by strong mortgage retention at improved
margins. Average customer assets increased due to growth from government scheme lending and strong mortgage
growth. Barclays International net interest margin increased 28bps to 3.95% driven by changes in product mix and lower
average customer assets.
Quarterly analysis for Barclays UK and Barclays International
Net interest
income
Average
customer
assets Net interest
margin
Three months ended 30.06.21 £m £m %
Barclays UK 1,305 205,168 2.55
Barclays International1 763 77,330 3.96
Total Barclays UK and Barclays International 2,068 282,498 2.94
Three months ended 31.03.21
Barclays UK 1,281 204,663 2.54
Barclays International1 755 78,230 3.92
Total Barclays UK and Barclays International 2,036 282,893 2.92
Three months ended 31.12.20
Barclays UK 1,317 204,315 2.56
Barclays International1,2 696 81,312 3.41
Total Barclays UK and Barclays International 2,013 285,627 2.80
Three months ended 30.09.20
Barclays UK 1,280 203,089 2.51
Barclays International1,2 838 88,032 3.79
Total Barclays UK and Barclays International 2,118 291,121 2.89
Three months ended 30.06.20
Barclays UK 1,225 199,039 2.48
Barclays International1,2 868 101,706 3.43
Total Barclays UK and Barclays International 2,093 300,745 2.80
1 Barclays International margins include IEL balances within the investment banking business.
2 The reclassification of expense of the premium paid for purchased financial guarantees from net investment income to net interest income was
recognised in full in Q420 and resulted in a 0.48% reduction on the Q420 Barclays International NIM and 0.14% reduction on the Q420 Total Barclays
UK and Barclays International NIM. Had the equivalent impact been reflected in the respective quarters, the Barclays International NIM would have
been 3.33% in Q220, 3.68% in Q320 and 3.77% in Q420. Total Barclays UK and Barclays International NIMs would have been 2.77% in Q220, 2.86% in
Q320 and 2.91% in Q420 respectively.
Performance Management
25

-- 28 of 125 --

Risk management and principal risks
The roles and responsibilities of the business groups, Risk and Compliance, in the management of risk in the Group are
defined in the Enterprise Risk Management Framework. The purpose of the framework is to identify the principal risks of
the Group, the process by which the Group sets its appetite for these risks in its business activities, and the consequent
limits which it places on related risk taking.
The framework identifies eight principal risks: credit risk, market risk, treasury and capital risk, operational risk, model risk,
conduct risk, reputation risk and legal risk. Further detail on these risks and how they are managed is available in the
Barclays PLC Annual Report 2020 (pages 145 to 166) or online at home.barclays/annualreport.
Material existing and emerging risks
There have been no significant changes to these principal risks or previously identified material existing and emerging
risks in the period other than an update to the risk relating to the impact of benchmark interest rates on the Group as a
result of developments relating to benchmark reform, as set out below.
Impact of benchmark interest rate reforms on the Group
For several years, global regulators and central banks have been driving international efforts to reform key benchmark
interest rates and indices, such as the London Interbank Offered Rate (LIBOR), which are used to determine the amounts
payable under a wide range of transactions and make them more reliable and robust. This has resulted in significant
changes to the methodology and operation of certain benchmarks and indices, the adoption of alternative ‘risk-free’
reference rates (RFRs) and the proposed discontinuation of certain reference rates (including LIBOR), with further
changes anticipated, including UK, EU and US legislative proposals to deal with ‘tough legacy’ contracts that cannot
convert into or cannot add fall-back RFRs. The consequences of reform are unpredictable and may have an adverse
impact on any financial instruments linked to, or referencing, any of these benchmark interest rates.
Uncertainty as to the nature of such potential changes, the availability and/or suitability of alternative RFRs, the
participation of customers and third-party market participants in the transition process and associated challenges with
respect to required documentation changes, and other reforms may adversely affect a broad range of transactions
(including any securities, loans and derivatives which use LIBOR to determine the amount of interest payable that are
included in the Group’s financial assets and liabilities) that use these reference rates and indices and introduce a number
of risks for the Group, including, but not limited to:
• Conduct risk: in undertaking actions to transition away from using certain reference rates (such as LIBOR) to new
alternative RFRs, the Group faces conduct risks. These may lead to customer complaints, regulatory sanctions or
reputational impact if the Group is considered to be (among other things) (i) undertaking market activities that are
manipulative or create a false or misleading impression, (ii) misusing sensitive information or not identifying or
appropriately managing or mitigating conflicts of interest, (iii) providing customers with inadequate advice, misleading
information, unsuitable products or unacceptable service, (iv) not taking a consistent approach to remediation for
customers in similar circumstances, (v) unduly delaying the communication and migration activities in relation to client
exposure, leaving them insufficient time to prepare, or (vi) colluding or inappropriately sharing information with
competitors
• Litigation risk: members of the Group may face legal proceedings, regulatory investigations and/or other actions or
proceedings regarding (among other things) (i) the conduct risks identified above, (ii) the interpretation and
enforceability of provisions in LIBOR-based contracts, and (iii) the Group’s preparation and readiness for the
replacement of LIBOR with alternative RFRs
• Financial risk: the valuation of certain of the Group’s financial assets and liabilities may change. Moreover,
transitioning to alternative RFRs may impact the ability of members of the Group to calculate and model amounts
receivable by them on certain financial assets and determine the amounts payable on certain financial liabilities (such
as debt securities issued by them) because currently alternative RFRs (such as the Sterling Overnight Index Average
(SONIA) and the Secured Overnight Financing Rate (SOFR)) are look-back rates whereas term rates (such as LIBOR)
allow borrowers to calculate at the start of any interest period exactly how much is payable at the end of such interest
period. This may have a material adverse effect on the Group’s cash flows
• Pricing risk: changes to existing reference rates and indices, discontinuation of any reference rate or indices and
transition to alternative RFRs may impact the pricing mechanisms used by the Group on certain transactions
Risk Management
26

-- 29 of 125 --

• Operational risk: changes to existing reference rates and indices, discontinuation of any reference rate or index and
transition to alternative RFRs may require changes to the Group’s IT systems, trade reporting infrastructure,
operational processes, and controls. In addition, if any reference rate or index (such as LIBOR) is no longer available
to calculate amounts payable, the Group may incur additional expenses in amending documentation for new and
existing transactions and/or effecting the transition from the original reference rate or index to a new reference rate or
index
• Accounting risk: an inability to apply hedge accounting in accordance with IAS 39 could lead to increased volatility in
the Group’s financial results and performance
Any of these factors may have a material adverse effect on the Group’s business, results of operations, financial condition
and prospects.
For further details on the impacts of benchmark interest rate reforms on the Group, see Note 41 to Barclays PLC’s
audited financial statements for the year ended 31 December 2020 and Note 23.
Risk Management
27

-- 30 of 125 --

Loans and advances at amortised cost by stage
The table below presents an analysis of loans and advances at amortised cost by gross exposure, impairment allowance,
impairment charge and coverage ratio by stage allocation and business segment as at 30 June 2021. Also included are
off-balance sheet loan commitments and financial guarantee contracts by gross exposure, impairment allowance and
coverage ratio by stage allocation as at 30 June 2021.
Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail
portfolios, the total impairment allowance is allocated to the drawn exposure to the extent that the allowance does not
exceed the exposure, as ECL is not reported separately. Any excess is reported on the liability side of the balance sheet
as a provision. For wholesale portfolios, the impairment allowance on the undrawn exposure is reported on the liability
side of the balance sheet as a provision.
Gross exposure Impairment allowance Net
exposure	Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
As at 30.06.21 £m £m £m £m £m £m £m £m £m
Barclays UK 158,587 23,576 2,715 184,878 313 1,035 944 2,292 182,586
Barclays International 23,286 2,886 1,760 27,932 575 781 1,004 2,360 25,572
Head Office 4,003 502 760 5,265 3 39 358 400 4,865
Total Barclays Group retail 185,876 26,964 5,235 218,075 891 1,855 2,306 5,052 213,023
Barclays UK 36,069 1,727 1,081 38,877 63 49 89 201 38,676
Barclays International 82,515 13,617 1,425 97,557 231 329 673 1,233 96,324
Head Office 522 3 32 557 — — 31 31 526
Total Barclays Group wholesale1 119,106 15,347 2,538 136,991 294 378 793 1,465 135,526
Total loans and advances at
amortised cost 304,982 42,311 7,773 355,066 1,185 2,233 3,099 6,517 348,549
Off-balance sheet loan
commitments and financial
guarantee contracts2
298,150 45,696 664 344,510 228 436 49 713 343,797
Total3 603,132 88,007 8,437 699,576 1,413 2,669 3,148 7,230 692,346
As at 30.06.21 Half year ended 30.06.21
Coverage ratio Loan impairment release and loan
loss rate
Stage 1 Stage 2 Stage 3 Total Loan impairment
release Loan loss rate
% % % % £m bps
Barclays UK 0.2 4.4 34.8 1.2 (259) —
Barclays International 2.5 27.1 57.0 8.4 (19) —
Head Office 0.1 7.8 47.1 7.6 (6) —
Total Barclays Group retail 0.5 6.9 44.0 2.3 (284) —
Barclays UK 0.2 2.8 8.2 0.5 (23) —
Barclays International 0.3 2.4 47.2 1.3 (75) —
Head Office — — 96.9 5.6 — —
Total Barclays Group wholesale1 0.2 2.5 31.2 1.1 (98) —
Total loans and advances at
amortised cost 0.4 5.3 39.9 1.8 (382) —
Off-balance sheet loan
commitments and financial
guarantee contracts2 0.1 1.0 7.4 0.2 (343)
Other financial assets subject to
impairment3 (17)
Total 0.2 3.0 37.3 1.0 (742)
1 Includes Wealth and Private Banking exposures measured on an individual basis, and excludes Business Banking exposures that are managed on a
collective basis. The net impact is a difference in total exposure of £7,796m of balances reported as wholesale loans on page 30 in the Loans and
advances at amortised cost by product disclosure.
2 Excludes loan commitments and financial guarantees of £21bn carried at fair value.
3 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair
value through other comprehensive income and other assets. These have a total gross exposure of £186.0bn and impairment allowance of £114m.
This comprises £9m ECL on £185.8bn Stage 1 assets, £3m on £58m Stage 2 fair value through other comprehensive income assets, cash collateral
and settlement balances and £102m on £109m Stage 3 other assets.
Credit Risk
28

-- 31 of 125 --

Gross exposure Impairment allowance Net
exposure	Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
As at 31.12.20 £m £m £m £m £m £m £m £m £m
Barclays UK 153,250 23,896 2,732 179,878 332 1,509 1,147 2,988 176,890
Barclays International1 21,048 5,500 1,992 28,540 396 1,329 1,205 2,930 25,610
Head Office 4,267 720 844 5,831 4 51 380 435 5,396
Total Barclays Group retail 178,565 30,116 5,568 214,249 732 2,889 2,732 6,353 207,896
Barclays UK 31,918 4,325 1,126 37,369 13 129 116 258 37,111
Barclays International1 79,911 16,565 2,270 98,746 288 546 859 1,693 97,053
Head Office 570 — 33 603 — — 31 31 572
Total Barclays Group wholesale2 112,399 20,890 3,429 136,718 301 675 1,006 1,982 134,736
Total loans and advances at
amortised cost 290,964 51,006 8,997 350,967 1,033 3,564 3,738 8,335 342,632
Off-balance sheet loan
commitments and financial
guarantee contracts3
289,939 52,891 2,330 345,160 256 758 50 1,064 344,096
Total4 580,903 103,897 11,327 696,127 1,289 4,322 3,788 9,399 686,728
As at 31.12.20 Year ended 31.12.20
Coverage ratio
Loan impairment charge and loan
loss rate5
Stage 1 Stage 2 Stage 3 Total Loan impairment
charge Loan loss rate
% % % % £m bps
Barclays UK 0.2 6.3 42.0 1.7 1,070 59
Barclays International1 1.9 24.2 60.5 10.3 1,680 589
Head Office 0.1 7.1 45.0 7.5 91 156
Total Barclays Group retail 0.4 9.6 49.1 3.0 2,841 133
Barclays UK — 3.0 10.3 0.7 154 41
Barclays International1 0.4 3.3 37.8 1.7 914 93
Head Office — — 93.9 5.1 — —
Total Barclays Group wholesale2 0.3 3.2 29.3 1.4 1,068 78
Total loans and advances at
amortised cost 0.4 7.0 41.5 2.4 3,909 111
Off-balance sheet loan
commitments and financial
guarantee contracts3 0.1 1.4 2.1 0.3 776
Other financial assets subject to
impairment4 153
Total5 0.2 4.2 33.4 1.4 4,838
1 Private Banking have refined the methodology to classify £5bn of their exposure between Wholesale and Retail during the year.
2 Includes Wealth and Private Banking exposures measured on an individual basis, and excludes Business Banking exposures that are managed on a
collective basis. The net impact is a difference in total exposure of £7,551m of balances reported as wholesale loans on page 30 in the Loans and
advances at amortised cost by product disclosure.
3 Excludes loan commitments and financial guarantees of £9.5bn carried at fair value.
4 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair
value through other comprehensive income and other assets. These have a total gross exposure of £180.3bn and impairment allowance of £165m.
This comprises £11m ECL on £175.7bn Stage 1 assets, £9m on £4.4bn Stage 2 fair value through other comprehensive income assets,other assets
and cash collateral and settlement balances and £145m on £154m Stage 3 other assets.
5 The loan loss rate is 138 bps after applying the total impairment charge of £4,838m.
Credit Risk
29

-- 32 of 125 --

Loans and advances at amortised cost by product
The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with
stage allocation by asset classification.
Stage 2
As at 30.06.21 Stage 1 Not past
due
<=30
days
past due >30 days
past due Total Stage 3 Total
Gross exposure £m £m £m £m £m £m £m
Home loans 144,103 17,991 1,666 823 20,480 2,235 166,818
Credit cards, unsecured loans and other retail lending 34,537 5,642 300 209 6,151 2,773 43,461
Wholesale loans 126,342 14,760 529 391 15,680 2,765 144,787
Total 304,982 38,393 2,495 1,423 42,311 7,773 355,066
Impairment allowance
Home loans 15 56 6 7 69 389 473
Credit cards, unsecured loans and other retail lending 834 1,547 100 120 1,767 1,852 4,453
Wholesale loans 336 381 5 11 397 858 1,591
Total 1,185 1,984 111 138 2,233 3,099 6,517
Net exposure
Home loans 144,088 17,935 1,660 816 20,411 1,846 166,345
Credit cards, unsecured loans and other retail lending 33,703 4,095 200 89 4,384 921 39,008
Wholesale loans 126,006 14,379 524 380 15,283 1,907 143,196
Total 303,797 36,409 2,384 1,285 40,078 4,674 348,549
Coverage ratio % % % % % % %
Home loans — 0.3 0.4 0.9 0.3 17.4 0.3
Credit cards, unsecured loans and other retail lending 2.4 27.4 33.3 57.4 28.7 66.8 10.2
Wholesale loans 0.3 2.6 0.9 2.8 2.5 31.0 1.1
Total 0.4 5.2 4.4 9.7 5.3 39.9 1.8
As at 31.12.20
Gross exposure £m £m £m £m £m £m £m
Home loans 138,639 16,651 1,785 876 19,312 2,234 160,185
Credit cards, unsecured loans and other retail lending 33,021 9,470 544 306 10,320 3,172 46,513
Wholesale loans 119,304 19,501 1,097 776 21,374 3,591 144,269
Total 290,964 45,622 3,426 1,958 51,006 8,997 350,967
Impairment allowance
Home Loans 33 57 13 14 84 421 538
Credit cards, unsecured loans and other retail lending 680 2,382 180 207 2,769 2,251 5,700
Wholesale Loans 320 650 50 11 711 1,066 2,097
Total 1,033 3,089 243 232 3,564 3,738 8,335
Net exposure
Home loans 138,606 16,594 1,772 862 19,228 1,813 159,647
Credit cards, unsecured loans and other retail lending 32,341 7,088 364 99 7,551 921 40,813
Wholesale loans 118,984 18,851 1,047 765 20,663 2,525 142,172
Total 289,931 42,533 3,183 1,726 47,442 5,259 342,632
Coverage ratio % % % % % % %
Home loans — 0.3 0.7 1.6 0.4 18.8 0.3
Credit cards, unsecured loans and other retail lending 2.1 25.2 33.1 67.6 26.8 71.0 12.3
Wholesale loans 0.3 3.3 4.6 1.4 3.3 29.7 1.5
Total 0.4 6.8 7.1 11.8 7.0 41.5 2.4
Credit Risk
30

-- 33 of 125 --

Loans and advances at amortised cost by selected sectors
The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance, with
gross exposure and stage allocation for selected industry sectors within the wholesale loans portfolio. The industry
sectors have been selected based upon the level of management focus they have received following the onset of the
COVID-19 pandemic.
The gross loans and advances to selected sectors have decreased over the year driven by repayments and lower
drawdowns. The reduction in provisions is informed by the improved macroeconomic outlook used in the Q221 scenario
refresh, partially offset by management judgments to reflect the risk of uncertainty still prevailing within these sectors. The
wholesale portfolio also benefits from a hedge protection programme that enables effective risk management against
systemic losses. An additional £0.1bn (December 2020: £0.1bn) impairment allowance has been applied to the undrawn
exposures not included in the table below.
Gross exposure Impairment allowance
Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
As at 30.06.21 £m £m £m £m £m £m £m £m
Air travel 305 322 21 648 3 13 18 34
Hospitality and leisure 4,019 1,907 298 6,224 48 68 49 165
Oil and gas 1,877 465 234 2,576 14 12 128 154
Retail 4,089 962 148 5,199 63 30 44 137
Shipping 485 220 12 717 5 35 — 40
Transportation 1,768 161 102 2,031 20 4 37 61
Total 12,543 4,037 815 17,395 153 162 276 591
Total of Wholesale exposures 10 % 26 % 29 % 12 % 45 % 41 % 32 % 37 %
Gross exposure Impairment allowance
Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
As at 31.12.20 £m £m £m £m £m £m £m £m
Air travel 367 525 56 948 9 27 23 59
Hospitality and leisure 4,440 2,387 313 7,140 53 115 61 229
Oil and gas 1,754 854 465 3,073 31 27 140 198
Retail 3,907 1,153 283 5,343 78 51 108 237
Shipping 308 389 12 709 2 30 1 33
Transportation 1,148 253 125 1,526 19 10 57 86
Total 11,924 5,561 1,254 18,739 192 260 390 842
Total of Wholesale exposures 10 % 26 % 35 % 13 % 60 % 37 % 37 % 40 %
The coverage ratio for selected sectors has decreased from 4.5% as at 31 December 2020 to 3.4% as at 30 June 2021.
Exposure to UK commercial real estate of £9.4bn, excluding government backed schemes, was in line with 31 December
2020 (£10.0bn). Coverage decreased from 0.98% to 0.61% in the period.
Credit Risk
31

-- 34 of 125 --

Movement in gross exposures and impairment allowance including provisions for
loan commitments and financial guarantees
The following tables present a reconciliation of the opening to the closing balance of the exposure and impairment
allowance. An explanation of the terms 12-month ECL, lifetime ECL and credit-impaired is included in the Barclays PLC
Annual Report 2020 on page 296. Transfers between stages in the table have been reflected as if they had taken place
at the beginning of the year. The movements are measured over a 6-month period.
Loans and advances at amortised cost
Stage 1 Stage 2 Stage 3 Total
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Home loans £m £m £m £m £m £m £m £m
As at 1 January 2021 138,639 33 19,312 84 2,234 421 160,185 538
Transfers from Stage 1 to Stage 2 (6,369) (2) 6,369 2 — — — —
Transfers from Stage 2 to Stage 1 3,615 21 (3,615) (21) — — — —
Transfers to Stage 3 (160) — (337) (7) 497 7 — —
Transfers from Stage 3 21 — 119 3 (140) (3) — —
Business activity in the year 19,231 2 380 1 — — 19,611 3
Changes to models used for calculation1 — — — (4) — 38 — 34
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
(4,670) (38) (667) 13 (124) (54) (5,461) (79)
Final repayments (6,204) (1) (1,081) (2) (220) (8) (7,505) (11)
Disposals — — — — — — — —
Write-offs2 — — — — (12) (12) (12) (12)
As at 30 June 20213 144,103 15 20,480 69 2,235 389 166,818 473
Credit cards, unsecured loans and other retail lending
As at 1 January 2021 33,021 680 10,320 2,769 3,172 2,251 46,513 5,700
Transfers from Stage 1 to Stage 2 (1,590) (72) 1,590 72 — — — —
Transfers from Stage 2 to Stage 1 4,376 1,080 (4,376) (1,080) — — — —
Transfers to Stage 3 (264) (12) (572) (282) 836 294 — —
Transfers from Stage 3 30 25 38 14 (68) (39) — —
Business activity in the year 3,855 50 58 14 31 8 3,944 72
Changes to models used for calculation1 — (5) — (33) — 14 — (24)
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes4
(3,134) (866) (808) 310 (123) 282 (4,065) (274)
Final repayments (1,757) (46) (99) (17) (140) (50) (1,996) (113)
Disposals5 — — — — (101) (74) (101) (74)
Write-offs2 — — — — (834) (834) (834) (834)
As at 30 June 20213 34,537 834 6,151 1,767 2,773 1,852 43,461 4,453
1 Changes to models used for calculation include a £34m movement in Home loans, £24m in Credit cards, unsecured loans and other retail lending and
£36m in Wholesale loans. These reflect methodology changes made during the year. Barclays continually review the output of models to determine
accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended
period of time. This ensures that the models used continue to reflect the risks inherent across the businesses.
2 In H121, gross write-offs amounted to £1,001m (H120: £953m) and post write-off recoveries amounted to £31m (H120: £15m). Net write-offs represent
gross write-offs less post write-off recoveries and amounted to £970m (H120: £938m).
3 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair
value through other comprehensive income and other assets. These have a total gross exposure of £186.0bn (December 2020: £180.3bn) and
impairment allowance of £114m (December 2020: £165m). This comprises £9m ECL (December 2020: £11m) on £185.8bn stage 1 assets (December
2020: £175.7bn), £3m (December 2020: £9m) on £58m stage 2 fair value through other comprehensive income assets, other assets and cash
collateral and settlement balances (December 2020: £4.4bn) and £102m (December 2020: £145m) on £109m stage 3 other assets (December 2020:
£154m).
4 Transfers and risk parameter changes include a £0.3bn net release in ECL arising from a reclassification of £2.2bn gross loans and advances from
Stage 2 to Stage 1 in Credit cards, unsecured loans and other retail lending. The reclassification followed a review of back-testing of results which
indicated that accuracy of origination probability of default characteristics require management adjustments to correct and was first established in
Q220.
5 The £101m disposals reported within Credit cards, unsecured loans and other retail lending portfolio relates to debt sales undertaken during the year.
The £1.7bn disposal reported within Wholesale loans includes a sale of £0.7bn debt securities as part of Group Treasury Operations and a £1.0bn sale
of Barclays Asset Finance.
Credit Risk
32

-- 35 of 125 --

Loans and advances at amortised cost
Stage 1 Stage 2 Stage 3 Total
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Wholesale loans £m £m £m £m £m £m £m £m
As at 1 January 2021 119,304 320 21,374 711 3,591 1,066 144,269 2,097
Transfers from Stage 1 to Stage 2 (4,636) (12) 4,636 12 — — — —
Transfers from Stage 2 to Stage 1 8,410 188 (8,410) (188) — — — —
Transfers to Stage 3 (249) (2) (226) (17) 475 19 — —
Transfers from Stage 3 515 14 376 13 (891) (27) — —
Business activity in the year 23,266 35 1,181 30 191 22 24,638 87
Changes to models used for calculation1 — (7) — (29) — — — (36)
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
81 (153) (47) (37) (185) (1) (151) (191)
Final repayments (18,854) (39) (3,042) (95) (203) (33) (22,099) (167)
Disposals2 (1,495) (8) (162) (3) (58) (33) (1,715) (44)
Write-offs3 — — — — (155) (155) (155) (155)
As at 30 June 20214 126,342 336 15,680 397 2,765 858 144,787 1,591
Reconciliation of ECL movement to impairment charge/(release) for the period £m
Home loans (53)
Credit cards, unsecured loans and other retail lending (339)
Wholesale loans (307)
ECL movement excluding assets derecognised due to disposals and write-offs (699)
Recoveries and reimbursements5 185
Exchange and other adjustments6 132
Impairment charge on loan commitments and other financial guarantees (343)
Impairment charge on other financial assets4 (17)
Income statement release for the period (742)
1 Changes to models used for calculation include a £34m movement in Home Loans, £24m in Credit cards, unsecured loans and other retail lending and
£36m in Wholesale loans. These reflect methodology changes made during the year. Barclays continually review the output of models to determine
accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended
period of time. This ensures that the models used continue to reflect the risks inherent across the businesses.
2 The £101m disposals reported within Credit cards, unsecured loans and other retail lending portfolio relates to debt sales undertaken during the year.
The £1.7bn disposal reported within Wholesale loans includes a sale of £0.7bn debt securities as part of Group Treasury Operations and a £1.0bn sale
of Barclays Asset Finance.
3 In H121, gross write-offs amounted to £1,001m (H120: £953m) and post write-off recoveries amounted to £31m (H120: £15m). Net write-offs represent
gross write-offs less post write-off recoveries and amounted to £970m (H120: £938m).
4 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair
value through other comprehensive income and other assets. These have a total gross exposure of £186.0bn (December 2020: £180.3bn) and
impairment allowance of £114m (December 2020: £165m). This comprises £9m ECL (December 2020: £11m) on £185.8bn stage 1 assets (December
2020: £175.7bn), £3m (December 2020: £9m) on £58m stage 2 fair value through other comprehensive income assets, other assets and cash
collateral and settlement balances (December 2020: £4.4bn) and £102m (December 2020: £145m) on £109m stage 3 other assets (December 2020:
£154m).
5 Recoveries and reimbursements includes a net loss in relation to reimbursements from financial guarantee contracts held with third parties of £216m
(H120 gain: £279m) and post write off recoveries of £31m (H120: £15m).
6 Includes foreign exchange and interest and fees in suspense.
Credit Risk
33

-- 36 of 125 --

Loan commitments and financial guarantees
Stage 1 Stage 2 Stage 3 Total
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Home loans £m £m £m £m £m £m £m £m
As at 1 January 2021 11,861 — 516 — 5 — 12,382 —
Net transfers between stages (74) — 71 — 3 — — —
Business activity in the year 6,287 — 1 — — — 6,288 —
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
(7,397) — (17) — (2) — (7,416) —
Limit management and final repayments (238) — (22) — (3) — (263) —
As at 30 June 2021 10,439 — 549 — 3 — 10,991 —
Credit cards, unsecured loans and other retail lending
As at 1 January 2021 114,371 55 12,117 305 229 23 126,717 383
Net transfers between stages 5,784 217 (6,081) (212) 297 (5) — —
Business activity in the year 3,378 1 32 1 1 1 3,411 3
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
(1,005) (215) 114 63 (248) 4 (1,139) (148)
Limit management and final repayments (4,941) (4) (398) (5) (57) (3) (5,396) (12)
As at 30 June 2021 117,587 54 5,784 152 222 20 123,593 226
Wholesale loans
As at 1 January 2021 163,707 201 40,258 453 2,096 27 206,061 681
Net transfers between stages 682 116 504 (112) (1,186) (4) — —
Business activity in the year 37,211 28 2,915 89 12 9 40,138 126
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
1,603 (146) 680 (63) (28) 2 2,255 (207)
Limit management and final repayments (33,079) (25) (4,994) (83) (455) (5) (38,528) (113)
As at 30 June 2021 170,124 174 39,363 284 439 29 209,926 487
Credit Risk
34

-- 37 of 125 --

Management adjustments to models for impairment
Management adjustments to impairment models are made in the ordinary course of business in order to reflect changes
in policy or correct model performance issues identified through model monitoring. These adjustments remain in place
until they are incorporated into future model development and are then retired. In addition, they may also be made in
response to circumstances or uncertainty at the period end and this is particularly true of the ongoing COVID-19
pandemic.
Total management adjustments to impairment allowance are presented by product below.
Overview of management adjustments to models for impairment allowance1
As at 30.06.21 As at 31.12.20
Management
adjustments
to
impairment
allowances
Proportion of
total
impairment
allowances
Management
adjustments
to
impairment
allowances
Proportion of
total
impairment
allowances
£m % £m %
Home loans 83 17.5 131 24.3
Credit cards, unsecured loans and other retail lending 1,145 24.5 1,234 20.3
Wholesale loans 643 30.9 23 0.8
Total 1,871 25.9 1,388 14.8
Management adjustments to models for impairment allowance1
Impairment
allowance
pre
management
adjustments2
Economic
uncertainty
adjustments
Other
adjustments
Total
impairment
allowance
As at 30.06.21 £m £m £m £m
Home loans 390 41 42 473
Credit cards, unsecured loans and other retail lending 3,534 1,398 (253) 4,679
Wholesale loans 1,435 651 (8) 2,078
Total 5,359 2,090 (219) 7,230
As at 31.12.20
Home loans 407 21 110 538
Credit cards, unsecured loans and other retail lending 4,849 1,625 (391) 6,083
Wholesale loans 2,755 421 (398) 2,778
Total 8,011 2,067 (679) 9,399
1 Positive values reflect an increase in impairment allowance.
2 Includes £4.3bn (December 2020: £6.8bn) of modelled ECL, £0.8bn (December 2020: £0.9bn) of individually assessed impairments and £0.3bn
(December 2020: £0.3bn) ECL from non-modelled exposures.
Economic uncertainty adjustments
The COVID-19 pandemic has impacted the global economy since early 2020 and macroeconomic forecasts indicate
longer-term impacts that will result in higher unemployment levels and customer and client stress. However, to date, little
real credit deterioration has occurred, largely as a result of government and other support measures. Observed 30-day
arrears rates have reduced in US cards 1.6% (December 2020: 2.5%; December 2019: 2.7%) and in UK cards 1.4%
(December 2020: 1.7%; December 2019: 1.7%) due to payment holidays granted to customers impacted by COVID-19
which reduced the delinquency entrance rate and overall flow through delinquency. However, uncertainty remains as
government and other support measures taper down as to whether these schemes have either averted or delayed credit
losses.
In order to address this uncertainty, adjustments to the modelled provisions were made in 2020. COVID-19 related
economic uncertainty adjustments of £2.1bn (December 2020: £2.1bn) continue to be recognised, specifically to address
whether support measures have averted or delayed credit losses. However, within this, the approach has been refined
and uncertainty is now captured in two distinct ways: firstly, the identification of specific customers and clients who may be
more vulnerable to the withdrawal of relief and secondly, macroeconomic and risk parameter uncertainties which are
applied at a portfolio level.
Credit Risk
35

-- 38 of 125 --

A summary of the adjustments is provided below:
• A £1.2bn adjustment has been applied to customers and clients considered potentially vulnerable to the
withdrawal of government and other support schemes. In US consumer card portfolios, the populations identified are
those who have higher potential risk indicators and in the UK we have specifically considered the impact of furlough
schemes ending (equivalent to UK unemployment increasing to 7.2%). In wholesale portfolios, the populations identified
are specific clients who may exhibit greater cross default risk between COVID-19 and other financing exposures,
including clients with Bounce Back Loans in Business Banking, and those corporate sectors deemed more vulnerable to
the economic impacts of COVID-19. This adjustment is split between credit cards and unsecured loans, £0.9bn, and
wholesale loans, £0.3bn
• Expert judgement has been used to adjust the probability of default at portfolio level to pre-COVID-19 levels to
reflect the impact of temporary support measures on underlying customer and client behaviour. Following a refinement to
methodology, this has reduced to £0.5bn from £0.7bn in December 2020. A £(0.1)bn PMA to recognise government
guarantees remains in place
• Macroeconomic variables which may be temporarily influenced by support measures have been adjusted at a
portfolio level enabling the model to consume the economic stress. This is reduced to £0.5bn from £1.2bn at December
2020 as management judgements have been refined towards potentially vulnerable customers and clients as the
pandemic evolves
Other adjustments
Home loans: The low average LTV nature of the UK Home Loans portfolio means that modelled ECL estimates are low in
all but the most severe economic scenarios. An adjustment is held to maintain an appropriate level of ECL.
Credit cards, unsecured loans and other retail lending: This materially relates to a net release in ECL due to
reclassification of loans and advances from Stage 2 to Stage 1 in credit cards and unsecured loans. The reclassification
followed a review of back-testing of results which indicated that the accuracy of origination probability of default
characteristics requires management adjustments to correct and was first established in Q220.
Wholesale loans: Represents the net of adjustments for Business Banking and Investment Bank for model inaccuracies
informed by back-testing. An adjustment to offset modelled ECL output in the Investment Bank to limit excessive ECL
sensitivity to the macroeconomic variable for Federal Tax Receipts in place at December 2020 is materially reduced due
to the Q221 scenario refresh.
Credit Risk
36

-- 39 of 125 --

Measurement uncertainty
The Group uses a five-scenario model to calculate ECL. An external consensus forecast is assembled from key sources,
including HM Treasury (short and medium-term forecasts), Bloomberg (based on median of economic forecasts) and the
Urban Land Institute (for US House Prices), which forms the Baseline scenario. In addition, two adverse scenarios
(Downside 1 and Downside 2) and two favourable scenarios (Upside 1 and Upside 2) are derived, with associated
probability weightings. The adverse scenarios are calibrated to a broadly similar severity to Barclays’ internal stress tests
and stress scenarios provided by regulators whilst also considering IFRS 9 specific sensitivities and non-linearity.
Downside 2 is benchmarked to the Bank of England’s stress scenarios and to the most severe scenario from Moody’s
inventory, but is not designed to be the same. The favourable scenarios are calibrated to reflect upside risks to the
Baseline scenario to the extent that is broadly consistent with recent favourable benchmark scenarios. All scenarios are
regenerated at a minimum semi-annually. The scenarios include eight economic variables, (GDP, unemployment, House
Price Index (HPI) and base rates, in both the UK and US markets), and expanded variables using statistical models based
on historical correlations. The upside and downside shocks are designed to evolve over a five-year stress horizon, with all
five scenarios converging to a steady state after approximately eight years.
Macroeconomic indicators were refreshed in Q221, with key drivers for the baseline scenario more optimistic than Q420,
resulting in a net ECL provision release. In the Baseline scenario, UK GDP returns to the pre-pandemic level by mid-2022
with peak UK unemployment of just over 6% in Q421. In the Upside 2 scenario, effective fiscal stimulus measures,
including public investments in infrastructure and skills, provide a boost to demand and confidence, which in turn leads to
economic activity in almost all advanced economies returning to the pre-COVID-19 pandemic levels by the end of 2021.
Unemployment levels decline back below 5% by H222 in the UK, and below 4% by early 2022 in the US. In the Downside
2 scenario supply and distribution issues slow the vaccination process and the emergence of new virus variants that are
not susceptible to the existing vaccines fuels the outbreak again resulting in full national lockdowns in Q321. This leads to
significant falls in GDP in Q321 and UK and US unemployment reaching c.10% and 12% respectively.
Although the macroeconomic outlook has improved, the Group’s view on uncertainty remains unchanged, believing
potential credit deterioration could be seen once government support is removed, particularly in vulnerable areas of the
portfolio. In response, economic uncertainty PMAs remained relatively stable at c.£2.1bn. For further details see page 35.
Limited defaults have been observed to date in response to the COVID-19 pandemic, partly as a result of government and
bank support measures. However, such support measures are scheduled to taper down from Q321 bringing with it
uncertainty. Despite improvement in macroeconomic variables in the period, unemployment remains at elevated levels but
portfolios are yet to respond, and may not do so until support measures fall away.
The methodology for estimating probability weights for each of the scenarios involves a comparison of the distribution of
key historical UK and US macroeconomic variables against the forecast paths of the 5 scenarios. The range of forecast
paths generated in the calculation of the weights at 30 June 2021 is slightly narrower than 31 December 2020 due to
lower levels of uncertainty. The Upside 2 and Downside 2 scenarios are therefore nearer the tails of the distribution than
previously resulting in lower weights. See page 40 for probability weightings used at H121.
The tables below show the key consensus macroeconomic variables used in the scenarios (3-year annual paths), the
probability weights applied to each scenario and the macroeconomic variables by scenario using ‘specific bases’ i.e. the
most extreme position of each variable in the context of the scenario, for example, the highest unemployment for
downside scenarios and the lowest unemployment for upside scenarios. The 5-year average table provides additional
transparency.
Credit Risk
37

-- 40 of 125 --

Baseline average macroeconomic variables used in the calculation of ECL
2021 2022 2023
As at 30.06.21 % % %
UK GDP1 4.9 5.6 2.3
UK unemployment2 5.8 5.7 5.1
UK HPI3 (0.5) 0.3 3.1
UK bank rate 0.1 0.2 0.4
US GDP1 5.7 3.9 1.6
US unemployment4 5.6 4.5 4.4
US HPI5 3.9 3.5 3.5
US federal funds rate 0.3 0.3 0.7
As at 31.12.20
UK GDP1 6.3 3.3 2.6
UK unemployment2 6.7 6.4 5.8
UK HPI3 2.4 2.3 5.0
UK bank rate — (0.1) —
US GDP1 3.9 3.1 2.9
US unemployment4 6.9 5.7 5.6
US HPI5 2.8 4.7 4.7
US federal funds rate 0.3 0.3 0.3
1 Average Real GDP seasonally adjusted change in year.
2 Average UK unemployment rate 16-year+.
3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4 Average US civilian unemployment rate 16-year+.
5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end.
Downside 2 average economic variables used in the calculation of ECL
2021 2022 2023
As at 30.06.21 % % %
UK GDP1 (1.7) 2.0 5.2
UK unemployment2 7.3 8.2 6.6
UK HPI3 (5.8) (5.8) 0.2
UK bank rate 0.1 — —
US GDP1 1.5 1.4 2.0
US unemployment4 8.7 11.0 9.3
US HPI5 (4.9) (3.0) 1.1
US federal funds rate 0.3 0.3 0.3
As at 31.12.20
UK GDP1 (3.9) 6.5 2.6
UK unemployment2 8.0 9.3 7.8
UK HPI3 (13.6) (10.8) 0.5
UK bank rate (0.2) (0.2) (0.1)
US GDP1 (2.4) 3.6 2.1
US unemployment4 13.4 11.9 10.1
US HPI5 (17.2) (0.7) 0.6
US federal funds rate 0.3 0.3 0.3
1 Average Real GDP seasonally adjusted change in year.
2 Average UK unemployment rate 16-year+.
3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4 Average US civilian unemployment rate 16-year+.
5 Change in average yearly US HPI = FHFA house price index, relative to prior year end.
Credit Risk
38

-- 41 of 125 --

Downside 1 average economic variables used in the calculation of ECL
2021 2022 2023
As at 30.06.21 % % %
UK GDP1 0.6 4.4 4.2
UK unemployment2 6.4 6.6 5.6
UK HPI3 (3.1) (2.7) 1.7
UK bank rate 0.1 0.1 0.2
US GDP1 3.4 2.5 1.6
US unemployment4 7.4 7.9 6.1
US HPI5 (0.5) 0.2 2.3
US federal funds rate 0.3 0.3 0.3
As at 31.12.20
UK GDP1 0.1 6.6 3.2
UK unemployment2 7.3 8.0 6.9
UK HPI3 (6.7) (3.5) 1.7
UK bank rate (0.1) (0.1) —
US GDP1 0.4 3.6 2.3
US unemployment4 11.0 8.9 6.9
US HPI5 (5.9) 1.8 2.6
US federal funds rate 0.3 0.3 0.3
1 Average Real GDP seasonally adjusted change in year.
2 Average UK unemployment rate 16-year+.
3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4 Average US civilian unemployment rate 16-year+.
5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end.
Upside 2 average economic variables used in the calculation of ECL
2021 2022 2023
As at 30.06.21 % % %
UK GDP1 6.8 9.4 4.0
UK unemployment2 5.5 4.9 4.4
UK HPI3 4.6 9.9 11.3
UK bank rate 0.1 0.4 0.6
US GDP1 6.5 8.2 3.4
US unemployment4 5.3 3.8 3.8
US HPI5 6.5 8.0 7.3
US federal funds rate 0.3 0.3 1.1
As at 31.12.20
UK GDP1 12.2 5.3 3.9
UK unemployment2 6.2 5.5 4.8
UK HPI3 6.6 10.4 10.8
UK bank rate 0.1 0.3 0.3
US GDP1 7.1 4.6 4.0
US unemployment4 5.5 4.3 4.1
US HPI5 8.8 9.1 8.9
US federal funds rate 0.3 0.4 0.6
1 Average Real GDP seasonally adjusted change in year.
2 Average UK unemployment rate 16-year+.
3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4 Average US civilian unemployment rate 16-year+.
5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end.
Credit Risk
39

-- 42 of 125 --

Upside 1 average economic variables used in the calculation of ECL
2021 2022 2023
As at 30.06.21 % % %
UK GDP1 5.9 7.3 3.0
UK unemployment2 5.6 5.2 4.7
UK HPI3 1.5 4.5 7.4
UK bank rate 0.1 0.2 0.6
US GDP1 6.1 5.8 2.4
US unemployment4 5.5 4.2 4.2
US HPI5 6.2 6.8 5.7
US federal funds rate 0.3 0.3 0.9
As at 31.12.20
UK GDP1 9.3 3.9 3.4
UK unemployment2 6.4 6.0 5.2
UK HPI3 4.6 6.1 6.1
UK bank rate 0.1 0.1 0.3
US GDP1 5.5 4.0 3.7
US unemployment4 6.0 4.8 4.6
US HPI5 6.8 6.7 6.3
US federal funds rate 0.3 0.3 0.5
1 Average Real GDP seasonally adjusted change in year.
2 Average UK unemployment rate 16-year+.
3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4 Average US civilian unemployment rate 16-year+.
5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end.
Scenario probability weighting
Upside 2 Upside 1 Baseline Downside 1 Downside 2
% % % % %
As at 30.06.21
Scenario probability weighting 19.6 24.5 26.4 16.9 12.6
As at 31.12.20
Scenario probability weighting 20.2 24.2 24.7 15.5 15.4
Credit Risk
40

-- 43 of 125 --

Specific bases show the most extreme position of each variable in the context of the scenario, for example, the highest
unemployment for downside scenarios, average unemployment for baseline scenarios and lowest unemployment for
upside scenarios. GDP and HPI downside and upside scenario data represents the lowest and highest points relative to
the start point in the 20 quarter period.
Macroeconomic variables (specific bases)1
Upside 2 Upside 1 Baseline Downside 1 Downside 2
As at 30.06.21 % % % % %
UK GDP2 25.9 20.2 3.3 (4.2) (8.1)
UK unemployment3 4.1 4.3 5.1 7.5 9.8
UK HPI4 48.2 25.5 1.6 (5.8) (11.8)
UK bank rate3 0.1 0.1 0.4 0.3 0.1
US GDP2 23.7 18.3 2.8 (0.2) (3.2)
US unemployment3 3.8 4.2 4.7 8.9 12.0
US HPI4 41.2 32.6 3.6 (1.3) (7.9)
US federal funds rate3 0.3 0.3 0.8 1.5 0.8
As at 31.12.20
UK GDP2 14.2 8.8 0.7 (22.1) (22.1)
UK unemployment3 4.0 4.0 5.7 8.4 10.1
UK HPI4 48.2 30.8 3.6 (4.5) (18.3)
UK bank rate3 0.1 0.1 — 0.6 0.6
US GDP2 15.7 12.8 1.6 (10.6) (10.6)
US unemployment3 3.8 3.8 6.4 13.0 13.7
US HPI4 42.2 30.9 3.8 (3.7) (15.9)
US federal funds rate3 0.1 0.1 0.3 1.3 1.3
1 UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HI = Halifax All Houses, All Buyers Index;
US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index. 20
quarter period starts from Q121 (2020: Q120).
2 Maximum growth relative to Q420 (2020: Q419), based on 20 quarter period in Upside scenarios; 5-year yearly average Compound Annual Growth
Rate (CAGR) in Baseline; minimum growth relative to Q420 (2020: Q419), based on 20 quarter period in Downside scenarios.
3 Lowest quarter in 20 quarter period in Upside scenarios; 5-year average in Baseline; highest quarter in 20 quarter period in Downside scenarios.
4 Maximum growth relative to Q420 (2020: Q419), based on 20 quarter period in Upside scenarios; 5-year quarter end CAGR in Baseline; minimum
growth relative to Q420 (2020: Q419), based on 20 quarter period in Downside scenarios.
Credit Risk
41

-- 44 of 125 --

Average basis represents the average quarterly value of variables in the 20 quarter period with GDP and HPI based on
yearly average and quarterly CAGRs respectively.
Macroeconomic variables (5 year averages)1
Upside 2 Upside 1 Baseline Downside 1 Downside 2
As at 30.06.21 % % % % %
UK GDP2 5.2 4.2 3.3 2.6 1.8
UK unemployment3 4.6 4.8 5.1 5.7 6.5
UK HPI4 8.2 4.7 1.6 — (1.6)
UK bank rate3 0.7 0.6 0.4 0.2 —
US GDP2 4.6 3.7 2.8 2.0 1.4
US unemployment3 4.1 4.4 4.7 6.3 8.5
US HPI4 7.1 5.8 3.6 1.6 (0.4)
US federal funds rate3 1.1 0.9 0.8 0.6 0.3
As at 31.12.20
UK GDP2 2.5 1.6 0.7 0.1 (0.9)
UK unemployment3 5.0 5.3 5.7 6.5 7.2
UK HPI4 8.2 5.5 3.6 (0.2) (3.6)
UK bank rate3 0.3 0.2 — — (0.1)
US GDP2 2.9 2.4 1.6 0.8 0.1
US unemployment3 5.3 5.7 6.4 8.3 10.4
US HPI4 7.3 5.5 3.8 0.8 (3.0)
US federal funds rate3 0.5 0.5 0.3 0.3 0.3
1 UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HPI = Halifax All Houses, All Buyers
Index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price
Index.
2 5-year yearly average CAGR, starting 2020 (2020: 2019).
3 5-year average. Period based on 20 quarters from Q121 (2020: Q120).
4 5-year quarter end CAGR, starting Q420 (2020: Q419).
Credit Risk
42

-- 45 of 125 --

ECL under 100% weighted scenarios for modelled portfolios
The table below shows the ECL assuming scenarios have been 100% weighted. Model exposures are allocated to a
stage based on the individual scenario rather than through a probability-weighted approach as required for Barclays
reported impairment allowances. As a result, it is not possible to back solve to the final reported weighted ECL from the
individual scenarios as a balance may be assigned to a different stage dependent on the scenario. Model exposure uses
exposure at default (EAD) values and is not directly comparable to gross exposure used in prior disclosures. For Credit
cards, unsecured loans and other retail lending, an average EAD measure is used (12-month or lifetime, depending on
stage allocation in each scenario). Therefore, the model exposure movement into Stage 2 is higher than the
corresponding Stage 1 reduction.
All ECL using a model is included, with the exception of Treasury assets (£4m of ECL). Non-modelled exposures and
management adjustments are excluded. Management adjustments can be found in the Management adjustments to
models for impairment section.
Model exposures allocated to Stage 3 do not change in any of the scenarios as the transition criteria relies only on
observable evidence of default as at 30 June 2021 and not on macroeconomic scenarios.
The Downside 2 scenario represents a severe global recession with substantial falls in both UK and US GDP.
Unemployment in UK markets rises towards 9.8% and US markets rises towards 12% and there are substantial falls in
asset prices including housing. Under the Downside 2 scenario, model exposure moves between stages as the economic
environment weakens. This can be seen in the movement of £18bn of model exposure into Stage 2 between the
Weighted and Downside 2 scenario. ECL increases in Stage 2 predominantly due to unsecured portfolios as economic
conditions deteriorate.
Credit Risk
43

-- 46 of 125 --

Scenarios
As at 30.06.21 Weighted Upside 2 Upside 1 Baseline Downside 1 Downside 2
Stage 1 Model Exposure (£m)
Home loans 131,134 133,584 132,343 130,694 128,711 126,953
Credit cards, unsecured loans and other retail lending 44,014 45,185 44,809 44,307 42,383 39,252
Wholesale loans 160,174 162,762 162,201 160,564 158,614 152,164
Stage 1 Model ECL (£m)
Home loans 4 2 3 4 6 8
Credit cards, unsecured loans and other retail lending 379 269 288 324 456 486
Wholesale loans 248 187 203 224 306 352
Stage 1 Coverage (%)
Home loans — — — — — —
Credit cards, unsecured loans and other retail lending 0.9 0.6 0.6 0.7 1.1 1.2
Wholesale loans 0.2 0.1 0.1 0.1 0.2 0.2
Stage 2 Model Exposure (£m)
Home loans 24,345 21,895 23,136 24,785 26,769 28,526
Credit cards, unsecured loans and other retail lending 7,175 5,733 6,205 6,819 9,066 12,625
Wholesale loans 33,666 31,077 31,639 33,276 35,225 41,676
Stage 2 Model ECL (£m)
Home loans 20 13 15 18 27 39
Credit cards, unsecured loans and other retail lending 1,076 733 841 976 1,544 2,517
Wholesale loans 773 594 646 709 939 1,342
Stage 2 Coverage (%)
Home loans 0.1 0.1 0.1 0.1 0.1 0.1
Credit cards, unsecured loans and other retail lending 15.0 12.8 13.6 14.3 17.0 19.9
Wholesale loans 2.3 1.9 2.0 2.1 2.7 3.2
Stage 3 Model Exposure (£m)
Home loans 1,829 1,829 1,829 1,829 1,829 1,829
Credit cards, unsecured loans and other retail lending 2,374 2,374 2,374 2,374 2,374 2,374
Wholesale loans1 1,374 1,374 1,374 1,374 1,374 1,374
Stage 3 Model ECL (£m)
Home loans 324 307 315 325 337 352
Credit cards, unsecured loans and other retail lending 1,878 1,850 1,864 1,875 1,905 1,920
Wholesale loans1 67 65 66 67 69 72
Stage 3 Coverage (%)
Home loans 17.7 16.8 17.2 17.8 18.4 19.2
Credit cards, unsecured loans and other retail lending 79.1 77.9 78.5 79.0 80.2 80.9
Wholesale loans1 4.9 4.7 4.8 4.9 5.0 5.2
Total Model ECL (£m)
Home loans 348 322 333 347 370 399
Credit cards, unsecured loans and other retail lending 3,333 2,852 2,993 3,175 3,905 4,923
Wholesale loans1 1,088 846 915 1,000 1,314 1,766
Total Model ECL 4,769 4,020 4,241 4,522 5,589 7,088
1 Material wholesale loan defaults are individually assessed across different recovery strategies. As a result, ECL of £783m is reported as individually
assessed impairments in the table below.
Reconciliation to total ECL £m
Total model ECL 4,769
ECL from individually assessed impairments on stage 3 loans 783
ECL from non-modelled and other management adjustments1 1,678
Total ECL 7,230
1 Includes £1.9bn post-model adjustments of which £0.4bn is included as part of total model ECL and £0.2bn ECL from non-modelled exposures.
Credit Risk
44

-- 47 of 125 --

The dispersion of results around the Baseline is an indication of uncertainty around the future projections. The disclosure
highlights the results of the alternative scenarios enabling the reader to understand the extent of the impact on exposure
and ECL from the upside/downside scenarios. Consequently, the use of five scenarios with associated weightings results
in a total weighted ECL uplift from the Baseline ECL of 5.5%, largely driven by credit card losses which have more linear
loss profiles than UK home loans and wholesale loan positions.
Home loans: Total weighted ECL of £348m represents a 0.3% increase over the Baseline ECL (£347m), and coverage
ratios remain steady across the Upside scenarios, Baseline and Downside 1 scenario. However, total ECL increases in
the Downside 2 scenario to £399m, driven by a significant fall in UK HPI (11.8%) reflecting the non-linearity of the UK
portfolio.
Credit cards, unsecured loans and other retail lending: Total weighted ECL of £3,333m represents a 5% increase
over the Baseline ECL (£3,175m) reflecting the range of economic scenarios used, mainly impacted by unemployment
and other key retail variables. Total ECL increases to £4,923m under Downside 2 scenario, mainly driven by Stage 2,
where coverage rates increase to 19.9% from a weighted scenario approach of 15% and circa £5.5bn increase in model
exposure that meets the Significant Increase in Credit Risk criteria and transitions from Stage 1 to Stage 2.
Wholesale loans: Total weighted ECL of £1,088m represents an 8.8% increase over the Baseline ECL (£1,000m)
reflecting the range of economic scenarios used, with exposures in the Investment Bank particularly sensitive to the
Downside 2 scenario.
Credit Risk
45

-- 48 of 125 --

Scenarios
As at 31.12.20 Weighted Upside 2 Upside 1 Baseline Downside 1 Downside 2
Stage 1 Model Exposure (£m)
Home loans 131,422 134,100 133,246 132,414 130,547 128,369
Credit cards, unsecured loans and other retail lending 51,952 53,271 52,932 51,995 50,168 48,717
Wholesale loans 149,099 155,812 154,578 152,141 144,646 131,415
Stage 1 Model ECL (£m)
Home loans 6 4 5 6 14 42
Credit cards, unsecured loans and other retail lending 392 316 340 372 415 415
Wholesale loans 262 242 258 249 278 290
Stage 1 Coverage (%)
Home loans — — — — — —
Credit cards, unsecured loans and other retail lending 0.8 0.6 0.6 0.7 0.8 0.9
Wholesale loans 0.2 0.2 0.2 0.2 0.2 0.2
Stage 2 Model Exposure (£m)
Home loans 19,180 16,502 17,356 18,188 20,055 22,233
Credit cards, unsecured loans and other retail lending 13,399 10,572 11,579 13,176 16,477 19,322
Wholesale loans 32,677 25,963 27,198 29,635 37,130 50,361
Stage 2 Model ECL (£m)
Home loans 37 31 32 33 42 63
Credit cards, unsecured loans and other retail lending 2,207 1,618 1,837 2,138 2,865 3,564
Wholesale loans 1,410 952 1,047 1,223 1,771 2,911
Stage 2 Coverage (%)
Home loans 0.2 0.2 0.2 0.2 0.2 0.3
Credit cards, unsecured loans and other retail lending 16.5 15.3 15.9 16.2 17.4 18.4
Wholesale loans 4.3 3.7 3.8 4.1 4.8 5.8
Stage 3 Model Exposure (£m)
Home loans 1,778 1,778 1,778 1,778 1,778 1,778
Credit cards, unsecured loans and other retail lending 2,585 2,585 2,585 2,585 2,585 2,585
Wholesale loans1 2,211 2,211 2,211 2,211 2,211 2,211
Stage 3 Model ECL (£m)
Home loans 307 282 286 290 318 386
Credit cards, unsecured loans and other retail lending 2,003 1,947 1,972 2,001 2,055 2,078
Wholesale loans1 146 128 134 141 157 184
Stage 3 Coverage (%)
Home loans 17.3 15.9 16.1 16.3 17.9 21.7
Credit cards, unsecured loans and other retail lending 77.5 75.3 76.3 77.4 79.5 80.4
Wholesale loans1 6.6 5.8 6.1 6.4 7.1 8.3
Total Model ECL (£m)
Home loans 350 317 323 329 374 491
Credit cards, unsecured loans and other retail lending 4,602 3,881 4,149 4,511 5,335 6,057
Wholesale loans1 1,818 1,322 1,439 1,613 2,206 3,385
Total Model ECL 6,770 5,520 5,911 6,453 7,915 9,933
1 Material wholesale loan defaults are individually assessed across different recovery strategies. As a result, ECL of £902m is reported as individually
assessed impairments in the table below.
Reconciliation to total ECL1 £m
Total model ECL 6,770
ECL from individually assessed impairments on stage 3 loans 902
ECL from non-modelled and other management adjustments 1,727
Total ECL 9,399
1 Includes £1.4bn of post-model adjustments and £0.3bn ECL from non-modelled exposures.
Credit Risk
46

-- 49 of 125 --

Analysis of specific portfolios and asset types
Payment holidays
Payment holidays are substantially concluded and due to roll off by the end of July 2021. The impact of payment holidays
on delinquency performance in the period has been modest and as such detail has not been included in the
commentaries below.
Secured home loans
The UK home loan portfolio primarily comprises first lien mortgages and accounts for 93% (December 2020: 93%) of the
Group’s total home loans balance.
Home loans principal portfolios Barclays UK
As at
30.06.21 As at
31.12.20
Gross loans and advances (£m) 155,247 148,343
90 day arrears rate, excluding recovery book (%) 0.1 0.2
Annualised gross charge-off rates - 180 days past due (%) 0.6 0.6
Recovery book proportion of outstanding balances (%) 0.6 0.6
Recovery book impairment coverage ratio (%) 3.4 3.2
Average marked to market LTV
Balance weighted % 51.3 50.7
Valuation weighted % 38.0 37.6
New lending
Half year
ended
30.06.21
Half year
ended
30.06.20
New home loan bookings (£m) 19,120 9,977
New home loan proportion > 90% LTV (%) 0.9 3.7
Average LTV on new home loans: balance weighted (%) 68.7 68.4
Average LTV on new home loans: valuation weighted (%) 61.3 60.0
Home loans principal portfolios – distribution of balances by LTV1
Distribution of balances Distribution of impairment
allowance Coverage ratio
Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
Barclays UK % % % % % % % % % % % %
As at 30.06.21
<=75% 74.4 11.8 0.7 86.9 6.0 16.4 24.4 46.8 — 0.1 1.7 —
>75% and <=90% 11.4 0.9 — 12.3 3.9 20.4 10.8 35.1 — 1.2 14.2 0.1
>90% and <=100% 0.7 — — 0.7 0.4 0.8 3.4 4.6 — 2.0 46.9 0.3
>100% 0.1 — — 0.1 0.2 2.9 10.4 13.5 0.2 8.1 83.5 9.0
As at 31.12.20
<=75% 75.7 11.6 0.6 87.9 17.9 15.0 19.0 51.9 — 0.1 1.8 —
>75% and <=90% 10.8 0.8 — 11.6 9.7 14.8 7.6 32.1 0.1 1.2 16.0 0.2
>90% and <=100% 0.4 — — 0.4 0.8 1.5 2.2 4.5 0.1 2.6 35.7 0.7
>100% 0.1 — — 0.1 0.7 3.4 7.4 11.5 0.7 10.3 69.1 8.0
1 Portfolio mark to market based on the most updated valuation including recovery book balances. Updated valuations reflect the application of the latest
HPI available as at 30 June 2021.
The increased level of new business was driven by elevated demand in the house purchase market supported by
government intervention including stamp duty relief. Also, with the gradual roll back of COVID restrictions, high LTV
products were re-introduced in a phased manner during 2021, including the introduction of a 95% LTV product under the
Government’s mortgage guarantee scheme in April 2021. The comparatively lower LTV > 90% new loan proportion is
primarily a result of the mortgage guarantee scheme being live for only 3 months of H121.
Head Office: Italian home loans and advances at amortised cost reduced to £5.1bn (2020: £5.7bn). The portfolio is
secured on residential property with an average balance weighted mark to market LTV of 61% (2020: 62.1%). 90 day
arrears decreased to 1.4% (2020: 1.7%), gross charge-off rates decreased to 0.8% (2020: 1.0%).
Credit Risk
47

-- 50 of 125 --

Credit cards, unsecured loans and other retail lending
The principal portfolios listed below accounted for 83% (December 2020: 84%) of the Group’s total credit cards, unsecured loans and
other retail lending.
Principal portfolios
Gross
exposure
30 day
arrears rate,
excluding
recovery
book
90 day
arrears rate,
excluding
recovery
book
Annualised
gross write-
off rate
Annualised
net write-off
rate
As at 30.06.21 £m % % % %
Barclays UK
UK cards 10,202 1.4 0.6 4.9 4.8
UK personal loans 4,075 2.3 1.4 3.9 3.6
Barclays Partner Finance 2,362 0.5 0.2 1.3 1.3
Barclays International
US cards 15,895 1.6 0.9 5.6 5.4
Germany consumer lending 3,398 1.5 0.7 0.9 0.8
As at 31.12.20
Barclays UK
UK cards 11,911 1.7 0.8 2.9 2.9
UK personal loans 4,591 2.3 1.2 3.4 3.1
Barclays Partner Finance 2,469 0.5 0.3 1.1 1.1
Barclays International
US cards 16,845 2.5 1.4 5.6 5.6
Germany consumer lending 3,458 1.9 0.8 1.2 1.1
UK cards: 30 and 90 day arrears rates reduced by 0.3% and 0.2% to 1.4% and 0.6% respectively, despite balances
reducing by c.£1.7bn. The reduction in arrears was driven by continued COVID support measures, along with improved
book quality reflecting lower consumer demand, tighter lending criteria and reduced customer credit limits. Gross and net
write-off rates increased significantly to 4.9% and 4.8% respectively as a result of the significant reduction in overall
balances since the accounts originally charged off. In addition, fewer debt sales in 2020, allowed balances to follow the
contractual write-off processes, rather than accelerated write-offs due to debt sales.
UK personal loans: 30 day arrears rate was stable at 2.3% whilst the 90 day arrears rate increased by 0.2% to 1.4%.
The increase in late cycle arrears was driven by a higher flow in to delinquency, specifically in Q121, of customers
previously granted a payment holiday, as well as an overall reduction in balances. Gross and net write-off rates increased
as a result of the reduction in overall balances.
Barclays Partner Finance: 30 and 90 day arrears rates remain stable and in line with December 2020.
US cards: 30 and 90 day arrears rates improved and remain below pre-pandemic levels due to government support
schemes and industry payment deferrals that were made available to consumers. These factors also contributed to the
decrease in balances.
Germany consumer lending: 30 and 90 day arrears rates decreased, reflecting better-than-expected customer
resilience, helped by government support schemes. In addition, improvements in collections processes and the
implementation of tighter underwriting criteria helped improve the credit quality of the book.
Credit Risk
48

-- 51 of 125 --

Analysis of management value at risk (VaR)
The table below shows the total management VaR on a diversified basis by asset class. Total management VaR includes
all trading positions in CIB and Treasury and it is calculated with a one-day holding period. VaR limits are applied to total
management VaR and by asset class. Additionally, the market risk management function applies VaR sub-limits to
material businesses and trading desks.
Management VaR (95%) by asset class
Half year ended 30.06.21 Half year ended 31.12.20 Half year ended 30.06.20
Average High Low Average High Low Average High Low
£m £m £m £m £m £m £m £m £m
Credit risk 18 30 9 19 23 15 22 38 10
Interest rate risk 8 15 4 11 17 6 9 17 6
Equity risk 10 15 6 10 16 7 15 35 6
Basis risk 7 10 4 10 12 7 10 16 7
Spread risk 4 6 3 5 7 4 5 9 3
Foreign exchange risk 3 6 2 5 7 3 5 7 2
Commodity risk — 1 — 1 1 — 1 1 —
Inflation risk 2 3 2 2 3 1 1 2 1
Diversification effect1 (30) n/a n/a (35) n/a n/a (33) n/a n/a
Total management VaR 22 36 13 28 35 20 35 57 18
1 Diversification effects recognise that forecast losses from different assets or businesses are unlikely to occur concurrently, hence the expected
aggregate loss is lower than the sum of the expected losses from each area. Historical correlations between losses are taken into account in making
these assessments. The high and low VaR figures reported for each category did not necessarily occur on the same day as the high and low VaR
reported as a whole. Consequently, a diversification effect balance for the high and low VaR figures would not be meaningful and is therefore omitted
from the above table.
Average management VaR decreased 21% to £22m (H220: £28m), reflecting a reduction of £5m due to a methodology
update which changed the historical lookback period of the VaR model from two years to one year and reduced risk
taking in the period. The methodology change has increased the responsiveness of the model to changes over time in
volatility levels in the lookback period.
Market Risk
49

-- 52 of 125 --

The Group has a comprehensive Key Risk Control Framework for managing its liquidity risk. The liquidity framework
meets the PRA standards and is designed to maintain liquidity resources that are sufficient in amount and quality, and a
funding profile that is appropriate to meet the Group’s Liquidity Risk Appetite (LRA). The liquidity framework is delivered
via a combination of policy formation, review and governance, analysis, stress testing, limit setting and monitoring.
Liquidity risk stress testing
The liquidity risk stress assessment measures the potential contractual and contingent stress outflows under a range of
scenarios, which are then used to determine the size of the liquidity pool that is immediately available to meet anticipated
outflows if a stress occurs. The short-term scenarios include a 30 day Barclays-specific stress event, a 90 day market-
wide stress event and a 30 day combined scenario consisting of both a Barclays specific and market-wide stress event.
The Group also runs a long-term liquidity stress test, which measures the anticipated outflows over a 12 month market-
wide scenario.
The CRR (as amended by CRR II) liquidity coverage ratio (LCR) requirement takes into account the relative stability of
different sources of funding and potential incremental funding requirements in a stress. The LCR is designed to promote
short-term resilience of a bank’s liquidity risk profile by holding sufficient high quality liquid assets to survive an acute
stress scenario lasting for 30 days.
As at 30 June 2021, the Group held eligible liquid assets in excess of 100% of net stress outflows to its internal and
external regulatory requirements.
Liquidity coverage ratio
As at
30.06.21
As at
31.12.20
£bn £bn
Eligible liquidity buffer 280 258
Net stress outflows (172) (159)
Surplus 108 99
Liquidity coverage ratio 162% 162%
The Group plans to maintain its surplus to the internal and regulatory stress requirements at an efficient level, while
considering risks to market funding conditions and its liquidity position. The continuous reassessment of these risks may
lead to execution of appropriate actions to resize the liquidity pool.
Treasury and Capital Risk
50

-- 53 of 125 --

Composition of the Group liquidity pool
As at 30.06.21
As at
31.12.20
Liquidity
pool
Liquidity pool of which CRD IV LCR
eligible3
Liquidity
pool	Cash Level 1 Level 2A
£bn £bn £bn £bn £bn
Cash and deposits with central banks1 224 217 — — 197
Government bonds2
AAA to AA- 39 — 30 1 31
A+ to A- 6 — 1 5 13
BBB+ to BBB- 2 — 2 — 1
Total government bonds 47 — 33 6 45
Other
Government Guaranteed Issuers, PSEs and GSEs 8 — 5 2 10
International Organisations and MDBs 4 — 4 — 6
Covered bonds 7 — 6 2 8
Other 1 — — — —
Total other 20 — 15 4 24
Total as at 30 June 2021 291 217 48 10 266
Total as at 31 December 2020 266 192 55 11
1 Includes cash held at central banks and surplus cash at central banks related to payment schemes. Over 98% (December 2020: over 98%) was placed
with the Bank of England, US Federal Reserve, European Central Bank, Bank of Japan and Swiss National Bank.
2 Of which over 76% (December 2020: over 78%) comprised UK, US, French, German, Japanese, Swiss and Dutch securities.
3 The LCR eligible liquidity pool is adjusted for trapped liquidity and other regulatory deductions. It also incorporates other CRR (as amended by CRR II)
qualifying assets that are not eligible under Barclays’ internal risk appetite.
The Group liquidity pool increased to £291bn as at 30 June 2021 (December 2020: £266bn) driven by continued deposit
growth, further borrowing from the Bank of England’s Term Funding Scheme with additional incentives for SMEs and a
seasonal increase in short-term wholesale funding, which were partly offset by an increase in business funding
consumption. During H121, the month-end liquidity pool ranged from £290bn to £308bn (H220: £266bn to £332bn), and
the month-end average balance was £296bn (H220: £318bn). The liquidity pool is held unencumbered and is not used to
support payment or clearing requirements. Such requirements are treated as part of our regular business funding. The
liquidity pool is intended to offset stress outflows, and comprises the above cash and unencumbered assets.
As at 30 June 2021, 60% (December 2020: 64%) of the liquidity pool was located in Barclays Bank PLC, 27% (December
2020: 23%) in Barclays Bank UK PLC and 6% (December 2020: 7%) in Barclays Bank Ireland PLC. The residual portion
of the liquidity pool is held outside of these entities, predominantly in US subsidiaries, to meet entity-specific stress
outflows and local regulatory requirements. To the extent the use of this residual portion of the liquidity pool is restricted
due to local regulatory requirements, it is assumed to be unavailable to the rest of the Group in calculating the LCR.
The composition of the pool is subject to limits set by the Board and the independent liquidity risk, credit risk and market
risk functions. In addition, the investment of the liquidity pool is monitored for concentration by issuer, currency and asset
type. Given returns generated by these highly liquid assets, the risk and reward profile is continuously managed.
Treasury and Capital Risk
51

-- 54 of 125 --

Deposit funding
As at 30.06.21 As at
31.12.20
Loans and
advances at
amortised
cost
Deposits at
amortised
cost
Loan:
deposit ratio1
Loan:
deposit ratio1
Funding of loans and advances £bn £bn % %
Barclays UK 222 256 87 89
Barclays International 122 245 50 51
Head Office 5
Barclays Group 349 501 70 71
1 The loan: deposit ratio is calculated as loans and advances at amortised cost divided by deposits at amortised cost.
Funding structure and funding relationships
The basis for liquidity risk management is a funding structure that reduces the probability of a liquidity stress leading to an
inability to meet funding obligations as they fall due. The Group’s overall funding strategy is to develop a diversified
funding base (geographically, by type and by counterparty) and maintain access to a variety of alternative funding
sources, to provide protection against unexpected fluctuations, while minimising the cost of funding.
Within this, the Group aims to align the sources and uses of funding. As such, retail and corporate loans and advances
are largely funded by deposits in the relevant entities, with the surplus primarily funding the liquidity pool. The majority of
reverse repurchase agreements are matched by repurchase agreements. Derivative liabilities and assets are largely
matched. A substantial proportion of balance sheet derivative positions qualify for counterparty netting and the remaining
portions are largely offset when netted against cash collateral received and paid. Wholesale debt and equity is used to
fund residual assets.
These funding relationships as at 30 June 2021 are summarised below:
As at
30.06.21
As at
31.12.20
As at
30.06.21
As at
31.12.20
Assets £bn £bn Liabilities and equity £bn £bn
Loans and advances at amortised cost1 340 335 Deposits at amortised cost 501 481
Group liquidity pool 291 266 <1 Year wholesale funding 58 43
>1 Year wholesale funding 101 102
Reverse repurchase agreements, trading
portfolio assets, cash collateral and
settlement balances 419 376
Repurchase agreements, trading portfolio
liabilities, cash collateral and settlement
balances 362 324
Derivative financial instruments 257 302 Derivative financial instruments 247 301
Other assets2 69 71 Other liabilities 39 32
Equity 68 67
Total assets 1,376 1,350 Total liabilities and equity 1,376 1,350
1 Adjusted for liquidity pool debt securities reported at amortised cost of £9bn (December 2020: £8bn).
2 Other assets include fair value assets that are not part of reverse repurchase agreements or trading portfolio assets, and other asset categories.
Treasury and Capital Risk
52

-- 55 of 125 --

Composition of wholesale funding
Wholesale funding outstanding (excluding repurchase agreements) was £158.7bn (December 2020: £145bn). In H121,
the Group issued £5.9bn of MREL eligible instruments from Barclays PLC (the Parent company) in a range of tenors and
currencies.
Our operating companies also access wholesale funding markets to maintain their stable and diversified funding bases.
Barclays Bank PLC continued to issue in the shorter-term and medium-term notes markets. In addition, Barclays Bank
UK PLC continued to issue in the shorter-term markets.
Wholesale funding of £57.8bn (December 2020: £42.7bn) matures in less than one year, representing 36% (December
2020: 29%) of total wholesale funding outstanding. This includes £18.8bn (December 2020: £20.3bn) related to term
funding2.
Maturity profile of wholesale funding1,2
<1 1-3 3-6 6-12 <1 1-2 2-3 3-4 4-5 >5
month month
s month
s month
s year years years years years years Total
£bn £bn £bn £bn £bn £bn £bn £bn £bn £bn £bn
Barclays PLC (the Parent
company)
Senior unsecured (public
benchmark) — 1.2 — 0.8 2.0 4.7 6.8 6.9 5.3 12.1 37.8
Senior unsecured (privately
placed) — — 0.1 — 0.1 — 0.3 — — 0.5 0.9
Subordinated liabilities — — — — — — — 0.9 1.5 6.8 9.2
Barclays Bank PLC (including
subsidiaries)
Certificates of deposit and
commercial paper 3.7 8.0 8.9 8.9 29.5 0.4 0.1 — — — 30.0
Asset backed commercial paper 2.1 3.2 0.3 0.1 5.7 — — — — — 5.7
Senior unsecured (public
benchmark) — 0.1 — 1.3 1.4 — 1.0 — — 0.5 2.9
Senior unsecured (privately
placed)3 0.9 2.6 2.3 5.3 11.1 7.7 7.5 4.9 3.5 21.8 56.5
Covered Bonds — — — — — — — — — — —
Asset backed securities — — 0.5 0.1 0.6 0.6 0.1 0.1 0.3 1.4 3.1
Subordinated liabilities — 0.4 — 1.0 1.4 1.1 0.1 0.1 — 0.9 3.6
Barclays Bank UK PLC
(including subsidiaries)
Certificates of deposit and
commercial paper 1.6 2.0 0.1 0.1 3.8 — — — — — 3.8
Senior unsecured (public
benchmark) — — — — — — — — — 0.2 0.2
Covered Bonds — — — 2.2 2.2 1.7 — — — 1.1 5.0
Total as at 30 June 2021 8.3 17.5 12.2 19.8 57.8 16.2 15.9 12.9 10.6 45.3 158.7
Of which secured 2.1 3.2 0.8 2.4 8.5 2.3 0.1 0.1 0.3 2.5 13.8
Of which unsecured 6.2 14.3 11.4 17.4 49.3 13.9 15.8 12.8 10.3 42.8 144.9
Total as at 31 December 2020 5.7 15.4 9.5 12.1 42.7 15.6 16.7 12.3 10.2 47.5 145.0
Of which secured 2.3 5.0 0.7 0.5 8.5 3.1 2.2 0.5 0.2 2.6 17.1
Of which unsecured 3.4 10.4 8.8 11.6 34.2 12.5 14.5 11.8 10.0 44.9 127.9
1 The composition of wholesale funds comprises the balance sheet reported financial liabilities at fair value, debt securities in issue and subordinated
liabilities. It does not include participation in the central bank facilities reported within repurchase agreements and other similar secured borrowing.
2 Term funding comprises public benchmark and privately placed senior unsecured notes, covered bonds, asset-backed securities and subordinated
debt where the original maturity of the instrument is more than 1 year.
3 Includes structured notes of £47.9bn, of which £10.2bn matures within one year.
Treasury and Capital Risk
53

-- 56 of 125 --

Capital
The Group’s Overall Capital Requirement for CET1 is 11.2% comprising a 4.5% Pillar 1 minimum, a 2.5% Capital
Conservation Buffer (CCB), a 1.5% Global Systemically Important Institution (G-SII) buffer, a 2.7% Pillar 2A requirement
and a 0% Countercyclical Capital Buffer (CCyB).
The Group’s CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. On 11
March 2020, the Financial Policy Committee (FPC) set the CCyB rate for UK exposures at 0% with immediate effect. The
buffer rates set by other national authorities for non-UK exposures are not currently material. Overall, this results in a
0.0% CCyB for the Group.
The Group’s Pillar 2A requirement as per the PRA’s Individual Capital Requirement is 4.8% of which at least 56.25%
needs to be met with CET1 capital, equating to approximately 2.7% of RWAs. The Pillar 2A requirement is subject to at
least annual review and has been set as a nominal capital amount. This is based on a point in time assessment and the
requirement (when expressed as a proportion of RWAs) will change depending on the total RWAs at each reporting
period.
Following the withdrawal of the UK from the EU, any references to CRR as amended by CRR II mean, unless otherwise
specified, CRR as amended by CRR II, as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018
and subject to the temporary transitional powers (TTP) available to UK regulators to delay or phase-in on-shoring
changes to UK regulatory requirements arising at the end of the transition period until 31 March 2022, as at the
applicable reporting date. With effect from 26 June 2021, the Financial Services Act 2021 amended CRR as amended by
CRR II in part. The amendments included an extension to the application of CRR II settlement netting to the CRR
leverage exposure which was due to expire on 27 June 2021 under CRR II quick fix measures. Throughout the TTP
period, the Bank of England (BoE) and PRA will continue to review the UK regulatory framework and the Group
disclosures will reflect the amended framework as applicable at the effective reporting date.
On 26 April 2019, a prudential backstop was implemented for qualifying exposures originating after 26 April 2019 that
have been non-performing for more than 2 years. Where minimum coverage requirements for qualifying non-performing
exposures are not met, the difference must be deducted from CET1 capital. Different conversion factors are applied for
secured and unsecured exposures depending on the length of time the exposures have been non-performing. For 2021,
the conversion factor applied to secured non-performing exposures is 0% and for unsecured non-performing exposures is
35% prior to any coverage being applied. For H121 the impact to CET1 capital is immaterial.
On 9 July 2021, the PRA published their near final policy statement on the implementation of Basel III standards. The
policy statement confirmed the PRA’s intention to revert to the previous treatment of 100% CET1 capital deduction for
qualifying software assets, meaning the c.40bps benefit in the CET1 ratio will be reversed from 1 January 2022.
Treasury and Capital Risk
54

-- 57 of 125 --

Capital ratios1,2,3 As at
30.06.21
As at
31.03.21
As at
31.12.20
CET1 15.1% 14.6% 15.1%
Tier 1 (T1) 18.9% 18.4% 19.0%
Total regulatory capital 22.3% 21.8% 22.1%
Capital resources £m £m £m
Total equity excluding non-controlling interests per the balance sheet 67,052 65,105 65,797
Less: other equity instruments (recognised as AT1 capital) (11,167) (11,179) (11,172)
Adjustment to retained earnings for foreseeable ordinary share dividends (510) (303) (174)
Adjustment to retained earnings for foreseeable repurchase of shares — (439) —
Adjustment to retained earnings for foreseeable other equity coupons (35) (42) (30)
Other regulatory adjustments and deductions
Additional value adjustments (PVA) (1,447) (1,496) (1,146)
Goodwill and intangible assets (6,814) (6,504) (6,914)
Deferred tax assets that rely on future profitability excluding temporary differences (664) (629) (595)
Fair value reserves related to gains or losses on cash flow hedges (665) (850) (1,575)
Gains or losses on liabilities at fair value resulting from own credit 934 1,202 870
Defined benefit pension fund assets (1,828) (1,192) (1,326)
Direct and indirect holdings by an institution of own CET1 instruments (50) (50) (50)
Adjustment under IFRS 9 transitional arrangements 1,331 2,285 2,556
Other regulatory adjustments 88 (4) 55
CET1 capital 46,225 45,904 46,296
AT1 capital
Capital instruments and related share premium accounts 11,167 11,179 11,172
Qualifying AT1 capital (including minority interests) issued by subsidiaries 648 655 646
Other regulatory adjustments and deductions (80) (80) (80)
AT1 capital 11,735 11,754 11,738
T1 capital 57,960 57,658 58,034
T2 capital
Capital instruments and related share premium accounts 8,969 8,951 7,836
Qualifying T2 capital (including minority interests) issued by subsidiaries 1,401 1,641 1,893
Credit risk adjustments (excess of impairment over expected losses) 79 95 57
Other regulatory adjustments and deductions (160) (160) (160)
Total regulatory capital 68,249 68,185 67,660
Total RWAs 306,424 313,356 306,203
1 CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9
transitional arrangements and the grandfathering of CRR and CRR II non-compliant capital instruments.
2 The fully loaded CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays PLC AT1 securities, was 14.7%, with £44.9bn of
CET1 capital and £306.2bn of RWAs calculated without applying the transitional arrangements of the CRR as amended by CRR II.
3 The Group’s CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays Bank PLC 7.625% Contingent Capital Notes, was
15.1%. For this calculation CET1 capital and RWAs are calculated applying the transitional arrangements under the CRR as amended by CRR II,
including the IFRS 9 transitional arrangements. The benefit of the Financial Services Authority (FSA) October 2012 interpretation of the transitional
provisions, relating to the implementation of CRD IV, expired in December 2017.
Treasury and Capital Risk
55

-- 58 of 125 --

Movement in CET1 capital Three
months
ended
30.06.21
Six months
ended
30.06.21
£m £m
Opening CET1 capital 45,904 46,296
Profit for the period attributable to equity holders 2,302 4,201
Own credit relating to derivative liabilities 3 17
Ordinary share dividends paid and foreseen (380) (509)
Purchased and foreseeable share repurchase — (700)
Other equity coupons paid and foreseen (187) (394)
Increase in retained regulatory capital generated from earnings 1,738 2,615
Net impact of share schemes 119 (48)
Fair value through other comprehensive income reserve 70 (250)
Currency translation reserve (17) (495)
Other reserves 5 (1)
Increase / (decrease) in other qualifying reserves 177 (794)
Pension remeasurements within reserves 289 103
Defined benefit pension fund asset deduction (636) (502)
Net impact of pensions (347) (399)
Additional value adjustments (PVA) 49 (301)
Goodwill and intangible assets (310) 100
Deferred tax assets that rely on future profitability excluding those arising from temporary differences (35) (69)
Adjustment under IFRS 9 transitional arrangements (954) (1,225)
Other regulatory adjustments 3 2
Decrease in regulatory capital due to adjustments and deductions (1,247) (1,493)
Closing CET1 capital 46,225 46,225
CET1 capital decreased £0.1bn to £46.2bn (December 2020: £46.3bn).
£4.2bn of capital generated from profits were partially offset by £1.6bn dividends paid and foreseen including £0.7bn for
the share buyback announced with FY20 results, a £0.5bn accrual towards a FY21 dividend and £0.4bn of equity
coupons paid. Other significant movements in the period were:
• A £0.3bn reduction in the fair value through other comprehensive income reserve driven by a decrease in the fair
value of bonds due to increasing bond yields
• A 0.5bn decrease in the currency translation reserves driven by the depreciation of period end EUR and USD against
GBP
• A £0.4bn decrease as a result of movements relating to pensions, largely due to deficit contribution payments of
£0.35bn in April 2021
• A £0.3bn increase in the PVA deduction due to the removal of temporary regulatory supporting measures applied to
certain additional valuation adjustments
• A £1.2bn decrease in IFRS 9 transitional relief, after tax, primarily due to a credit impairment net release, impairment
migrations from stage 2 to stage 3 and a decrease to the amount of relief applied to the pre-2020 impairment charge
reducing to 50% in 2021 from 70% in 2020
Treasury and Capital Risk
56

-- 59 of 125 --

RWAs by risk type and business
Credit risk Counterparty credit risk Market Risk
Operational
risk
Total
RWAs
STD IRB STD IRB
Settlem
ent
Risk CVA STD IMA
As at 30.06.21 £m £m £m £m £m £m £m £m £m £m
Barclays UK 7,151 52,995 437 — — 163 33 — 11,381 72,160
Corporate and
Investment Bank 26,406 71,540 15,343 18,973 101 2,668 17,761 18,010 23,453 194,255
Consumer, Cards and
Payments 19,218 2,509 158 40 — 29 — 55 6,948 28,957
Barclays
International 45,624 74,049 15,501 19,013 101 2,697 17,761 18,065 30,401 223,212
Head Office 4,591 7,269 — — — — — — (808) 11,052
Barclays Group 57,366 134,313 15,938 19,013 101 2,860 17,794 18,065 40,974 306,424
As at 30.03.21
Barclays UK 7,066 53,512 431 — — 217 64 — 11,381 72,671
Corporate and
Investment Bank 25,832 75,854 13,781 19,218 102 2,452 16,479 24,083 23,452 201,253
Consumer, Cards and
Payments 18,621 2,875 178 41 — 28 — 59 6,949 28,751
Barclays
International 44,453 78,729 13,959 19,259 102 2,480 16,479 24,142 30,401 230,004
Head Office 4,424 7,065 — — — — — — (808) 10,681
Barclays Group 55,943 139,306 14,390 19,259 102 2,697 16,543 24,142 40,974 313,356
As at 31.12.20
Barclays UK 7,360 54,340 394 — — 136 72 — 11,359 73,661
Corporate and
Investment Bank 24,660 73,792 12,047 20,280 246 2,351 13,123 22,363 23,343 192,205
Consumer, Cards and
Payments 19,754 3,041 177 45 — 31 — 71 6,996 30,115
Barclays
International 44,414 76,833 12,224 20,325 246 2,382 13,123 22,434 30,339 222,320
Head Office 4,153 6,869 — — — — — — (800) 10,222
Barclays Group 55,927 138,042 12,618 20,325 246 2,518 13,195 22,434 40,898 306,203
Movement analysis of RWAs
Credit risk Counterparty
credit risk Market risk Operational
risk Total RWAs
£m £m £m £m £m
Opening RWAs (as at 31.12.20) 193,969 35,707 35,629 40,898 306,203
Book size 378 1,698 1,519 76 3,671
Acquisitions and disposals (874) — — — (874)
Book quality 1,074 277 — — 1,351
Model updates (1,070) (186) — — (1,256)
Methodology and policy (115) 416 (1,289) — (988)
Foreign exchange movements1 (1,683) — — — (1,683)
Total RWA movements (2,290) 2,205 230 76 221
Closing RWAs (as at 30.06.21) 191,679 37,912 35,859 40,974 306,424
1 Foreign exchange movements does not include foreign exchange for counterparty credit risk or market risk.
Treasury and Capital Risk
57

-- 60 of 125 --

Overall RWAs remained broadly stable at £306.4bn (December 2020: £306.2bn).
Credit risk RWAs decreased £2.3bn:
• A £1.1bn increase in book quality is primarily due to reduction in credit quality
• A £1.1bn decrease in model updates primarily due to modelled risk weight recalibrations
• A £1.7bn decrease in FX is due to the depreciation of period end EUR and USD against GBP
Counterparty Credit risk RWAs increased £2.2bn:
• A £1.7bn increase in book size primarily due to an increase in trading activities across SFTs and derivatives
Market risk RWAs increased £0.2bn:
• A £1.5bn increase in book size primarily due to increased client and trading activities
• A £1.3bn decrease in methodology and policy is driven by a change in the historical look back period of the VaR
model from two years to one year
Treasury and Capital Risk
58

-- 61 of 125 --

Leverage ratio and exposures
The Group is subject to a leverage ratio requirement of 3.8% as at 30 June 2021. This comprises the 3.25% minimum
requirement, a G-SII additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer of
0.0%. Although the leverage ratio is expressed in terms of T1 capital, 75% of the minimum requirement, equating to
2.4375%, needs to be met with CET1 capital. In addition, the G-SII ALRB must be covered solely with CET1 capital. The
CET1 capital held against the 0.53% G-SII ALRB was £6.3bn.
The Group is required to disclose an average UK leverage ratio which is based on capital on the last day of each month
in the quarter and an exposure measure for each day in the quarter. The Group is also required to disclose a UK leverage
ratio based on capital and exposure on the last day of the quarter. Both approaches exclude qualifying claims on central
banks from the leverage exposures and include the PRA’s adoption of CRR II settlement netting.
On 29 June 2021, the FPC and PRA issued a consultation paper on proposed changes to the UK leverage ratio
framework. The consultation states the intention to move to a single UK leverage ratio requirement meaning that the CRR
leverage ratio will no longer apply for UK banks from 1 January 2022. Whilst largely upholding the existing framework,
some technical changes to the exposure measure have been proposed that will align to the Basel III standards. Minimum
requirements for the Group remain the same with minimum requirements also expected to be applied at the individual
level; individual requirements may be replaced with a sub-consolidated measure, subject to permission from the PRA,
from 1 January 2023.
Treasury and Capital Risk
59

-- 62 of 125 --

Leverage ratios1,2
As at
30.06.21
As at
31.03.21
As at
31.12.20
£m £m £m
Average UK leverage ratio 4.8% 4.9% 5.0%
Average T1 capital3 57,280 57,040 57,069
Average UK leverage exposure 1,191,986 1,174,887 1,146,919
UK leverage ratio 5.0% 5.0% 5.3%
CET1 capital 46,225 45,904 46,296
AT1 capital 11,087 11,099 11,092
T1 capital3 57,312 57,003 57,388
UK leverage exposure 1,153,570 1,145,413 1,090,907
UK leverage exposure
Accounting assets
Derivative financial instruments 256,636 270,717 302,446
Derivative cash collateral 54,063 51,797 64,798
Securities financing transactions (SFTs) 182,820 189,496 164,034
Loans and advances and other assets 882,814 867,646 818,236
Total IFRS assets 1,376,333 1,379,656 1,349,514
Regulatory consolidation adjustments (1,406) (1,926) (1,144)
Derivatives adjustments
Derivatives netting (229,123) (242,857) (272,275)
Adjustments to collateral (42,774) (45,464) (57,414)
Net written credit protection 16,730 16,814 14,986
Potential future exposure (PFE) on derivatives 135,162 128,454 117,010
Total derivatives adjustments (120,005) (143,053) (197,693)
SFTs adjustments 23,511 22,294 21,114
Regulatory deductions and other adjustments (22,525) (18,111) (17,469)
Weighted off-balance sheet commitments 111,870 118,134 113,704
Qualifying central bank claims (172,465) (167,054) (155,890)
Settlement netting (41,743) (44,527) (21,229)
UK leverage exposure 1,153,570 1,145,413 1,090,907
1 Fully loaded average UK leverage ratio was 4.7%, with £55.5bn of T1 capital and £1,190.2bn of leverage exposure. Fully loaded UK leverage ratio was
4.9%, with £56.0bn of T1 capital and £1,152.2bn of leverage exposure. Fully loaded UK leverage ratios are calculated without applying the transitional
arrangements of the CRR as amended by CRR II.
2 Capital and leverage measures are calculated applying the transitional arrangements of the CRR as amended by CRR II.
3 T1 capital is calculated in line with the PRA Handbook.
Treasury and Capital Risk
60

-- 63 of 125 --

The average UK leverage ratio decreased to 4.8% (December 2020: 5.0%). The average leverage exposure increased
by £45.1bn to £1,192.0bn (December 2020: £1,146.9bn) largely driven by an increase in SFTs, TPAs and PFE on
derivatives.
The UK leverage ratio decreased to 5.0% (December 2020: 5.3%). The UK leverage exposure increased by £62.7bn to
£1,153.6bn (December 2020: £1,090.9bn) primarily driven by a £19.3bn increase in TPAs, a £18.8bn increase in SFTs
and a £18.2bn increase in PFE on derivatives due to increased trading activity in CIB.
The Group also discloses a CRR leverage ratio1 within its additional regulatory disclosures prepared in accordance with
EBA guidelines on disclosure under Part Eight of the CRR (see Barclays PLC Pillar 3 Report H1 2021, expected to be
published on 13 August 2021 and which will be available at home.barclays/investor-relations/reports-and-events/latest-
financial-results).
1 CRR leverage ratio as amended by CRR II.
Treasury and Capital Risk
61

-- 64 of 125 --

MREL
The Group is currently required to meet the higher of: (i) the requirements set by the BoE based on RWAs and the higher
of average and UK leverage exposures; and (ii) the requirements in CRR as amended by CRR II based on RWAs and
CRR leverage exposures. The MREL requirements are subject to phased implementation and will be fully implemented
by 1 January 2022. As at 30 June 2021, the Group’s MREL requirement was to meet 6.9% of CRR leverage exposures.
On 22 July 2021 the BoE published a consultation paper on its approach to setting MREL. Under the proposed changes
to their 2018 Statement of Policy, from 1 January 2022, the Group’s expected MREL requirements will be to meet the
higher of: (i) two times the sum of Pillar 1 and Pillar 2A; and (ii) the higher of two times the applicable leverage ratio
requirement or 6.75% of leverage exposures. As the FPC and PRA’s intention is to move to a single UK leverage
framework, this means that CRR leverage exposure requirements in relation to MREL may no longer apply from 1
January 2022. Additionally, the proposals clarify that own funds instruments issued by subsidiaries will no longer be
eligible to count towards the Group’s MREL from 1 January 2022.
CET1 capital cannot be counted towards both MREL and the capital buffers, meaning that the buffers will effectively be
applied above MREL requirements.
Own funds and eligible liabilities ratios1,2 As a percentage of RWAs
As a percentage of CRR
leverage exposure
As at
30.06.21
As at
31.03.21
As at
31.12.20
As at
30.06.21
As at
31.03.21
As at
31.12.20
Total Barclays PLC (the Parent company) own funds and
eligible liabilities 33.7% 32.1% 32.7% 7.7% 7.6% 8.0%
Total own funds and eligible liabilities, including eligible
Barclays Bank PLC instruments 34.4% 32.8% 33.6% 7.9% 7.8% 8.2%
Own funds and eligible liabilities1,2 As at
30.06.21
As at
31.03.21
As at
31.12.20
£m £m £m
CET1 capital 46,225 45,904 46,296
AT1 capital instruments and related share premium accounts3 11,087 11,099 11,092
T2 capital instruments and related share premium
accounts3 8,888 8,886 7,733
Eligible liabilities 37,095 34,571 35,086
Total Barclays PLC (the Parent company) own funds and eligible liabilities 103,295 100,460 100,207
Qualifying AT1 capital (including minority interests) issued by subsidiaries 648 655 646
Qualifying T2 capital (including minority interests) issued by subsidiaries 1,401 1,641 1,893
Total own funds and eligible liabilities, including eligible Barclays Bank PLC instruments 105,344 102,756 102,746
Total RWAs 306,424 313,356 306,203
Total CRR leverage exposure4 1,334,929 1,320,628 1,254,157
1 CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9
transitional arrangements and the grandfathering of CRR and CRR II non-compliant capital instruments.
2 The BoE has set external MREL based on the higher of RWAs and CRR or UK leverage exposures which could result in the binding measure changing
in future periods. The 30 June 2021 Barclays PLC (the Parent company) own funds and eligible liabilities ratio as a percentage of the UK leverage
exposure was 9.0% and as a percentage of the average UK leverage exposure was 8.7%.
3 Includes other AT1 capital regulatory adjustments and deductions of £80m (December 2020: £80m), and other T2 credit risk adjustments and
deductions of £81m (December 2020: £103m).
4 Fully loaded CRR leverage exposure is calculated without applying the transitional arrangements of the CRR as amended by CRR II.
Treasury and Capital Risk
62

-- 65 of 125 --

Condensed consolidated income statement (unaudited)
Half year
ended
30.06.21
Half year
ended
30.06.20
Notes1 £m £m
Interest and similar income 5,279 6,437
Interest and similar expense (1,376) (2,214)
Net interest income 3,903 4,223
Fee and commission income 3 4,682 4,399
Fee and commission expense 3 (976) (1,090)
Net fee and commission income 3 3,706 3,309
Net trading income 3,482 4,198
Net investment income 152 (136)
Other income 72 27
Total income 11,315 11,621
Credit impairment releases/(charges) 742 (3,738)
Net operating income 12,057 7,883
Staff costs 4 (4,334) (4,053)
Infrastructure, administration and general expenses 5 (2,798) (2,510)
Litigation and conduct (99) (30)
Operating expenses (7,231) (6,593)
Share of post-tax results of associates and joint ventures 154 (31)
Profit on disposal of subsidiaries, associates and joint ventures (1) 13
Profit before tax 4,979 1,272
Tax charge 6 (759) (113)
Profit after tax 4,220 1,159
Attributable to:
Equity holders of the parent 3,812 695
Other equity instrument holders 389 427
Total equity holders of the parent 4,201 1,122
Non-controlling interests 7 19 37
Profit after tax 4,220 1,159
Earnings per share p p
Basic earnings per ordinary share 8 22.2 4.0
Diluted earnings per ordinary share 8 21.7 3.9
1 For notes to the Financial Statements see pages 69 to 94.
Condensed Consolidated Financial Statements
63

-- 66 of 125 --

Condensed consolidated statement of comprehensive income (unaudited)
Half year
ended
30.06.21
Half year
ended
30.06.20
Notes1 £m £m
Profit after tax 4,220 1,159
Other comprehensive income/(loss) that may be recycled to profit or loss:2
Currency translation reserve 19 (495) 1,220
Fair value through other comprehensive income reserve 19 (365) 137
Cash flow hedging reserve 19 (911) 912
Other 19 — (6)
Other comprehensive income that may be recycled to profit (1,771) 2,263
Other comprehensive income/(loss) not recycled to profit or loss:2
Retirement benefit remeasurements 16 103 645
Fair value through other comprehensive income reserve 19 115 (515)
Own credit 19 (47) 496
Other comprehensive income not recycled to profit 171 626
Other comprehensive income for the period (1,600) 2,889
Total comprehensive income for the period 2,620 4,048
Attributable to:
Equity holders of the parent 2,601 4,011
Non-controlling interests 19 37
Total comprehensive income for the period 2,620 4,048
1 For notes to the Financial Statements see pages 69 to 94.
2 Reported net of tax.
Condensed Consolidated Financial Statements
64

-- 67 of 125 --

Condensed consolidated balance sheet (unaudited)
As at
30.06.21
As at
31.12.20
Assets Notes1 £m £m
Cash and balances at central banks 216,963 191,127
Cash collateral and settlement balances 111,921 101,367
Loans and advances at amortised cost 12 348,549 342,632
Reverse repurchase agreements and other similar secured lending 4,459 9,031
Trading portfolio assets 147,239 127,950
Financial assets at fair value through the income statement 194,421 175,151
Derivative financial instruments 10 256,636 302,446
Financial assets at fair value through other comprehensive income 73,260 78,688
Investments in associates and joint ventures 907 781
Goodwill and intangible assets 13 8,196 7,948
Property, plant and equipment 3,581 4,036
Current tax assets 228 477
Deferred tax assets 6 3,771 3,444
Retirement benefit assets 16 2,701 1,814
Other assets 3,501 2,622
Total assets 1,376,333 1,349,514
Liabilities
Deposits at amortised cost 12 500,895 481,036
Cash collateral and settlement balances 101,923 85,423
Repurchase agreements and other similar secured borrowing 20,005 14,174
Debt securities in issue 90,733 75,796
Subordinated Liabilities 14 12,839 16,341
Trading portfolio liabilities 56,986 47,405
Financial liabilities designated at fair value 264,164 249,765
Derivative financial instruments 10 247,034 300,775
Current tax liabilities 592 645
Deferred tax liabilities 6 8 15
Retirement benefit liabilities 16 338 291
Other liabilities 10,928 8,662
Provisions 15 1,772 2,304
Total liabilities 1,308,217 1,282,632
Equity
Called up share capital and share premium 17 4,568 4,637
Other reserves 19 2,856 4,461
Retained earnings 48,461 45,527
Shareholders' equity attributable to ordinary shareholders of the parent 55,885 54,625
Other equity instruments 18 11,167 11,172
Total equity excluding non-controlling interests 67,052 65,797
Non-controlling interests 7 1,064 1,085
Total equity 68,116 66,882
Total equity and liabilities 1,376,333 1,349,514
1 For notes to the Financial Statements see pages 69 to 94.
Condensed Consolidated Financial Statements
65

-- 68 of 125 --

Condensed consolidated statement of changes in equity (unaudited)
Called up
share
capital and
share
premium1 Other equity
instruments1 Other
reserves1
Retained
earnings Total
Non-
controlling
interests2
Total
equity
Half year ended 30.06.21 £m £m £m £m £m £m £m
Balance as at 1 January 2021 4,637 11,172 4,461 45,527 65,797 1,085 66,882
Profit after tax — 389 — 3,812 4,201 19 4,220
Currency translation movements — — (495) — (495) — (495)
Fair value through other
comprehensive income reserve — — (250) — (250) — (250)
Cash flow hedges — — (911) — (911) — (911)
Retirement benefit remeasurements — — — 103 103 — 103
Own credit — — (47) — (47) — (47)
Total comprehensive income for
the period — 389 (1,703) 3,915 2,601 19 2,620
Equity settled share schemes 25 — — 289 314 — 314
Other equity instruments coupon
paid — (389) — — (389) — (389)
Vesting of employee share schemes — — 4 (397) (393) — (393)
Dividends paid — — — (173) (173) (16) (189)
Repurchase of shares (94) — 94 (700) (700) — (700)
Other movements — (5) — — (5) (24) (29)
Balance as at 30 June 2021 4,568 11,167 2,856 48,461 67,052 1,064 68,116
Half year ended 31.12.20
Balance as at 1 July 2020 4,620 10,871 6,996 45,817 68,304 1,237 69,541
Profit after tax — 430 — 831 1,261 41 1,302
Currency translation movements — — (1,693) — (1,693) — (1,693)
Fair value through other
comprehensive income reserve — — 570 — 570 — 570
Cash flow hedges — — (339) — (339) — (339)
Retirement benefit remeasurements — — — (756) (756) — (756)
Own credit — — (1,077) — (1,077) — (1,077)
Other — — — 11 11 — 11
Total comprehensive income for
the period — 430 (2,539) 86 (2,023) 41 (1,982)
Equity settled share schemes 17 — — (300) (283) — (283)
Issue and exchange of other equity
instruments — 311 — (55) 256 (158) 98
Other equity instruments coupon
paid — (430) — — (430) — (430)
Vesting of employee share schemes — — 4 (20) (16) — (16)
Dividends paid — — — — — (42) (42)
Other movements — (10) — (1) (11) 7 (4)
Balance as at 31 December 2020 4,637 11,172 4,461 45,527 65,797 1,085 66,882
1 Details of share capital, other equity instruments and other reserves are shown on pages 84 to 85.
2 Details of non-controlling interests are shown on page 73.
Condensed Consolidated Financial Statements
66

-- 69 of 125 --

Condensed consolidated statement of changes in equity (unaudited)
Called up
share
capital and
share
premium1
Other equity
instruments1
Other
reserves1
Retained
earnings Total
Non-
controlling
interests2
Total
equity
Half year ended 30.06.20 £m £m £m £m £m £m £m
Balance as at 1 January 2020 4,594 10,871 4,760 44,204 64,429 1,231 65,660
Profit after tax — 427 — 695 1,122 37 1,159
Currency translation movements — — 1,220 — 1,220 — 1,220
Fair value through other comprehensive
income reserve — — (378) — (378) — (378)
Cash flow hedges — — 912 — 912 — 912
Retirement benefit remeasurements — — — 645 645 — 645
Own credit — — 496 — 496 — 496
Other — — — (6) (6) — (6)
Total comprehensive income for the
period — 427 2,250 1,334 4,011 37 4,048
Equity settled share schemes 26 — — 603 629 — 629
Other equity instruments coupon paid — (427) — — (427) — (427)
Vesting of employee share schemes — — (14) (327) (341) — (341)
Dividends paid — — — — — (37) (37)
Other movements — — — 3 3 6 9
Balance as at 30 June 2020 4,620 10,871 6,996 45,817 68,304 1,237 69,541
1 Details of share capital, other equity instruments and other reserves are shown on pages 84 to 85.
2 Details of non-controlling interests are shown on page 73.
Condensed Consolidated Financial Statements
67

-- 70 of 125 --

Condensed consolidated cash flow statement (unaudited)
Half year
ended
30.06.21
Half year
ended
30.06.201
£m £m
Profit before tax 4,979 1,272
Adjustment for non-cash items2 6,900 (1,431)
Net increase in loans and advances at amortised cost2 432 (12,868)
Net increase in deposits at amortised cost 19,859 51,126
Net increase in debt securities in issue 13,041 24,183
Changes in other operating assets and liabilities3 (5,559) (6,770)
Corporate income tax paid (712) (351)
Net cash from operating activities 38,940 55,161
Net cash from investing activities2 (3,389) (17,844)
Net cash from financing activities (2,562) 3,133
Effect of exchange rates on cash and cash equivalents (5,535) 7,814
Net increase/(decrease) in cash and cash equivalents 27,454 48,264
Cash and cash equivalents at beginning of the period3 210,142 166,613
Cash and cash equivalents at end of the period3 237,596 214,877
1 H120 comparative figures have been restated to make the condensed cash flow statement more relevant following a review of the disclosure and the
accounting policies applied that was undertaken in H220. Amendments, which were first applied in the Barclays PLC Annual Report 2020, have been
made to the classification of cash collateral reported within cash and cash equivalents and to the presentation of items within net cash flows from
operating and investing activities. Footnotes 2 and 3 below quantify the impact of the changes to the respective cash flow categories in H120 and
provide further detail.
2 Movements in cash and cash equivalents relating to debt securities at amortised cost were previously shown within loans and advances at amortised
cost in operating activities. These debt securities holdings are now considered to be part of the investing activity performed by the Group following a
change in accounting policy and have been presented within investing activities in H121. Comparatives have been restated. The effect of this change
was to reclassify £6,245m of net cash outflows from operating activities to investing activities in H120.
3 Cash and cash equivalents have been restated to exclude cash collateral and settlement balances, with the exception of balances that the Group holds
at central banks related to payment schemes. The effect of this change decreased cash and cash equivalents by £28,301m as at 30 June 2020 and
£16,774m as at 31 December 2019. As a result, net cash from operating activities decreased by £11,527m in H120, representing the net increase in the
cash collateral and settlement balances line item in this period.
Condensed Consolidated Financial Statements
68

-- 71 of 125 --

1. Basis of preparation
These condensed consolidated interim financial statements for the six months ended 30 June 2021 have been prepared
in accordance with the Disclosure and Transparency Rules (DTR) of the UK’s Financial Conduct Authority (FCA) and IAS
34, Interim Financial Reporting, as published by the International Accounting Standards Board (IASB) and adopted by the
UK. The condensed consolidated interim financial statements should be read in conjunction with the annual financial
statements for the year ended 31 December 2020. The annual financial statements for the year ended 31 December 2020
were prepared in accordance with international accounting standards in conformity with the requirements of the
Companies Act 2006 and in accordance with International Financial Reporting Standards (IFRS) and interpretations
(IFRICs) as issued by the IASB and adopted pursuant to Regulation (EC) No 1606/2002 as it applies in the European
Union as well as adopted by the UK. UK adopted IFRS and EU adopted IFRS are currently the same and were the same
as at 31 December 2020.
The accounting policies and methods of computation used in these condensed consolidated interim financial statements
are the same as those used in the Barclays PLC Annual Report 2020.
1. Going concern
The financial statements are prepared on a going concern basis, as the Directors are satisfied that the Group and parent
company have the resources to continue in business for a period of at least 12 months from approval of the interim
financial statements. In making this assessment, the Directors have considered a wide range of information relating to
present and future conditions and includes a review of a working capital report (WCR). The WCR is used by the Directors
to assess the future performance of the business and that it has the resources in place that are required to meet its
ongoing regulatory requirements. The WCR also includes an assessment of the impact of internally generated stress
testing scenarios on the liquidity and capital requirement forecasts. The stress tests used were based upon an
assessment of reasonably possible downside economic scenarios that the Group could experience.
The WCR indicated that the Group had sufficient capital in place to support its future business requirements and
remained above its regulatory minimum requirements in the internal stress scenarios.
2. Other disclosures
The Credit risk disclosures on pages 28 to 46 form part of these interim financial statements.
Financial Statement Notes
69

-- 72 of 125 --

2. Segmental reporting
Analysis of results by business
Barclays
UK
Barclays
International
Head
Office
Barclays
Group
Half year ended 30.06.21 £m £m £m £m
Total income 3,199 8,218 (102) 11,315
Credit impairment releases 443 293 6 742
Net operating income/(expenses) 3,642 8,511 (96) 12,057
Operating expenses (2,114) (4,606) (412) (7,132)
Litigation and conduct (22) (84) 7 (99)
Total operating expenses (2,136) (4,690) (405) (7,231)
Other net income1 — 22 131 153
Profit/(loss) before tax 1,506 3,843 (370) 4,979
As at 30.06.21 £bn £bn £bn £bn
Total assets 311.2 1,046.8 18.3 1,376.3
Barclays
UK
Barclays
International
Head
Office
Barclays
Group
Half year ended 30.06.20 £m £m £m £m
Total income 3,171 8,654 (204) 11,621
Credit impairment charges (1,064) (2,619) (55) (3,738)
Net operating income/(expenses) 2,107 6,035 (259) 7,883
Operating expenses (2,041) (4,405) (117) (6,563)
Litigation and conduct (11) (11) (8) (30)
Total operating expenses (2,052) (4,416) (125) (6,593)
Other net income/(expenses)1 13 10 (41) (18)
Profit/(loss) before tax 68 1,629 (425) 1,272
As at 31.12.20 £bn £bn £bn £bn
Total assets 289.1 1,041.8 18.6 1,349.5
1 Other net income/(expenses) represents the share of post-tax results of associates and joint ventures, profit (or loss) on disposal of subsidiaries,
associates and joint ventures and gains on acquisitions.
Split of income by geographic region1
Half year
ended
30.06.21
Half year
ended
30.06.20
£m £m
United Kingdom 5,895 5,989
Europe 1,222 1,199
Americas 3,608 3,776
Africa and Middle East 20 20
Asia 570 637
Total 11,315 11,621
1 The geographical analysis is based on the location of the office where the transactions are recorded.
Financial Statement Notes
70

-- 73 of 125 --

3. Net fee and commission income
Fee and commission income is disaggregated below and includes a total for fees in scope of IFRS 15, Revenue from
Contracts with Customers:
Barclays UK
Barclays
International Head Office Total
Half year ended 30.06.21 £m £m £m £m
Fee type
Transactional 408 1,181 — 1,589
Advisory 83 459 1 543
Brokerage and execution 109 553 — 662
Underwriting and syndication — 1,715 — 1,715
Other 35 73 3 111
Total revenue from contracts with customers 635 3,981 4 4,620
Other non-contract fee income — 62 — 62
Fee and commission income 635 4,043 4 4,682
Fee and commission expense (108) (861) (7) (976)
Net fee and commission income 527 3,182 (3) 3,706
Barclays UK
Barclays
International Head Office Total
Half year ended 30.06.20 £m £m £m £m
Fee type
Transactional 386 1,157 — 1,543
Advisory 79 306 1 386
Brokerage and execution 102 685 — 787
Underwriting and syndication — 1,468 — 1,468
Other 38 115 2 155
Total revenue from contracts with customers 605 3,731 3 4,339
Other non-contract fee income — 60 — 60
Fee and commission income 605 3,791 3 4,399
Fee and commission expense (148) (940) (2) (1,090)
Net fee and commission income 457 2,851 1 3,309
Transactional fees are service charges on deposit accounts, cash management services and transactional processing
fees. These include interchange and merchant fee income generated from credit and bank card usage.
Advisory fees are generated from wealth management services and investment banking advisory services related to
mergers, acquisitions and financial restructurings.
Brokerage and execution fees are earned for executing client transactions with various exchanges and over-the-counter
markets and assisting clients in clearing transactions.
Underwriting and syndication fees are earned for the distribution of client equity or debt securities and the arrangement
and administration of a loan syndication. These include commitment fees to provide loan financing.
Financial Statement Notes
71

-- 74 of 125 --

4. Staff costs
Half year
ended
30.06.21
Half year
ended
30.06.20
Compensation costs £m £m
Upfront bonus charge 824 476
Deferred bonus charge 262 269
Other incentives 6 4
Performance costs 1,092 749
Salaries 2,117 2,153
Social security costs 336 317
Post-retirement benefits 275 268
Other compensation costs 223 254
Total compensation costs 4,043 3,741
Other resourcing costs
Outsourcing 171 175
Redundancy and restructuring 23 39
Temporary staff costs 55 58
Other 42 40
Total other resourcing costs 291 312
Total staff costs 4,334 4,053
Barclays Group compensation costs as a % of total income 35.7 32.2
No material awards have yet been granted in relation to the 2021 bonus pool as decisions regarding incentive awards are
not taken by the Remuneration Committee until the performance for the full year can be assessed. The current year
bonus charge for the first six months represents an accrual for estimated costs in accordance with accounting
requirements. One of the primary considerations when evaluating the accrual is Group and business level returns,
aligning colleague and shareholder interests.
The Group has entered into physically settled forward contracts to hedge the settlement of certain share-based payment
schemes. The present value of the fixed forward price to be paid under these outstanding contracts is £158m and has
been recorded in retained earnings.
5. Infrastructure, administration and general expenses
Half year
ended
30.06.21
Half year
ended
30.06.20
Infrastructure costs £m £m
Property and equipment 709 757
Depreciation and amortisation 832 751
Lease payments 20 26
Impairment of property, equipment and intangible assets 304 32
Total infrastructure costs 1,865 1,566
Administration and general expenses
Consultancy, legal and professional fees 262 270
Marketing and advertising 163 158
Other administration and general expenses 508 516
Total administration and general expenses 933 944
Total infrastructure, administration and general expenses 2,798 2,510
Financial Statement Notes
72

-- 75 of 125 --

6. Tax
The tax charge for H121 was £759m (H120: £113m), representing an effective tax rate of 15.2% (H120: 8.9%). The
effective tax rate for H121 includes a benefit recognised as a result of the increase in the UK corporation tax rate and
absent this benefit the tax charge would have been £1,151m and the effective tax rate would have been 23.1%. The H120
effective tax rate included a benefit recognised for re-measurement of the Group’s UK deferred tax assets as a result of
UK corporation tax previously being maintained at a rate of 19%. Included in the H121 tax charge is a credit of £104m
(H120: £112m) in respect of payments made on AT1 instruments that are classified as equity for accounting purposes.
In its Budget held in March 2021, the UK Government announced that the UK rate of corporation tax will increase from
19% to 25% from 1 April 2023. This legislative change has been enacted, resulting in the Group’s UK deferred tax assets
increasing by £223m with a tax benefit in the income statement of £392m and a tax charge within other comprehensive
income of £169m.
The UK Government also announced that it will undertake a review of the additional 8% banking surcharge during 2021.
The Budget Report issued on 3 March 2021 outlines that “the government will set out how it intends to ensure that the
combined rate of tax on banks’ profits does not increase substantially from its current level”. Any subsequent reduction in
the banking surcharge arising from the Government’s review would result in a tax charge in the income statement and tax
credit within the other comprehensive income upon enactment as the Group’s UK deferred tax assets are again re-
measured and decreased, the timing of which is uncertain but is expected to occur in H122.
In the USA, the Biden administration published in April 2021 The Made In America Tax Plan, which proposes an increase
in the US federal corporate income tax rate. This would result in a re-measurement to increase the Group’s US deferred
tax assets upon enactment, the timing of which is uncertain. In addition, revisions to international elements of the US tax
regime are being considered that could affect the Group’s US tax position in future.
The G7 finance ministers published a communiqué on 5 June 2021 which sets out high level political agreement on global
tax reform, including the implementation of a global minimum tax rate. The Group will continue to monitor developments
and assess the potential impact of associated future legislative changes.
As at
30.06.21
As at
31.12.20
Deferred tax assets and liabilities £m £m
USA 1,908 2,049
UK 1,380 886
Other territories 483 509
Deferred tax assets 3,771 3,444
Deferred tax liabilities (8) (15)
Analysis of deferred tax assets
Temporary differences 2,972 2,709
Tax losses 799 735
Deferred tax assets 3,771 3,444
7. Non-controlling interests
Profit attributable to
non-controlling interests
Equity attributable to
non-controlling interests
Half year
ended
30.06.21
Half year
ended
30.06.20
As at
30.06.21
As at
31.12.20
£m £m £m £m
Barclays Bank PLC issued:
- Preference shares 13 28 529 529
- Upper T2 instruments 3 9 533 533
Other non-controlling interests 3 — 2 23
Total 19 37 1,064 1,085
Financial Statement Notes
73

-- 76 of 125 --

8. Earnings per share
Half year
ended
30.06.21
Half year
ended
30.06.20
£m £m
Profit attributable to ordinary equity holders of the parent 3,812 695
m m
Basic weighted average number of shares in issue 17,140 17,294
Number of potential ordinary shares 467 319
Diluted weighted average number of shares 17,607 17,613
p p
Basic earnings per ordinary share 22.2 4.0
Diluted earnings per ordinary share 21.7 3.9
9. Dividends on ordinary shares
A half year dividend for 2021 of 2.0p (H120: 0p) per ordinary share will be paid on 17 September 2021 to shareholders on
the register on 13 August 2021.
Half year ended 30.06.21 Half year ended 30.06.20
Per share Total Per share Total
Dividends paid during the period p £m p £m
Full year dividend paid during period 1.0 173 — —
For qualifying US and Canadian resident ADR holders, the half year dividend of 2.0p per ordinary share becomes 8.0p
per ADS (representing 4 shares). The ADR depositary will post the half year dividend on 17 September 2021 to ADR
holders on the record at close of business on 13 August 2021.
The Directors have confirmed their intention to initiate a share buyback of up to £500m after the balance sheet date. The
share buyback is expected to commence in the third quarter of 2021. The financial statements for the six months ended
30 June 2021 do not reflect the impact of the proposed share buyback, which will be accounted for as and when shares
are repurchased by the Company.
Financial Statement Notes
74

-- 77 of 125 --

10. Derivative financial instruments
Contract
notional
amount
Fair value
Assets Liabilities
As at 30.06.21 £m £m £m
Foreign exchange derivatives 5,654,026 66,963 (64,194)
Interest rate derivatives 37,888,009 134,734 (123,436)
Credit derivatives 920,030 5,469 (5,960)
Equity and stock index and commodity derivatives 1,541,007 48,530 (52,444)
Derivative assets/(liabilities) held for trading 46,003,072 255,696 (246,034)
Derivatives in hedge accounting relationships
Derivatives designated as cash flow hedges 91,278 806 —
Derivatives designated as fair value hedges 107,879 128 (993)
Derivatives designated as hedges of net investments 1,595 6 (7)
Derivative assets/(liabilities) designated in hedge accounting relationships 200,752 940 (1,000)
Total recognised derivative assets/(liabilities) 46,203,824 256,636 (247,034)
As at 31.12.20
Foreign exchange derivatives 5,554,037 84,739 (84,381)
Interest rate derivatives 35,257,371 172,144 (162,402)
Credit derivatives 847,845 4,605 (5,004)
Equity and stock index and commodity derivatives 1,510,718 40,392 (48,008)
Derivative assets/(liabilities) held for trading 43,169,971 301,880 (299,795)
Derivatives in hedge accounting relationships
Derivatives designated as cash flow hedges 74,437 386 —
Derivatives designated as fair value hedges 114,556 155 (980)
Derivatives designated as hedges of net investments 791 25 —
Derivative assets/(liabilities) designated in hedge accounting relationships 189,784 566 (980)
Total recognised derivative assets/(liabilities) 43,359,755 302,446 (300,775)
The IFRS netting posted against derivative assets was £33bn including £4bn of cash collateral netted (December 2020:
£44bn including £5bn cash collateral netted) and £31bn for liabilities including £5bn of cash collateral netted (December
2020: £42bn including £7bn of cash collateral netted). Derivative asset exposures would be £230bn (December 2020:
£276bn) lower than reported under IFRS if netting were permitted for assets and liabilities with the same counterparty or
for which the Group holds cash collateral of £36bn (December 2020: £43bn). Similarly, derivative liabilities would be
£225bn (December 2020: £276bn) lower reflecting counterparty netting and cash collateral placed of £31bn (December
2020: £43bn). In addition, non-cash collateral of £5bn (December 2020: £5bn) was held in respect of derivative assets
and £3bn (December 2020: £4bn) was placed in respect of derivative liabilities. Collateral amounts are limited to net on
balance sheet exposure so as to not include over-collateralisation.
Financial Statement Notes
75

-- 78 of 125 --

11. Fair value of financial instruments
This section should be read in conjunction with Note 17, Fair value of financial instruments of the Barclays PLC Annual
Report 2020 which provides more detail about accounting policies adopted, valuation methodologies used in calculating
fair value and the valuation control framework which governs oversight of valuations. There have been no changes in the
accounting policies adopted or the valuation methodologies used.
Valuation
The following table shows the Group’s assets and liabilities that are held at fair value disaggregated by valuation
technique (fair value hierarchy) and balance sheet classification:
Valuation technique using
Quoted
market
prices
Observable
inputs
Significant
unobservable
inputs
(Level 1) (Level 2) (Level 3) Total
As at 30.06.21 £m £m £m £m
Trading portfolio assets 73,405 71,282 2,552 147,239
Financial assets at fair value through the income statement 1,229 185,415 7,777 194,421
Derivative financial instruments 11,643 241,336 3,657 256,636
Financial assets at fair value through other comprehensive income 21,375 51,837 48 73,260
Investment property — — 8 8
Total assets 107,652 549,870 14,042 671,564
Trading portfolio liabilities (30,911) (26,058) (17) (56,986)
Financial liabilities designated at fair value (142) (263,710) (312) (264,164)
Derivative financial instruments (11,227) (230,207) (5,600) (247,034)
Total liabilities (42,280) (519,975) (5,929) (568,184)
As at 31.12.20
Trading portfolio assets 60,671 65,416 1,863 127,950
Financial assets at fair value through the income statement 4,503 162,142 8,506 175,151
Derivative financial instruments 9,155 288,822 4,469 302,446
Financial assets at fair value through other comprehensive income 19,792 58,743 153 78,688
Investment property — — 10 10
Total assets 94,121 575,123 15,001 684,245
Trading portfolio liabilities (24,391) (22,986) (28) (47,405)
Financial liabilities designated at fair value (159) (249,251) (355) (249,765)
Derivative financial instruments (8,762) (285,774) (6,239) (300,775)
Total liabilities (33,312) (558,011) (6,622) (597,945)
Financial Statement Notes
76

-- 79 of 125 --

The following table shows the Group’s Level 3 assets and liabilities that are held at fair value disaggregated by product
type:
As at 30.06.21 As at 31.12.20
Assets Liabilities Assets Liabilities
£m £m £m £m
Interest rate derivatives 916 (1,269) 1,613 (1,615)
Foreign exchange derivatives 151 (129) 144 (143)
Credit derivatives 100 (364) 196 (351)
Equity derivatives 2,490 (3,838) 2,498 (4,112)
Commodity derivatives — — 18 (18)
Corporate debt 981 (38) 698 (3)
Reverse repurchase and repurchase agreements — (161) — (174)
Non-asset backed loans 6,338 — 6,394 —
Asset backed securities 562 — 767 (24)
Equity cash products 402 — 542 —
Private equity investments 979 (16) 873 (14)
Other1 1,123 (114) 1,258 (168)
Total 14,042 (5,929) 15,001 (6,622)
1 Other includes commercial real estate loans, funds and fund-linked products, asset backed loans, issued debt, commercial paper, government
sponsored debt and investment property.
Assets and liabilities reclassified between Level 1 and Level 2
During the period, there were no material transfers between Level 1 and Level 2 (period ended 31 December 2020: no
material transfers between Level 1 and Level 2).
Level 3 movement analysis
The following table summarises the movements in the balances of Level 3 assets and liabilities during the period. The
table shows gains and losses and includes amounts for all financial assets and liabilities that are held at fair value
transferred to and from Level 3 during the period. Transfers have been reflected as if they had taken place at the
beginning of the period.
Asset and liability moves between Level 2 and Level 3 are primarily due to i) an increase or decrease in observable
market activity related to an input or ii) a change in the significance of the unobservable input, with assets and liabilities
classified as Level 3 if an unobservable input is deemed significant.
Financial Statement Notes
77

-- 80 of 125 --

Level 3 movement analysis
Total gains and losses
in the period
recognised in the
income statement
Total gains
or losses
recognised
in OCI
Transfers
As at
01.01.21 Purchases Sales Issues
Settle-
ments
Trading
income
Other
income In Out
As at
30.06.21
£m £m £m £m £m £m £m £m £m £m £m
Corporate debt 151 305 (87) — — 25 — — 40 (11) 423
Non-asset backed loans 709 620 (131) — (84) 13 — — 124 (106) 1,145
Asset backed securities 686 112 (294) — — (10) — — 43 (48) 489
Equity cash products 214 13 (17) — — 32 — — 29 (9) 262
Other 103 21 — — (51) (1) — — 162 (1) 233
Trading portfolio assets 1,863 1,071 (529) — (135) 59 — — 398 (175) 2,552
Non-asset backed loans 5,580 698 (299) — (687) (119) — — 69 (48) 5,194
Equity cash products 326 160 (194) — — (171) 18 — 1 — 140
Private equity investments 874 106 (9) — (8) (5) 92 — — (71) 979
Other 1,726 2,291 (2,389) — (162) (19) 1 — 16 — 1,464
Financial assets at fair value
through the income
statement
8,506 3,255 (2,891) — (857) (314) 111 — 86 (119) 7,777
Non-asset backed loans 106 — — — — — — — — (106) —
Asset backed securities 47 4 — — (5) — — 2 — — 48
Assets at fair value through
other comprehensive income 153 4 — — (5) — — 2 — (106) 48
Investment property 10 — (2) — — — — — — — 8
— —
Trading portfolio liabilities (28) (3) 14 — — (7) — — — 7 (17)
Financial liabilities
designated at fair value (355) — — — 98 7 (2) — (78) 18 (312)
Interest rate derivatives (2) 9 — — 33 (121) 4 — 21 (297) (353)
Foreign exchange derivatives 1 — — — 58 (6) — — 3 (34) 22
Credit derivatives (155) (117) 2 — (5) 12 (1) — 1 (1) (264)
Equity derivatives (1,614) (315) (1) — (32) (221) (1) — 28 808 (1,348)
Net derivative financial
instruments1 (1,770) (423) 1 — 54 (336) 2 — 53 476 (1,943)
Total 8,379 3,904 (3,407) — (845) (591) 111 2 459 101 8,113
1 Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £3,657m and derivative financial
liabilities were £5,600m.
Financial Statement Notes
78

-- 81 of 125 --

Level 3 movement analysis
As at
01.01.20 Purchases Sales Issues
Settle-
ments
Total gains and losses
in the period
recognised in the
income statement
Total
gains or
losses
recognise
d in OCI
Transfers
As at
30.06.20
Trading
income
Other
income In Out
£m £m £m £m £m £m £m £m £m £m £m
Corporate debt 120 25 — — — (26) — — 4 (17) 106
Non-asset backed loans 974 1,926 (740) — (4) (111) — — 97 (320) 1,822
Asset backed securities 656 249 (224) — (76) (12) — — 41 (11) 623
Equity cash products 392 2 (4) — — (67) — — 28 (4) 347
Other 122 48 — — — 2 — — 8 — 180
Trading portfolio assets 2,264 2,250 (968) — (80) (214) — — 178 (352) 3,078
Non-asset backed loans 5,494 1,050 (270) — (410) 381 — — — (58) 6,187
Equity cash products 835 14 — — — (22) (28) — — — 799
Private equity investments 900 19 (6) — (2) 2 (44) — 23 (12) 880
Other 1,271 1,870 (2,017) — (18) (8) 64 — 24 — 1,186
Financial assets at fair value
through the income statement 8,500 2,953 (2,293) — (430) 353 (8) — 47 (70) 9,052
Non-asset backed loans 343 79 — — (157) — — (3) — — 262
Asset backed securities 86 — (1) — — 1 — (1) — — 85
Assets at fair value through
other comprehensive income 429 79 (1) — (157) 1 — (4) — — 347
Investment property 13 — (1) — — — (2) — 2 (2) 10
Trading portfolio liabilities — — — — — — — — — — —
Financial liabilities designated
at fair value (362) — 1 (3) — (10) 2 — (22) 25 (369)
Interest rate derivatives (206) 18 — — 10 268 1 — 300 (10) 381
Foreign exchange derivatives (7) — — — (12) 89 — — 5 (8) 67
Credit derivatives 198 (258) 11 — (376) 151 1 — 2 8 (263)
Equity derivatives (819) (448) (1) — 17 (90) — — (5) (23) (1,369)
Net derivative financial
instruments1 (834) (688) 10 — (361) 418 2 — 302 (33) (1,184)
Total 10,010 4,594 (3,252) (3) (1,028) 548 (6) (4) 507 (432) 10,934
1 Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £7,748m and derivative financial
liabilities were £8,932m.
Financial Statement Notes
79

-- 82 of 125 --

Unrealised gains and losses on Level 3 financial assets and liabilities
The following table discloses the unrealised gains and losses recognised in the period arising on Level 3 financial assets
and liabilities held at the period end.
Half year ended 30.06.21 Half year ended 30.06.20
Income statement Other
compre
hensive
income Total
Income statement Other
compre
hensive
income Total
Trading
income
Other
income
Trading
income
Other
income
£m £m £m £m £m £m £m £m
Trading portfolio assets 35 — — 35 (177) — — (177)
Financial assets at fair value
through the income statement (201) 114 — (87) 397 (53) — 344
Financial assets at fair value
through other comprehensive
income — — — — — — (2) (2)
Investment properties — — — — — (2) — (2)
Trading portfolio liabilities (6) — — (6) — — — —
Financial liabilities designated at
fair value 7 — — 7 (16) (1) — (17)
Net derivative financial
instruments (367) — — (367) 248 — — 248
Non-current assets/liabilities held
for sale — — — — — — — —
Total (532) 114 — (418) 452 (56) (2) 394
Valuation techniques and sensitivity analysis
Sensitivity analysis is performed on products with significant unobservable inputs (Level 3) to generate a range of
reasonably possible alternative valuations. The sensitivity methodologies applied take account of the nature of valuation
techniques used, as well as the availability and reliability of observable proxy and historical data and the impact of using
alternative models.
Current year valuation and sensitivity methodologies are consistent with those described within Note 17, Fair value of
financial instruments in the Barclays PLC Annual Report 2020.
Sensitivity analysis of valuations using unobservable inputs
As at 30.06.21 As at 31.12.20
Favourable changes
Unfavourable
changes Favourable changes
Unfavourable
changes
Income
statement Equity
Income
statement Equity
Income
statement Equity
Income
statement Equity
£m £m £m £m £m £m £m £m
Interest rate derivatives 52 — (83) — 82 — (123) —
Foreign exchange derivatives 6 — (10) — 6 — (11) —
Credit derivatives 53 — (44) — 55 — (44) —
Equity derivatives 185 — (193) — 174 — (179) —
Commodity derivatives 2 — (2) — 2 — (2) —
Corporate debt 22 — (16) — 16 — (14) —
Non-asset backed loans 202 — (310) — 190 3 (409) (3)
Equity cash products 130 — (119) — 158 — (141) —
Private equity investments 223 — (198) — 199 — (227) —
Other1 18 — (18) — 21 — (21) —
Total 893 — (993) — 903 3 (1,171) (3)
1 Other includes commercial real estate loans, funds and fund-linked products, asset backed loans, issued debt, commercial paper, government
sponsored debt and investment property.
Financial Statement Notes
80

-- 83 of 125 --

The effect of stressing unobservable inputs to a range of reasonably possible alternatives, alongside considering the
impact of using alternative models, would be to increase fair values by up to £893m (December 2020: £906m) or to
decrease fair values by up to £993m (December 2020: £1,174m) with substantially all the potential effect impacting profit
and loss rather than reserves.
Significant unobservable inputs
The valuation techniques and significant unobservable inputs for assets and liabilities recognised at fair value and
classified as Level 3 are consistent with Note 17, Fair value of financial instruments in the Barclays PLC Annual Report
2020.
Fair value adjustments
Key balance sheet valuation adjustments are quantified below:
As at
30.06.21
As at
31.12.20
£m £m
Exit price adjustments derived from market bid-offer spreads (500) (493)
Uncollateralised derivative funding (80) (115)
Derivative credit valuation adjustments (210) (268)
Derivative debit valuation adjustments 91 113
• Exit price adjustments derived from market bid-offer spreads increased by £7m to £500m
• Uncollateralised derivative funding decreased by £35m to £80m as a result of tightening input funding spreads
• Derivative credit valuation adjustments decreased by £58m to £210m as a result of tightening input counterparty
credit spreads
• Derivative debit valuation adjustments decreased by £22m to £91m as a result of tightening input Barclays Bank
PLC credit spreads
Portfolio exemption
The Group uses the portfolio exemption in IFRS 13, Fair Value Measurement to measure the fair value of groups of
financial assets and liabilities. Instruments are measured using the price that would be received to sell a net long position
(i.e. an asset) for a particular risk exposure or to transfer a net short position (i.e. a liability) for a particular risk exposure
in an orderly transaction between market participants at the balance sheet date under current market conditions.
Accordingly, the Group measures the fair value of the group of financial assets and liabilities consistently with how market
participants would price the net risk exposure at the measurement date.
Unrecognised gains as a result of the use of valuation models using unobservable inputs
The amount that has yet to be recognised in income that relates to the difference between the transaction price (the fair
value at initial recognition) and the amount that would have arisen had valuation models using unobservable inputs been
used on initial recognition, less amounts subsequently recognised, is £126m (December 2020: £116m) for financial
instruments measured at fair value and £240m (December 2020: £247m) for financial instruments carried at amortised
cost. There are additions of £32m (December 2020: £27m) and amortisation and releases of £22m (December 2020:
£24m) for financial instruments measured at fair value and additions of £nil (December 2020: £6m) and amortisation and
releases of £7m (December 2020: £14m) for financial instruments carried at amortised cost.
Third party credit enhancements
Structured and brokered certificates of deposit issued by the Group are insured up to $250,000 per depositor by the
Federal Deposit Insurance Corporation (FDIC) in the United States. The FDIC is funded by premiums that Barclays and
other banks pay for deposit insurance coverage. The carrying value of these issued certificates of deposit that are
designated under the IFRS 9 fair value option includes this third party credit enhancement. The on balance sheet value of
these brokered certificates of deposit amounted to £1,241m (December 2020: £1,494m).
Financial Statement Notes
81

-- 84 of 125 --

Comparison of carrying amounts and fair values for assets and liabilities not held at fair value
Valuation methodologies employed in calculating the fair value of financial assets and liabilities measured at amortised
cost are consistent with those described within Note 17, Fair value of financial instruments in the Barclays PLC Annual
Report 2020.
The following table summarises the fair value of financial assets and liabilities measured at amortised cost on the Group’s
balance sheet.
As at 30.06.21 As at 31.12.20
Carrying
amount Fair value
Carrying
amount Fair value
Financial assets £m £m £m £m
Loans and advances at amortised cost 348,549 347,733 342,632 340,516
Reverse repurchase agreements and other similar secured lending 4,459 4,459 9,031 9,031
Financial liabilities
Deposits at amortised cost (500,895) (500,933) (481,036) (481,106)
Repurchase agreements and other similar secured borrowing (20,005) (20,005) (14,174) (14,174)
Debt securities in issue (90,733) (92,746) (75,796) (77,813)
Subordinated liabilities (12,839) (13,434) (16,341) (16,918)
12. Loans and advances and deposits at amortised cost
As at
30.06.21
As at
31.12.20
£m £m
Loans and advances at amortised cost to banks 11,032 8,900
Loans and advances at amortised cost to customers 309,194 309,927
Debt securities at amortised cost 28,323 23,805
Total loans and advances at amortised cost 348,549 342,632
Deposits at amortised cost from banks 17,165 17,343
Deposits at amortised cost from customers 483,730 463,693
Total deposits at amortised cost 500,895 481,036
13. Goodwill and intangible assets
Goodwill and intangible assets are allocated to business operations according to business segments as follows:
As at 30.06.21 As at 31.12.20
Goodwill Intangibles Total Goodwill Intangibles Total
£m £m £m £m £m £m
Barclays UK 3,560 1,570 5,130 3,560 1,618 5,178
Barclays International 286 2,735 3,021 289 2,435 2,724
Head Office 42 3 45 42 4 46
Total 3,888 4,308 8,196 3,891 4,057 7,948
The Group performed an impairment review to assess the recoverability of its goodwill and intangible asset balances as at
31 December 2020. The outcome of this review is disclosed on pages 332-335 of the Barclays PLC Annual Report 2020.
The review highlighted that there had been a significant reduction in the value in use of the Personal Banking and
Business Banking cash generating units within Barclays UK. No impairment was recognised as a result of the review as
value in use exceeded carrying amount. Since the 2020 impairment review, management have observed improvements in
the UK macroeconomic environment and interest rate outlook. The Group’s goodwill and intangible assets have been
reviewed for indicators of impairment in the period, with no indicators being identified.
Financial Statement Notes
82

-- 85 of 125 --

14. Subordinated liabilities
Half year
ended
30.06.21
Year ended
31.12.20
£m £m
Opening balance as at 1 January 16,341 18,156
Issuances 1,734 1,438
Redemptions (4,534) (3,464)
Other (702) 211
Closing balance 12,839 16,341
Issuances of £1,734m comprise £855m EUR 1.125% Fixed Rate Resetting Subordinated Callable Notes and £724m USD
3.811% Fixed Rate Resetting Subordinated Callable Notes, both issued externally by Barclays PLC and £82m ZAR
Floating Rate Notes and £73m USD Floating Rate Notes issued externally by Barclays subsidiaries.
Redemptions of £4,534m comprise £1,961m GBP 10% Fixed Rate Subordinated Notes, £1,339m EUR 6% Fixed Rate
Subordinated Notes, £1,075m USD 10.179% Fixed Rate Subordinated Notes and £86m EUR Subordinated Floating Rate
Notes, issued externally by Barclays Bank PLC and £73m USD Floating Rate Notes issued externally by a Barclays
subsidiary.
Other movements predominantly comprise foreign exchange movements and fair value hedge adjustments.
15. Provisions
As at
30.06.21 As at
31.12.20
£m £m
Customer redress 449 497
Legal, competition and regulatory matters 223 268
Redundancy and restructuring 88 158
Undrawn contractually committed facilities and guarantees 713 1,064
Onerous contracts 14 28
Sundry provisions 285 289
Total 1,772 2,304
16. Retirement benefits
As at 30 June 2021, the Group’s IAS 19 pension surplus across all schemes was £2.4bn (December 2020: £1.5bn). The
UK Retirement Fund (UKRF), which is the Group’s main scheme, had an IAS 19 pension surplus of £2.6bn (December
2020: £1.8bn). The movement for the UKRF was driven by payment of deficit reduction contributions, and an increase in
the discount rate, partially offset by higher than expected long-term price inflation.
UKRF funding valuations
The latest annual update as at 30 September 2020 showed the funding deficit had improved to £0.9bn from the £2.3bn
shown at the 30 September 2019 triennial valuation. The improvement was mainly due to £1.0bn of deficit reduction
contributions paid over the year. The deficit recovery plan agreed at the last triennial valuation requires deficit reduction
contributions from Barclays Bank PLC of £700m in 2021, £294m in 2022 and £286m in 2023. The deficit reduction
contributions are in addition to the regular contributions to meet the Group’s share of the cost of benefits accruing over
each year. £350m of the 2021 deficit reduction contributions were paid in April 2021, with the remaining £350m for 2021
due in September 2021. The next triennial actuarial valuation of the UKRF is due to be completed in 2023 with an
effective date of 30 September 2022.
Financial Statement Notes
83

-- 86 of 125 --

17. Called up share capital
Ordinary
share capital
Share
premium
Total share
capital and
share
premium
Half year ended 30.06.21 £m £m £m
Opening balance as at 1 January 4,340 297 4,637
Issue of shares under employee share schemes 3 22 25
Repurchase of shares (94) — (94)
Closing balance 4,249 319 4,568
Called up share capital comprised 16,998m (December 2020: 17,359m) ordinary shares of 25p each. The decrease is
mainly due to the repurchase of 377m shares as part of the £0.7bn share buyback, partially offset by an increase due to
the issuance of shares under employee share schemes.
18. Other equity instruments
Half year
ended
30.06.21
Year ended
31.12.20
£m £m
Opening balance as at 1 January 11,172 10,871
Issuances — 1,142
Redemptions — (831)
Securities held by the Group (5) (10)
Closing balance 11,167 11,172
Other equity instruments of £11,167m (December 2020: £11,172m) include AT1 securities issued by Barclays PLC. There
have been no issuances or redemptions in the period.
The AT1 securities are perpetual securities with no fixed maturity and are structured to qualify as AT1 instruments under
prevailing capital rules applicable as at the relevant issue date. AT1 securities are undated and are redeemable, at the
option of Barclays PLC, in whole on (i) the initial call date, or on any fifth anniversary after the initial call date or (ii) any
day falling in a named period ending on the initial reset date, or on any fifth anniversary after the initial reset date. In
addition, the AT1 securities are redeemable, at the option of Barclays PLC, in whole in the event of certain changes in the
tax or regulatory treatment of the securities. Any redemptions require the prior consent of the PRA.
All Barclays PLC AT1 securities will be converted into ordinary shares of Barclays PLC, at a pre-determined price, should
the fully loaded CET1 ratio of the Group fall below 7%.
19. Other reserves
As at
30.06.21
As at
31.12.20
£m £m
Currency translation reserve 2,376 2,871
Fair value through other comprehensive income reserve (245) 5
Cash flow hedging reserve 664 1,575
Own credit reserve (1,001) (954)
Other reserves and treasury shares 1,062 964
Total 2,856 4,461
Currency translation reserve
The currency translation reserve represents the cumulative gains and losses on the retranslation of the Group’s net
investment in foreign operations, net of the effects of hedging.
Financial Statement Notes
84

-- 87 of 125 --

As at 30 June 2021, there was a credit balance of £2,376m (December 2020: £2,871m credit) in the currency translation
reserve. The £495m debit movement principally reflects the strengthening of GBP against USD and EUR during the
period.
Fair value through other comprehensive income reserve
The fair value through other comprehensive income reserve represents the unrealised change in the fair value through
other comprehensive income investments since initial recognition.
As at 30 June 2021, there was a debit balance of £245m (December 2020: £5m credit) in the fair value through other
comprehensive income reserve. The loss of £250m is principally driven by a loss of £325m from the decrease in fair value
of bonds due to increasing bond yields and £199m of net gains transferred to the income statement. This is partially offset
by a gain of £114m due to an increase in the Absa Group Limited share price and a tax credit of £168m. £8m release in
impairment was also noted during the period.
Cash flow hedging reserve
The cash flow hedging reserve represents the cumulative gains and losses on effective cash flow hedging instruments
that will be recycled to the income statement when the hedged transactions affect profit or loss.
As at 30 June 2021, there was a credit balance of £664m (December 2020: £1,575m credit) in the cash flow hedging
reserve. The decrease of £911m principally reflects a £902m decrease in the fair value of interest rate swaps held for
hedging purposes as major interest rate forward curves increased and £287m of gains transferred to the income
statement. This is partially offset by a tax credit of £282m.
Own credit reserve
The own credit reserve reflects the cumulative own credit gains and losses on financial liabilities at fair value. Amounts in
the own credit reserve are not recycled to profit or loss in future periods.
As at 30 June 2021, there was a debit balance of £1,001m (December 2020: £954m debit) in the own credit reserve. The
movement of £47m principally reflects a £266m loss from the tightening of Barclays’ funding spreads. This is partially
offset by other activity of £100m and a tax credit of £115m.
Other reserves and treasury shares
Other reserves relate to redeemed ordinary and preference shares issued by the Group. Treasury shares relate to
Barclays PLC shares held principally in relation to the Group’s various share schemes.
As at 30 June 2021, there was a credit balance of £1,062m (December 2020: £964m credit) in other reserves and
treasury shares. This is driven by an increase of £94m due to the repurchase of 377m shares as part of the £0.7bn share
buyback and a £4m increase due to a reduction in treasury shares held in relation to employee share schemes.
20. Contingent liabilities and commitments
As at
30.06.21
As at
31.12.20
Contingent liabilities £m £m
Guarantees and letters of credit pledged as collateral security 13,519 15,665
Performance guarantees, acceptances and endorsements 5,679 5,944
Total 19,198 21,609
Commitments
Documentary credits and other short-term trade related transactions 1,017 1,086
Standby facilities, credit lines and other commitments 345,281 331,963
Total 346,298 333,049
In addition to the above, Note 21, Legal, competition and regulatory matters details out further contingent liabilities where
it is not practicable to disclose an estimate of the potential financial effect on Barclays.
21. Legal, competition and regulatory matters
The Group faces legal, competition and regulatory challenges, many of which are beyond our control. The extent of the
impact of these matters cannot always be predicted but may materially impact our operations, financial results, condition
Financial Statement Notes
85

-- 88 of 125 --

and prospects. Matters arising from a set of similar circumstances can give rise to either a contingent liability or a
provision, or both, depending on the relevant facts and circumstances.
The recognition of provisions in relation to such matters involves critical accounting estimates and judgments in
accordance with the relevant accounting policies applicable to Note 15, Provisions. We have not disclosed an estimate of
the potential financial impact or effect on the Group of contingent liabilities where it is not currently practicable to do so.
Various matters detailed in this note seek damages of an unspecified amount. While certain matters specify the damages
claimed, such claimed amounts do not necessarily reflect the Group’s potential financial exposure in respect of those
matters.
Matters are ordered under headings corresponding to the financial statements in which they are disclosed.
1. Barclays PLC and Barclays Bank PLC
Investigations into certain advisory services agreements and related civil action
FCA proceedings
In 2008, Barclays Bank PLC and Qatar Holdings LLC entered into two advisory service agreements (the Agreements).
The Financial Conduct Authority (FCA) conducted an investigation into whether the Agreements may have related to
Barclays PLC’s capital raisings in June and November 2008 (the Capital Raisings) and therefore should have been
disclosed in the announcements or public documents relating to the Capital Raisings. In 2013, the FCA issued warning
notices (the Notices) finding that Barclays PLC and Barclays Bank PLC acted recklessly and in breach of certain
disclosure-related listing rules, and that Barclays PLC was also in breach of Listing Principle 3. The financial penalty
provided in the Notices is £50m. Barclays PLC and Barclays Bank PLC continue to contest the findings. Following the
conclusion of the Serious Fraud Office (SFO) proceedings against certain former Barclays executives resulting in their
acquittals, the FCA proceedings, which were stayed, have resumed.
Civil action
In 2021, the High Court of Justice (High Court) dismissed a claim brought by PCP Capital Partners LLP and PCP
International Finance Limited (PCP) against Barclays Bank PLC for fraudulent misrepresentation and deceit, arising from
certain statements made by Barclays Bank PLC to PCP relating to the November 2008 capital raising. PCP’s application
to appeal the High Court’s decision has also been refused which concludes these proceedings.
Investigations into LIBOR and other benchmarks and related civil actions
Regulators and law enforcement agencies, including certain competition authorities, from a number of governments have
conducted investigations relating to Barclays Bank PLC’s involvement in allegedly manipulating certain financial
benchmarks, such as LIBOR. The SFO closed its investigation with no action to be taken against the Group. Various
individuals and corporates in a range of jurisdictions have threatened or brought civil actions against the Group and other
banks in relation to the alleged manipulation of LIBOR and/or other benchmarks.
USD LIBOR civil actions
The majority of the USD LIBOR cases, which have been filed in various US jurisdictions, have been consolidated for pre-
trial purposes in the US District Court in the Southern District of New York (SDNY). The complaints are substantially
similar and allege, among other things, that Barclays PLC, Barclays Bank PLC, Barclays Capital Inc. (BCI) and other
financial institutions individually and collectively violated provisions of the US Sherman Antitrust Act (Antitrust Act), the US
Commodity Exchange Act (CEA), the US Racketeer Influenced and Corrupt Organizations Act (RICO), the Securities
Exchange Act of 1934 and various state laws by manipulating USD LIBOR rates.
Putative class actions and individual actions seek unspecified damages with the exception of three lawsuits, in which the
plaintiffs are seeking a combined total of approximately $100m in actual damages and additional punitive damages
against all defendants, including Barclays Bank PLC. Some of the lawsuits also seek trebling of damages under the
Antitrust Act and RICO. Barclays Bank PLC has previously settled certain claims. Two class action settlements where
Barclays Bank PLC has respectively paid $7.1m and $20m, have received final court approval. Barclays Bank PLC also
settled a further matter for $7.5m, paid in June 2021.
Sterling LIBOR civil actions
In 2016, two putative class actions filed in the SDNY against Barclays Bank PLC, BCI and other Sterling LIBOR panel
banks alleging, among other things, that the defendants manipulated the Sterling LIBOR rate in violation of the Antitrust
Act, CEA and RICO, were consolidated. The defendants’ motion to dismiss the claims was granted in 2018. The plaintiffs
have appealed the dismissal.
Financial Statement Notes
86

-- 89 of 125 --

Japanese Yen LIBOR civil actions
In 2012, a putative class action was filed in the SDNY against Barclays Bank PLC and other Japanese Yen LIBOR panel
banks by a lead plaintiff involved in exchange-traded derivatives and members of the Japanese Bankers Association’s
Euroyen Tokyo Interbank Offered Rate (Euroyen TIBOR) panel. The complaint alleges, among other things, manipulation
of the Euroyen TIBOR and Yen LIBOR rates and breaches of the CEA and the Antitrust Act. In 2014, the court dismissed
the plaintiff’s antitrust claims, and, in 2020, the court dismissed the plaintiff’s remaining CEA claims. The plaintiff has
appealed the lower court’s dismissal of such claims.
In 2015, a second putative class action, making similar allegations to the above class action, was filed in the SDNY
against Barclays PLC, Barclays Bank PLC and BCI. The plaintiffs filed an amended complaint in 2020, and the
defendants have filed a motion to dismiss.
SIBOR/SOR civil action
In 2016, a putative class action was filed in the SDNY against Barclays PLC, Barclays Bank PLC, BCI and other
defendants, alleging manipulation of the Singapore Interbank Offered Rate (SIBOR) and Singapore Swap Offer Rate
(SOR). In 2018, the court dismissed all claims against Barclays PLC, Barclays Bank PLC and BCI. The plaintiffs’ appeal of
the dismissal of their claims was granted in March 2021 and the matter has been remanded to the lower court for further
proceedings.
ICE LIBOR civil actions
In 2019, several putative class actions were filed in the SDNY against a panel of banks, including Barclays PLC, Barclays
Bank PLC, BCI, other financial institution defendants and Intercontinental Exchange Inc. and certain of its affiliates (ICE),
asserting antitrust claims that defendants manipulated USD LIBOR through defendants’ submissions to ICE. These
actions have been consolidated. The defendants’ motion to dismiss was granted in 2020. The plaintiffs have appealed the
dismissal.
In August 2020, an ICE LIBOR-related action was filed by a group of individual plaintiffs in the US District Court for the
Northern District of California on behalf of individual borrowers and consumers of loans and credit cards with variable
interest rates linked to USD ICE LIBOR. Plaintiffs have filed motions seeking, among other things, preliminary and
permanent injunctions to enjoin the defendants from continuing to set LIBOR or enforce any financial instrument that
relies in whole or in part on USD LIBOR.
Non-US benchmarks civil actions
Legal proceedings (which include the claims referred to below in ‘Local authority civil actions concerning LIBOR’) have
been brought or threatened against Barclays Bank PLC (and, in certain cases, Barclays Bank UK PLC) in the UK in
connection with alleged manipulation of LIBOR, EURIBOR and other benchmarks. Proceedings have also been brought
in a number of other jurisdictions in Europe and Israel. Additional proceedings in other jurisdictions may be brought in the
future.
Credit Default Swap civil action
In July 2021, the New Mexico Attorney General, on behalf of the New Mexico State Investment Council, filed an antitrust
class action in the US District Court for the District of New Mexico against Barclays PLC, Barclays Bank PLC, BCI and
other financial institutions. The plaintiff alleges that the defendants conspired to manipulate the benchmark price used to
value Credit Default Swap (CDS) contracts at settlement (i.e. the CDS final auction price). The plaintiff alleges violations
of the Antitrust Act and the CEA, and unjust enrichment under state law.
Foreign Exchange investigations and related civil actions
In 2015, the Group reached settlements totalling approximately $2.38bn with various US federal and state authorities and
the FCA in relation to investigations into certain sales and trading practices in the Foreign Exchange market. The Group
continues to provide relevant information to certain authorities.
The European Commission is one of a number of authorities still conducting an investigation into certain trading practices
in Foreign Exchange markets. The European Commission announced two settlements in May 2019 and the Group paid
penalties totalling approximately €210m. In June 2019, the Swiss Competition Commission announced two settlements
and the Group paid penalties totalling approximately CHF 27m. The financial impact of the ongoing matters is not
expected to be material to the Group’s operating results, cash flows or financial position.
Various individuals and corporates in a range of jurisdictions have threatened or brought civil actions against the Group
and other banks in relation to alleged manipulation of Foreign Exchange markets.
Financial Statement Notes
87

-- 90 of 125 --

FX opt out civil action
In 2018, Barclays Bank PLC and BCI settled a consolidated action filed in the SDNY, alleging manipulation of Foreign
Exchange markets (Consolidated FX Action), for a total amount of $384m. Also in 2018, a group of plaintiffs who opted
out of the Consolidated FX Action filed a complaint in the SDNY against Barclays PLC, Barclays Bank PLC, BCI and other
defendants. Some of the plaintiff’s claims were dismissed in 2020.
Retail basis civil action
In 2015, a putative class action was filed against several international banks, including Barclays PLC and BCI, on behalf
of a proposed class of individuals who exchanged currencies on a retail basis at bank branches (Retail Basis Claims). The
SDNY has ruled that the Retail Basis Claims are not covered by the settlement agreement in the Consolidated FX Action.
The Court subsequently dismissed all Retail Basis Claims against the Group and all other defendants. The plaintiffs have
filed an amended complaint.
Non-US FX civil actions
Legal proceedings have been brought or are threatened against Barclays PLC, Barclays Bank PLC, BCI and Barclays
Execution Services Limited (BX) in connection with alleged manipulation of Foreign Exchange in the UK, a number of
other jurisdictions in Europe, Israel and Australia and additional proceedings may be brought in the future.
These include two purported class actions filed against Barclays PLC, Barclays Bank PLC, BX, BCI and other financial
institutions in the UK Competition Appeal Tribunal in 2019 following the settlements with the European Commission
described above. Also in 2019, a separate claim was filed in the UK in the High Court by various banks and asset
management firms against Barclays Bank PLC and other financial institutions alleging breaches of European and UK
competition laws related to FX trading.
Metals investigations and related civil actions
Barclays Bank PLC previously provided information to the US Department of Justice (DoJ), the US Commodity Futures
Trading Commission and other authorities in connection with investigations into metals and metals-based financial
instruments.
A number of US civil complaints, each on behalf of a proposed class of plaintiffs, have been consolidated and transferred
to the SDNY. The complaints allege that Barclays Bank PLC and other members of The London Gold Market Fixing Ltd.
manipulated the prices of gold and gold derivative contracts in violation of the Antitrust Act and other federal laws. This
consolidated putative class action remains pending. A separate US civil complaint by a proposed class of plaintiffs against
a number of banks, including Barclays Bank PLC, BCI and BX, alleging manipulation of the price of silver in violation of
the CEA, the Antitrust Act and state antitrust and consumer protection laws, has been dismissed as against the Barclays
entities. The plaintiffs have the option to seek the court’s permission to appeal.
Civil actions have also been filed in Canadian courts against Barclays PLC, Barclays Bank PLC, Barclays Capital Canada
Inc. and BCI on behalf of proposed classes of plaintiffs alleging manipulation of gold and silver prices.
US residential mortgage related civil actions
There are various pending civil actions relating to US Residential Mortgage-Backed Securities (RMBS), including four
actions arising from unresolved repurchase requests submitted by Trustees for certain RMBS, alleging breaches of
various loan-level representations and warranties (R&Ws) made by Barclays Bank PLC and/or a subsidiary acquired in
2007. The unresolved repurchase requests had an original principal balance of approximately $2.1bn. The Trustees have
also alleged that the relevant R&Ws may have been breached with respect to a greater (but unspecified) amount of loans
than previously stated in the unresolved repurchase requests.
These repurchase actions are ongoing. In one repurchase action, the New York Court of Appeals held that claims related
to certain R&Ws are time-barred. Barclays Bank PLC has reached a settlement to resolve two of the repurchase actions,
which is subject to final court approval. The financial impact of the settlement is not expected to be material to the Group’s
operating results, cash flows or financial position. The remaining two repurchase actions are pending.
In 2020, a civil litigation claim was filed in the New Mexico First Judicial District Court by the State of New Mexico against
six banks, including BCI, on behalf of two New Mexico state pension funds and the New Mexico State Investment Council
relating to legacy RMBS purchases. As to BCI, the complaint alleges that the funds purchased approximately $22m in
RMBS underwritten by BCI. The plaintiffs have asserted claims under New Mexico state law, which provides for the ability
to claim treble damages and civil penalties.
Financial Statement Notes
88

-- 91 of 125 --

Government and agency securities civil actions and related matters
Certain governmental authorities have conducted investigations into activities relating to the trading of certain government
and agency securities in various markets. The Group provided information in cooperation with such investigations.
Civil actions have also been filed on the basis of similar allegations, as described below.
Treasury auction securities civil actions
Consolidated putative class action complaints filed in US federal court against Barclays Bank PLC, BCI and other financial
institutions under the Antitrust Act and state common law allege that the defendants (i) conspired to manipulate the US
Treasury securities market and/or (ii) conspired to prevent the creation of certain platforms by boycotting or threatening to
boycott such trading platforms. The court dismissed the consolidated action in March 2021. The plaintiffs have filed an
amended complaint, which the defendants have moved to dismiss.
In addition, certain plaintiffs have filed a related, direct action against BCI and certain other financial institutions, alleging
that defendants conspired to fix and manipulate the US Treasury securities market in violation of the Antitrust Act, the CEA
and state common law.
Supranational, Sovereign and Agency bonds civil actions
Civil antitrust actions have been filed in the SDNY and Federal Court of Canada in Toronto against Barclays Bank PLC,
BCI, BX, Barclays Capital Securities Limited and, with respect to the civil action filed in Canada only, Barclays Capital
Canada, Inc. and other financial institutions alleging that the defendants conspired to fix prices and restrain competition in
the market for US dollar-denominated Supranational, Sovereign and Agency bonds.
In one of the actions filed in the SDNY, the court granted the defendants’ motions to dismiss the plaintiffs’ complaint. The
dismissal was affirmed on appeal. The plaintiffs have voluntarily dismissed the other SDNY action. In the Federal Court of
Canada action, the plaintiffs reached settlements with a small number of banks in 2020 (not including Barclays Capital
Canada, Inc.), but the plaintiffs have not commenced the class certification process and the action remains at an early
stage.
Variable Rate Demand Obligations civil actions
Civil actions have been filed against Barclays Bank PLC and BCI and other financial institutions alleging the defendants
conspired or colluded to artificially inflate interest rates set for Variable Rate Demand Obligations (VRDOs). VRDOs are
municipal bonds with interest rates that reset on a periodic basis, most commonly weekly. Two actions in state court have
been filed by private plaintiffs on behalf of the states of Illinois and California. Three putative class action complaints, two
of which have been consolidated, have been filed in the SDNY (the third complaint was filed in June 2021). In the
consolidated SDNY class action, certain of the plaintiff’s claims were dismissed in November 2020. In the California
action, the plaintiffs’ claims were dismissed in June 2021. The plaintiffs may appeal.
Government bond civil actions
In a putative class action filed in the SDNY in 2019, plaintiffs alleged that BCI and certain other bond dealers conspired to
fix the prices of US Government sponsored entity bonds in violation of US antitrust law. BCI agreed to a settlement of
$87m, which received final court approval in 2020. Separately, various entities in Louisiana, including the Louisiana
Attorney General and the City of Baton Rouge, have commenced litigation against Barclays Bank PLC and other financial
institutions making similar allegations as the SDNY class action plaintiffs. The parties have reached a settlement to
resolve these matters. The financial impact of the settlement is not expected to be material to the Group’s operating
results, cash flows or financial position.
In 2018, a separate putative class action against various financial institutions including Barclays PLC, Barclays Bank PLC,
BCI, Barclays Bank Mexico, S.A., and certain other subsidiaries of the Group was consolidated in the SDNY. The plaintiffs
asserted antitrust and state law claims arising out of an alleged conspiracy to fix the prices of Mexican Government
bonds. Barclays PLC has settled the claim for $5.7m, which is subject to final court approval.
Odd-lot corporate bonds antitrust class action
In 2020, BCI, together with other financial institutions, were named as defendants in a putative class action. The
complaint alleges a conspiracy to boycott developing electronic trading platforms for odd-lots and price fixing. Plaintiffs
demand unspecified money damages. The defendants have filed a motion to dismiss.
Interest rate swap and credit default swap US civil actions
Barclays PLC, Barclays Bank PLC and BCI, together with other financial institutions that act as market makers for interest
rate swaps (IRS) are named as defendants in several antitrust class actions which were consolidated in the SDNY in
Financial Statement Notes
89

-- 92 of 125 --

2016. The complaints allege the defendants conspired to prevent the development of exchanges for IRS and demand
unspecified money damages.
In 2018, trueEX LLC filed an antitrust class action in the SDNY against a number of financial institutions including
Barclays PLC, Barclays Bank PLC and BCI based on similar allegations with respect to trueEX LLC’s development of an
IRS platform. In 2017, Tera Group Inc. filed a separate civil antitrust action in the SDNY claiming that certain conduct
alleged in the IRS cases also caused the plaintiff to suffer harm with respect to the Credit Default Swaps market. In 2018
and 2019, respectively, the court dismissed certain claims in both cases for unjust enrichment and tortious interference
but denied motions to dismiss the federal and state antitrust claims, which remain pending.
BDC Finance L.L.C.
In 2008, BDC Finance L.L.C. (BDC) filed a complaint in the Supreme Court of the State of New York (NY Supreme Court),
demanding damages of $298m, alleging that Barclays Bank PLC had breached a contract in connection with a portfolio of
total return swaps governed by an ISDA Master Agreement (the Agreement). Following a trial, the court ruled in 2018 that
Barclays Bank PLC was not a defaulting party, which was affirmed on appeal. In April 2021, the trial court entered
judgement in favour of Barclays Bank PLC for $3.3m and as yet to be determined legal fees and costs, BDC has
appealed.
In 2011, BDC’s investment advisor, BDCM Fund Adviser, L.L.C. and its parent company, Black Diamond Capital Holdings,
L.L.C. also sued Barclays Bank PLC and BCI in Connecticut State Court for unspecified damages allegedly resulting from
Barclays Bank PLC’s conduct relating to the Agreement, asserting claims for violation of the Connecticut Unfair Trade
Practices Act and tortious interference with business and prospective business relations. This case is currently stayed.
Civil actions in respect of the US Anti-Terrorism Act
There are a number of civil actions, on behalf of more than 4,000 plaintiffs, filed in US federal courts in the US District
Court in the Eastern District of New York (EDNY) and SDNY against Barclays Bank PLC and a number of other banks.
The complaints generally allege that Barclays Bank PLC and those banks engaged in a conspiracy to facilitate US dollar-
denominated transactions for the Iranian Government and various Iranian banks, which in turn funded acts of terrorism
that injured or killed plaintiffs or plaintiffs’ family members. The plaintiffs seek to recover damages for pain, suffering and
mental anguish under the provisions of the US Anti-Terrorism Act, which allow for the trebling of any proven damages.
The court granted the defendants’ motions to dismiss three out of the six actions in the EDNY. Plaintiffs have appealed in
one action. The remaining actions are stayed pending decisions on the appeal. Out of the two actions in the SDNY, the
court also granted the defendants’ motion to dismiss one action. The remaining action is stayed pending any appeal in the
former case.
Shareholder derivative action
In November 2020, a purported Barclays shareholder filed a putative derivative action in New York state court against BCI
and a number of current and former members of the Board of Directors of Barclays PLC and senior executives or
employees of the Group. The shareholder filed the claim on behalf of nominal defendant Barclays PLC, alleging that the
individual defendants harmed the company through breaches of their duties, including under the Companies Act 2006.
The plaintiff seeks damages on behalf of Barclays PLC for the losses that Barclays PLC allegedly suffered as a result of
these alleged breaches. An amended complaint was filed in April 2021, which BCI and certain other defendants have
moved to dismiss.
Derivative transactions civil action
In July 2021, Vestia (a Dutch housing association) issued a claim against Barclays Bank PLC in the UK in the High Court
in relation to a series of derivative transactions entered into with Barclays Bank PLC between 2008 and 2012. The claim
has not been served on Barclays.
Skilled person review and associated matters
In August 2020, the FCA granted an application by Clydesdale Financial Services Limited (CFS), which trades as
Barclays Partner Finance and houses Barclays’ point-of-sale finance business, for a validation order with respect to
certain loans to customers brokered by Azure Services Limited (ASL), a timeshare operator, which did not, at the point of
sale, hold the necessary broker licence. As a condition to the validation order, the FCA required CFS to undertake a
skilled person review of the assessment of affordability processes for the loans brokered by ASL (ASL Loans) as well as
CFS’ policies and procedures for assessing affordability and oversight of brokers more generally, and dictated a
remediation methodology in the event that ASL Loans did not pass the affordability test. CFS has voluntarily agreed to
Financial Statement Notes
90

-- 93 of 125 --

remediate the ASL Loans, which is expected to amount to £37m, in accordance with the FCA’s methodology. The
remaining scope of the skilled person review is ongoing and the skilled person is expected to report in the fourth quarter
of 2021.
It is not currently possible to predict the outcome of the skilled person review and/or whether remediation activity will be
undertaken or required in relation to other parts of CFS’ loan portfolio and the scope of, and methodology for, any such
remediation.
2. Barclays PLC, Barclays Bank PLC and Barclays Bank UK PLC
Investigation into UK cards’ affordability
The FCA is investigating certain aspects of the affordability assessment processes used by Barclays Bank UK PLC and
Barclays Bank PLC for credit card applications made to Barclays’ UK credit card business. Barclays is providing
information in cooperation with the investigation.
HM Revenue & Customs (HMRC) assessments concerning UK Value Added Tax
In 2018, HMRC issued notices that have the effect of removing certain overseas subsidiaries that have operations in the
UK from Barclays’ UK VAT group, in which group supplies between members are generally free from VAT. The notices
have retrospective effect and correspond to assessments of £181m (inclusive of interest), of which Barclays would expect
to attribute an amount of approximately £128m to Barclays Bank UK PLC and £53m to Barclays Bank PLC. HMRC’s
decision has been appealed to the First Tier Tribunal (Tax Chamber).
Local authority civil actions concerning LIBOR
Following settlement by Barclays Bank PLC of various governmental investigations concerning certain benchmark interest
rate submissions referred to above in ‘Investigations into LIBOR and other benchmarks and related civil actions’, in the
UK, certain local authorities have brought claims against Barclays Bank PLC and Barclays Bank UK PLC asserting that
they entered into loans in reliance on misrepresentations made by Barclays Bank PLC in respect of its conduct in relation
to LIBOR. Barclays Bank PLC and Barclays Bank UK PLC were successful in their applications to strike out the claims.
One local authority has obtained permission to pursue an appeal against this decision, while the claims brought by the
other local authorities have been settled on terms such that the parties have agreed not to pursue these claims and to
bear their own costs.
3. Barclays PLC
Alternative trading systems
Barclays PLC has been named as a defendant in a claim brought in the UK in the High Court by various shareholders
regarding Barclays PLC’s share price based on the allegations contained within a complaint by the New York State
Attorney General (NYAG) in 2014. The NYAG complaint was filed against Barclays PLC and BCI in the NY Supreme
Court alleging, among other things, that Barclays PLC and BCI engaged in fraud and deceptive practices in connection
with LX, BCI’s SEC-registered alternative trading system. Such claim was settled in 2016, as previously disclosed. This
new shareholder claim is seeking unquantified damages.
General
The Group is engaged in various other legal, competition and regulatory matters in the UK, the US and a number of other
overseas jurisdictions. It is subject to legal proceedings brought by and against the Group which arise in the ordinary
course of business from time to time, including (but not limited to) disputes in relation to contracts, securities, debt
collection, consumer credit, fraud, trusts, client assets, competition, data management and protection, intellectual
property, money laundering, financial crime, employment, environmental and other statutory and common law issues.
The Group is also subject to enquiries and examinations, requests for information, audits, investigations and legal and
other proceedings by regulators, governmental and other public bodies in connection with (but not limited to) consumer
protection measures, compliance with legislation and regulation, wholesale trading activity and other areas of banking and
business activities in which the Group is or has been engaged. The Group is cooperating with the relevant authorities and
keeping all relevant agencies briefed as appropriate in relation to these matters and others described in this note on an
ongoing basis.
At the present time, Barclays PLC does not expect the ultimate resolution of any of these other matters to have a material
adverse effect on the Group’s financial position. However, in light of the uncertainties involved in such matters and the
matters specifically described in this note, there can be no assurance that the outcome of a particular matter or matters
(including formerly active matters or those matters arising after the date of this note) will not be material to Barclays PLC’s
Financial Statement Notes
91

-- 94 of 125 --

results, operations or cash flow for a particular period, depending on, among other things, the amount of the loss resulting
from the matter(s) and the amount of profit otherwise reported for the reporting period.
22. Related party transactions
Related party transactions in the half year ended 30 June 2021 were similar in nature to those disclosed in the Barclays
PLC Annual Report 2020. No related party transactions that have taken place in the half year ended 30 June 2021 have
materially affected the financial position or the performance of the Group during this period.
23. Interest rate benchmark reform
Following the financial crisis, the reform and replacement of benchmark interest rates such as LIBOR has become a
priority for global regulators. The FCA and other global regulators have instructed market participants to prepare for the
cessation of LIBOR after the end of 2021, and to adopt RFRs. While it is expected that most reforms affecting the Group
will be completed by the end of 2021, consultations and regulatory changes are in progress and as certain US Dollar
tenors will continue to be published up to mid-2023, significant remediation efforts will continue beyond the end of 2021.
How the Group is managing the transition to alternative benchmark rates
Barclays has established a Group-wide LIBOR Transition Programme, further detail on the transition programme is
available in the Barclays PLC Annual Report 2020 (page 367).
In March 2021, the FCA announced the dates that panel bank submissions for all LIBOR settings will cease, after which
representative LIBOR rates will no longer be available, these are: immediately after 31 December 2021, in the case of all
sterling, euro, Swiss franc and Japanese yen settings, and the 1-week and 2-month US dollar settings; and immediately
after 30 June 2023, in the case of the remaining US dollar settings. Throughout 2021, the FCA will consult with market
participants to require continued publication on a ‘synthetic’ basis for some sterling LIBOR settings and, for 1 additional
year, some Japanese yen LIBOR settings.
Approaches to transition exposure expiring post the expected end dates for LIBOR vary by product and nature of
counterparty. The transition we are undertaking is at the request of the regulators, in line with their expectations and
according to the regulatory endorsed timetable. The rates to which clients and customers are being transitioned are
endorsed by the regulators. We are making disclosures as part of the transition to clarify the rate to be applied and the
potential risks inherent in the transition. Barclays is actively engaging with counterparties to transition or include
appropriate fallback provisions and transition mechanisms in its floating rate assets and liabilities with maturities after
2021, when most IBORs are expected to cease to be published, or will be published on a non-representative basis for a
limited time.
Barclays is working with central clearing counterparties where the transition of cleared derivative contracts will follow a
market-wide, standardised approach to reform. Barclays is working to the UK Risk Free Rate Working Group (RFRWG)
target of completion of active conversion of, and/or addition of robust fallbacks to legacy GBP LIBOR contracts, where
viable by the end of Q321. Additionally, plans are in place to address non-GBP and other official sector industry
milestones and targets.
Progress made during H121
Building on the progress made in 2020, the Group has delivered further alternative RFR product capabilities and
alternatives to LIBOR across loans, bonds and derivatives. Client outreach is progressing to plan and we have continued
to engage actively with customers and counterparties to transition or include the appropriate fallback provisions. The
Group has in place detailed plans, processes and procedures to support the transition of the remainder during 2021.
Barclays has adhered to the ISDA IBOR Fallbacks Protocol for its major derivative dealing entities and we continue to
track progress and engage with clients on their own adherence. Following the progress made during 2020, the Group
continues to deliver technology and business process changes in preparation for LIBOR cessation and transitions to
RFRs that will be necessary during 2021 and beyond in line with official sector expectations and milestones.
The Group met the Q121 UK RFRWG milestone to cease initiation of GBP LIBOR linked loans, securitisations or linear
derivatives and the Q221 milestones to cease initiation of new non-linear derivatives, exchange traded futures and Bank
Of Japan milestone to cease issuance of JPY LIBOR linked loans and bonds. The Group has put in place controls so that
any exceptions or exemptions are approved, and is taking a similar approach to forthcoming cessation milestones.
Financial Statement Notes
92

-- 95 of 125 --

24. Barclays PLC parent company balance sheet
As at
30.06.21
As at
31.12.20
Assets £m £m
Investment in subsidiaries 58,828 58,886
Loans and advances to subsidiaries 23,295 24,710
Financial assets at fair value through the income statement 21,046 17,521
Derivative financial instruments 2 7
Other assets 19 65
Total assets 103,190 101,189
Liabilities
Deposits at amortised cost 476 482
Cash collateral and settlement balances — —
Debt securities in issue 26,663 28,428
Subordinated liabilities 9,170 7,724
Financial liabilities designated at fair value 12,130 9,507
Other liabilities 135 176
Total liabilities 48,574 46,317
Equity
Called up share capital 4,249 4,340
Share premium account 319 297
Other equity instruments 11,169 11,169
Other reserves 488 394
Retained earnings 38,391 38,672
Total equity 54,616 54,872
Total liabilities and equity 103,190 101,189
Investment in subsidiaries
The investment in subsidiaries of £58,828m (December 2020: £58,886m) predominantly relates to investments in
Barclays Bank PLC and Barclays Bank UK PLC, as well as holdings of their AT1 securities of £10,995m (December 2020:
£10,995m). Barclays PLC considers the carrying value of its investment in subsidiaries to be fully recoverable.
Financial assets and liabilities designated at fair value
Financial liabilities designated at fair value of £12,130m (December 2020: £9,507m) comprises material issuances during
the period of €750m Floating Notes, $1,000m Fixed Rate Resetting Senior Callable Notes, 600m AUD Fixed-to-Floating
and Floating Rate Debt Instruments, and 77,000m JPY Fixed Rate Resetting Senior Callable Notes. The proceeds raised
through these transactions were used to invest in subsidiaries of Barclays PLC which are included within the financial
assets designated at fair value through the income statement balance of £21,046m (December 2020: £17,521m).
Loans and advances to subsidiaries
During the period, loans and advances to subsidiaries decreased by £1,415m to £23,295m (December 2020: £24,710m).
The decrease was driven by the maturity of £2,200m senior loans to Barclays Bank PLC and a foreign exchange impact
of £500m due to appreciation of GBP against major currencies (although the negative FX impact is offset across the
balance sheet liabilities). There was also a £700m decrease in relation to the share buyback which took place in Q1 2020.
This decrease was partially offset by £1,600m of new issuances of dated subordinated notes by Barclays Bank PLC to
Barclays PLC and £776m dividend receipts from Barclays Bank PLC and Barclays Execution Services Limited.
Subordinated liabilities and debt securities in issue
Financial Statement Notes
93

-- 96 of 125 --

During H121, Barclays PLC issued €1,000m and $1,000m of Fixed Rate Resetting Subordinated Callable Notes, which is
included within the subordinated liabilities balance of £9,170m (December 2020: £7,724m). Debt securities in issue of
£26,663m (December 2020: £28,428m) have reduced in the year due to the £2,200m maturity of senior issuances, offset
in part by new issuances of €1,250m.
Other equity instruments
Other equity instruments comprises AT1 securities issued by Barclays PLC. There have been no new issuances or
redemptions during the period.
Other reserves
As at 30 June 2021, there was a balance of £488m (December 2020: £394m) in other reserves. The increase is due to
the repurchase of shares as part of the share buyback.
Management of internal investments, loans and advances
Barclays PLC retains the discretion to manage the nature of its internal investments in subsidiaries according to their
regulatory and business needs. Barclays PLC may invest capital and funding into Barclays Bank PLC, Barclays Bank UK
PLC and other Group subsidiaries such as Barclays Execution Services Limited and the US Intermediate Holding
Company (IHC).
Financial Statement Notes
94

-- 97 of 125 --

The Group’s management believes that the non-IFRS performance measures included in this document provide valuable
information to the readers of the financial statements as they enable the reader to identify a more consistent basis for
comparing the businesses’ performance between financial periods, and provide more detail concerning the elements of
performance which the managers of these businesses are most directly able to influence or are relevant for an
assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and
performance is monitored by management.
However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers
should consider the IFRS measures as well.
Non-IFRS performance measures glossary
Measure Definition
Loan: deposit ratio Loans and advances at amortised cost divided by deposits at amortised cost. The components of
the calculation have been included on page 52.
Period end allocated tangible equity Allocated tangible equity is calculated as 13.5% (2020: 13.0%) of RWAs for each business,
adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the
assumptions the Group uses for capital planning purposes. Head Office allocated tangible equity
represents the difference between the Group’s tangible shareholders’ equity and the amounts
allocated to businesses.
Average tangible shareholders’
equity
Calculated as the average of the previous month’s period end tangible equity and the current
month’s period end tangible equity. The average tangible shareholders’ equity for the period is the
average of the monthly averages within that period.
Average allocated tangible equity Calculated as the average of the previous month’s period end allocated tangible equity and the
current month’s period end allocated tangible equity. The average allocated tangible equity for the
period is the average of the monthly averages within that period.
Return on average tangible
shareholders’ equity
Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of
average shareholders’ equity excluding non-controlling interests and other equity instruments
adjusted for the deduction of intangible assets and goodwill. The components of the calculation
have been included on page 96 to 99.
Return on average allocated
tangible equity
Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of
average allocated tangible equity. The components of the calculation have been included on page
97 to 99.
Cost: income ratio Total operating expenses divided by total income.
Loan loss rate Quoted in basis points and represents total annualised impairment charges divided by gross
loans and advances held at amortised cost at the balance sheet date. The components of the
calculation have been included on page 28. Quoted as zero across the current reporting period
due to credit impairment net release.
Net interest margin Annualised net interest income divided by the sum of average customer assets. The components
of the calculation have been included on page 25.
Tangible net asset value per share Calculated by dividing shareholders’ equity, excluding non-controlling interests and other equity
instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The
components of the calculation have been included on page 99.
Appendix: Non-IFRS Performance Measures
95

-- 98 of 125 --

Returns
Return on average tangible equity is calculated as profit after tax attributable to ordinary equity holders of the parent as a
proportion of average tangible equity, excluding non-controlling and other equity interests for businesses. Allocated
tangible equity has been calculated as 13.5% (2020: 13.0%) of RWAs for each business, adjusted for capital deductions,
excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head
Office average allocated tangible equity represents the difference between the Group’s average tangible shareholders’
equity and the amounts allocated to businesses.
Profit/(loss)
attributable
to ordinary
equity
holders of
the parent
Average
tangible
equity
Return on
average
tangible
equity
Half year ended 30.06.21 £m £bn %
Barclays UK 1,019 9.9 20.6
Corporate and Investment Bank 2,312 28.3 16.3
Consumer, Cards and Payments 386 4.0 19.1
Barclays International 2,698 32.3 16.7
Head Office 95 4.3 n/m
Barclays Group 3,812 46.5 16.4
Half year ended 30.06.20
Barclays UK 52 10.2 1.0
Corporate and Investment Bank 1,514 27.7 11.0
Consumer, Cards and Payments (517) 4.7 (21.9)
Barclays International 997 32.4 6.2
Head Office (354) 6.0 n/m
Barclays Group 695 48.6 2.9
Appendix: Non-IFRS Performance Measures
96

-- 99 of 125 --

Half year ended 30.06.21
Barclays UK
Corporate
and
Investment
Bank
Consumer,
Cards and
Payments
Barclays
International Head Office
Barclays
Group
Return on average tangible
shareholders' equity £m £m £m £m £m £m
Attributable profit 1,019 2,312 386 2,698 95 3,812
£bn £bn £bn £bn £bn £bn
Average shareholders' equity 13.5 28.3 4.6 32.9 8.0 54.4
Average goodwill and intangibles (3.6) — (0.6) (0.6) (3.7) (7.9)
Average tangible shareholders'
equity 9.9 28.3 4.0 32.3 4.3 46.5
Return on average tangible
shareholders' equity 20.6% 16.3% 19.1% 16.7% n/m 16.4%
Half year ended 30.06.20
Barclays UK
Corporate
and
Investment
Bank
Consumer,
Cards and
Payments
Barclays
International Head Office
Barclays
Group
Return on average tangible
shareholders' equity £m £m £m £m £m £m
Attributable profit/(loss) 52 1,514 (517) 997 (354) 695
£bn £bn £bn £bn £bn £bn
Average shareholders' equity 13.8 27.7 5.4 33.1 9.9 56.8
Average goodwill and intangibles (3.6) — (0.7) (0.7) (3.9) (8.2)
Average tangible shareholders'
equity 10.2 27.7 4.7 32.4 6.0 48.6
Return on average tangible
shareholders' equity 1.0% 11.0% (21.9)% 6.2% n/m 2.9%
Barclays Group
Return on average tangible
shareholders' equity
Q221 Q121 Q420 Q320 Q220 Q120 Q419 Q319
£m £m £m £m £m £m £m £m
Attributable profit/(loss) 2,108 1,704 220 611 90 605 681 (292)
£bn £bn £bn £bn £bn £bn £bn £bn
Average shareholders' equity 54.4 54.4 55.7 56.4 58.4 55.2 54.5 56.4
Average goodwill and intangibles (7.9) (7.9) (8.1) (8.1) (8.2) (8.2) (8.1) (8.0)
Average tangible shareholders' equity 46.5 46.5 47.6 48.3 50.2 47.0 46.4 48.4
Return on average tangible
shareholders' equity 18.1% 14.7% 1.8% 5.1% 0.7% 5.1% 5.9% (2.4)%
Appendix: Non-IFRS Performance Measures
97

-- 100 of 125 --

Barclays UK
Q221 Q121 Q420 Q320 Q220 Q120 Q419 Q319
Return on average allocated tangible
equity £m £m £m £m £m £m £m £m
Attributable profit/(loss) 721 298 160 113 (123) 175 438 (907)
£bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 13.5 13.5 13.4 13.7 13.9 13.7 13.8 13.9
Average goodwill and intangibles (3.6) (3.6) (3.6) (3.6) (3.6) (3.6) (3.5) (3.5)
Average allocated tangible equity 9.9 9.9 9.8 10.1 10.3 10.1 10.3 10.4
Return on average allocated tangible
equity 29.1% 12.0% 6.5% 4.5% (4.8)% 6.9% 17.0% (34.9)%
Barclays International
Q221 Q121 Q420 Q320 Q220 Q120 Q419 Q319
Return on average allocated tangible
equity £m £m £m £m £m £m £m £m
Attributable profit 1,267 1,431 441 782 468 529 397 799
£bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 33.0 32.8 31.1 31.2 34.2 31.9 31.9 33.3
Average goodwill and intangibles (0.6) (0.5) (0.6) (0.6) (0.7) (0.7) (1.0) (1.1)
Average allocated tangible equity 32.4 32.3 30.5 30.6 33.5 31.2 30.9 32.2
Return on average allocated tangible
equity 15.6% 17.7% 5.8% 10.2% 5.6% 6.8% 5.1% 9.9%
Corporate and Investment Bank
Q221 Q121 Q420 Q320 Q220 Q120 Q419 Q319
Return on average allocated tangible
equity £m £m £m £m £m £m £m £m
Attributable profit 1,049 1,263 413 627 694 820 193 609
£bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 28.4 28.2 26.3 26.4 29.1 26.2 25.9 26.9
Average goodwill and intangibles — — — — (0.1) — (0.1) —
Average allocated tangible equity 28.4 28.2 26.3 26.4 29.0 26.2 25.8 26.9
Return on average allocated tangible
equity 14.8% 17.9% 6.3% 9.5% 9.6% 12.5% 3.0% 9.1%
Appendix: Non-IFRS Performance Measures
98

-- 101 of 125 --

Consumer, Cards and Payments
Q221 Q121 Q420 Q320 Q220 Q120 Q419 Q319
Return on average allocated tangible
equity £m £m £m £m £m £m £m £m
Attributable profit/(loss) 218 168 28 155 (226) (291) 204 190
£bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 4.6 4.6 4.8 4.8 5.1 5.7 6.0 6.4
Average goodwill and intangibles (0.6) (0.5) (0.6) (0.6) (0.6) (0.7) (0.9) (1.1)
Average allocated tangible equity 4.0 4.1 4.2 4.2 4.5 5.0 5.1 5.3
Return on average allocated tangible
equity 21.8% 16.5% 2.7% 14.7% (20.2)% (23.5)% 15.9% 14.2%
Tangible net asset value per share As at
30.06.21
As at
31.12.20
As at
30.06.20
£m £m £m
Total equity excluding non-controlling interests 67,052 65,797 68,304
Other equity instruments (11,167) (11,172) (10,871)
Shareholders' equity attributable to ordinary shareholders of the parent 55,885 54,625 57,433
Goodwill and intangibles (8,196) (7,948) (8,163)
Tangible shareholders' equity attributable to ordinary shareholders of the parent 47,689 46,677 49,270
m m m
Shares in issue 16,998 17,359 17,345
p p p
Net asset value per share 329 315 331
Tangible net asset value per share 281 269 284
Appendix: Non-IFRS Performance Measures
99

-- 102 of 125 --

Profit/(loss) attributable to
ordinary equity holders of the
parent H121 H120 Q221 Q121 Q420 Q320 Q220 Q120 Q419 Q319
£m £m £m £m £m £m £m £m £m £m
Barclays UK 1,019 52 721 298 160 113 (123) 175 438 (907)
Corporate and Investment
Bank 2,312 1,514 1,049 1,263 413 627 694 820 193 609
Consumer, Cards and
Payments 386 (517) 218 168 28 155 (226) (291) 204 190
Barclays International 2,698 997 1,267 1,431 441 782 468 529 397 799
Head Office 95 (354) 120 (25) (381) (284) (255) (99) (154) (184)
Barclays Group 3,812 695 2,108 1,704 220 611 90 605 681 (292)
H121 H120 Q221 Q121 Q420 Q320 Q220 Q120 Q419 Q319
Average equity £bn £bn £bn £bn £bn £bn £bn £bn £bn £bn
Barclays UK 13.5 13.8 13.5 13.5 13.4 13.7 13.9 13.7 13.8 13.9
Corporate and Investment
Bank 28.3 27.7 28.4 28.2 26.3 26.4 29.1 26.2 25.9 26.9
Consumer, Cards and
Payments 4.6 5.4 4.6 4.6 4.8 4.8 5.1 5.7 6.0 6.4
Barclays International 32.9 33.1 33.0 32.8 31.1 31.2 34.2 31.9 31.9 33.3
Head Office 8.0 9.9 7.9 8.1 11.2 11.5 10.3 9.6 8.8 9.2
Barclays Group 54.4 56.8 54.4 54.4 55.7 56.4 58.4 55.2 54.5 56.4
H121 H120 Q221 Q121 Q420 Q320 Q220 Q120 Q419 Q319
Return on average equity % % % % % % % % % %
Barclays UK 15.1 0.8 21.4 8.8 4.8 3.3 (3.6) 5.1 12.7 (26.1)
Corporate and Investment
Bank 16.3 10.9 14.8 17.9 6.3 9.5 9.5 12.5 3.0 9.1
Consumer, Cards and
Payments 16.8 (19.3) 19.0 14.6 2.4 12.9 (17.7) (20.7) 13.6 11.8
Barclays International 16.4 6.0 15.4 17.4 5.7 10.0 5.5 6.6 5.0 9.6
Head Office n/m n/m n/m n/m n/m n/m n/m n/m n/m n/m
Barclays Group 14.0 2.5 15.5 12.5 1.6 4.3 0.6 4.4 5.0 (2.1)
Appendix: Non-IFRS Performance Measures
100

-- 103 of 125 --

Results timetable1 Date
Ex-dividend date 12 August 2021
Dividend record date 13 August 2021
Cut off time of 5:00pm (UK time) for the receipt of Dividend
Re-investment Programme (DRIP) Application Form
27 August 2021
Dividend payment date 17 September 2021
Q321 Results Announcement 21 October 2021
For qualifying US and Canadian resident ADR holders, the half year dividend of 2.0p per ordinary share becomes 8.0p per ADS
(representing four shares). The ex-dividend, dividend record and dividend payment dates for ADR holders are as shown above.
% Change3
Exchange rates2 30.06.21 31.12.20 30.06.20 31.12.20 30.06.20
Period end - USD/GBP 1.38 1.37 1.24 1% 11%
6 month average - USD/GBP 1.39 1.31 1.26 6% 10%
3 month average - USD/GBP 1.40 1.32 1.24 6% 13%
Period end - EUR/GBP 1.17 1.12 1.10 4% 6%
6 month average - EUR/GBP 1.15 1.11 1.14 4% 1%
3 month average - EUR/GBP 1.16 1.11 1.13 5% 3%
Share price data
Barclays PLC (p) 171.12 146.68 114.42
Barclays PLC number of shares (m) 16,998 17,359 17,345
For further information please contact
Investor relations Media relations
Chris Manners +44 (0) 20 7773 2136 Tom Hoskin +44 (0) 20 7116 4755
More information on Barclays can be found on our
website: home.barclays.
Registered office
1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839.
Registrar
Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom.
Tel: 0371 384 20554 from the UK or +44 121 415 7004 from overseas.
American Depositary Receipts (ADRs)
Shareowner Services
StockTransfer@equiniti.com
Tel: +1 800 990 1135 (toll free in US and Canada), +1 651 453 2128 (outside the US and Canada)
Shareowner Services, PO Box 64504, St Paul, MN 55164-0504, USA.
Delivery of ADR certificates and overnight mail
Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120, USA.
Qualifying US and Canadian resident ADR holders should contact Shareowner Services for further details regarding the DRIP
1 Note that these dates are provisional and subject to change.
2 The average rates shown above are derived from daily spot rates during the year.
3 The change is the impact to GBP reported information.
4 Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales.
Shareholder Information
101

-- 104 of 125 --

‘Advanced-Internal Ratings Based (A-IRB)’ See ‘Internal Ratings Based (IRB)’.
‘Acceptances and endorsements’ An acceptance is an undertaking by a bank to pay a bill of exchange drawn on a
customer, for which reimbursement by the customer is normally immediate. Endorsements are to change the payee of a
bill of exchange but with no change to the bank’s liability.
‘Additional Tier 1 (AT1) capital’ AT1 capital largely comprises eligible non-common equity capital securities and any related
share premium.
‘Additional Tier 1 (AT1) securities’ Non-common equity securities that are eligible as AT1 capital.
‘Advanced Measurement Approach (AMA)’ Under the AMA, banks are allowed to develop their own empirical model to
quantify required capital for operational risk. Banks can only use this approach subject to approval from their local
regulators.
‘Agencies’ Bonds issued by state and / or government agencies or government-sponsored entities.
‘Agency Mortgage-Backed Securities’ Mortgage-Backed Securities issued by government-sponsored entities.
‘All price risk (APR)’ An estimate of all the material market risks, including rating migration and default for the correlation
trading portfolio.
‘American Depository Receipts (ADR)’ A negotiable certificate that represents the ownership of shares in a non-US
company (e.g. Barclays) trading in US financial markets.
‘Americas’ Geographic segment comprising the US, Canada and countries where Barclays operates within Latin America.
‘Annual Earnings at Risk (AEaR)’ A measure of the potential change in Net Interest Income (NII) due to an interest rate
movement over a one-year period.
‘Annualised cumulative weighted average lifetime PD’ The probability of default over the remaining life of the asset,
expressed as an annual rate, reflecting a range of possible economic scenarios.
‘Application scorecards’ Algorithm based decision tools used to aid business decisions and manage credit risk based on
available customer data at the point of application for a product.
‘Arrears’ Customers are said to be in arrears when they are behind in fulfilling their obligations with the result that an
outstanding loan is unpaid or overdue. Such customers are also said to be in a state of delinquency. When a customer is
in arrears, their entire outstanding balance is said to be delinquent, meaning that delinquent balances are the total
outstanding loans on which payments are overdue.
‘Asia’ Geographic segment comprising countries where Barclays operates within Asia and the Middle East.
‘Asset Backed Commercial Paper (ABCP)’ Typically short-term notes secured on specified assets issued by consolidated
special purpose entities for funding purposes.
‘Asset Backed Securities (ABS)’ Securities that represent an interest in an underlying pool of referenced assets. The
referenced pool can comprise any assets which attract a set of associated cash flows but are commonly pools of
residential or commercial mortgages and, in the case of a Collateralised Debt Obligation (CDO), the referenced pool may
be ABS or other classes of assets.
‘Attributable profit’ Profit after tax that is attributable to ordinary equity holders of Barclays adjusted for the after tax
amounts of capital securities classified as equity.
‘Average allocated tangible equity’ Calculated as the average of the previous month’s period end allocated tangible equity
and the current month’s period end allocated tangible equity. The average allocated tangible equity for the period is the
average of the monthly averages within that period.
‘Average tangible shareholders’ equity’ Calculated as the average of the previous month’s period end tangible equity and
the current month’s period end tangible equity. The average tangible shareholders’ equity for the period is the average of
the monthly averages within that period.
‘Average UK leverage ratio’ As per the PRA rulebook, calculated as the average capital measure based on the last day of
each month in the quarter divided by the average exposure measure for the quarter, where the average exposure is
based on each day in the quarter.
‘Back testing’ Includes a number of techniques that assess the continued statistical validity of a model by simulating how
the model would have predicted recent experience.
‘Bank of England (BoE)’ The central bank of the United Kingdom with devolved responsibility for managing monetary
policy and to oversee regulation of the UK’s financial sector. Through the Prudential Regulation Committee, the BoE
exercises control over the PRA.
‘Barclays Africa’ or ‘Absa’ or ‘Absa Group Limited’ Barclays Africa Group Limited (now Absa Group Limited), which was
previously a subsidiary of the Barclays Group. Following a sell down of shares resulting in a loss of control, the Barclays
Glossary of Terms
102

-- 105 of 125 --

Group’s shareholding in Absa Group Limited is now classified as a financial asset at fair value through other
comprehensive income (FVOCI).
‘Balance weighted Loan to Value (LTV) ratio’ In the context of the credit risk disclosures on secured home loans, a means
of calculating marked to market LTVs derived by calculating individual LTVs at account level and weighting it by the
balances to arrive at the average position. Balance weighted Loan to Value ratio is calculated using the following formula:
LTV = ((loan 1 balance x Marked to market (MTM) LTV% for loan 1) + (loan 2 balance x Marked to market (MTM) LTV%
for loan 2) + ...) / total outstandings in portfolio.
‘Barclaycard Consumer UK’ The UK Barclaycard business.
‘Barclays’ or ’Barclays Group’ Barclays PLC, together with its subsidiaries.
‘Barclays Bank Group’ Barclays Bank PLC, together with its subsidiaries.
‘Barclays Bank UK Group’ Barclays Bank UK PLC, together with its subsidiaries.
‘Barclays Operating businesses’ The core Barclays businesses operated by Barclays UK (which include the UK Personal
Banking; UK Business Banking and the Barclaycard Consumer UK businesses) and Barclays International (the large UK
Corporate business; the International Corporate and Private Bank businesses; the Investment Bank; the Barclaycard
International business; and Payments).
‘Barclays Execution Services’ or ‘BX’ or ‘Group Service Company’ Barclays Execution Services Limited, the Group
services company set up to provide services to Barclays UK and Barclays International to deliver operational continuity.
‘Barclays International’ The segment of Barclays held by Barclays Bank PLC. The division includes the large UK
Corporate business; the International Corporate and Private Bank businesses; the Investment Bank; the Barclaycard
International business; and Payments.
‘Barclays UK’ The segment of Barclays held by Barclays Bank UK PLC. The division includes the UK Personal Banking;
UK Business Banking and the Barclaycard Consumer UK businesses. Following a transfer from Barclays International in
Q2 2020, this also includes Barclays Partner Finance (BPF).
‘Basel 3’ The third of the Basel Accords, setting minimum requirements and standards that apply to internationally active
banks. Basel 3 is a set of measures developed by the Basel Committee on Banking Supervision aiming to strengthen the
regulation, supervision and risk management of banks.
‘Basel Committee on Banking Supervision (BCBS)’ or ‘The Basel Committee’ A forum for regular cooperation on banking
supervisory matters which develops global supervisory standards for the banking industry. Its 45 members are officials
from central banks or prudential supervisors from 28 jurisdictions.
‘Basic Indicator Approach (BIA)’ Under the BIA, banks are required to hold regulatory capital for operational risk equal to
15% of the annual average, calculated over a rolling three-year period, of the relevant income indicator for the bank as
whole.
‘Basis point(s)’ or ‘bp(s)’ One hundredth of a per cent (0.01%); 100 basis points is 1%. The measure is used in quoting
movements in interest rates, yields on securities and for other purposes.
‘Basis risk’ Index/tenor risk, that arises when floating rate products are linked to different interest rate indices, which are
imperfectly correlated, especially under stressed market conditions.
‘Behavioural scorecards’ Algorithm based decision tools used to aid business decisions and manage credit risk based on
existing customer data derived from account usage.
‘Book quality’ In the context of the Capital Risk section of the Barclays PLC Annual Report, changes in RWAs caused by
factors such as underlying customer behaviour or demographics leading to changes in risk profile.
‘Book size’ In the context of the Capital Risk section of the Barclays PLC Annual Report, changes in RWAs driven by
business activity, including net originations or repayments.
‘Bounce Back Loan Scheme (BBLS)’ A UK Government (British Business Bank) backed loan scheme which allows small
and medium-sized businesses to borrow between £2,000 and £50,000. The UK Government guarantees 100% of the loan
and pays the first 12 months of interest on behalf of the borrowers, subject to terms and conditions.
‘Business Banking’ Business Banking in Barclays UK offers specialist advice, products and services to small and medium
enterprises in the UK.
‘Business scenario stresses’ Multi asset scenario analysis of extreme, but plausible events that may impact the market
risk exposures of the Investment Bank.
‘Buy to let mortgage’ A mortgage where the intention of the customer is to let the property at origination.
Glossary of Terms
103

-- 106 of 125 --

‘Capital Conservation Buffer (CCB)’ A capital buffer of 2.5% of a bank’s total exposures that needs to be met with an
additional amount of Common Equity Tier 1 capital above the 4.5% minimum requirement for Common Equity Tier 1 set
out in CRR. Its objective is to conserve a bank’s capital by ensuring that banks build up surplus capital outside periods of
stress which can be drawn down if losses are incurred.
‘Capital ratios’ Key financial ratios measuring the bank's capital adequacy or financial strength expressed as a percentage
of RWAs.
‘Capital Requirements Directive (CRD)’ Directive 2013/36/EU, a component of the CRD IV package which accompanies
the Capital Requirements Regulation and sets out macroprudential standards including the countercyclical capital buffer
and capital buffers for systemically important institutions. Directive (EU) 2019/878, published as part of the EU Risk
Reduction Measure package amends CRD. These amendments entered into force from 27 June 2019, with EU member
states required to adopt the measures within the Directive by 28 December 2020. CRD forms part of UK law pursuant to
the European Union (Withdrawal) Act 2018, as amended and is subject to the temporary transitional powers available to
UK regulators to delay or phase-in on-shoring changes to UK regulatory requirements arising at the end of the transition
period until 31 March 2022.
‘Capital Requirements Regulation (CRR)’ Regulation (EU) No 575/2013, a component of the CRD IV package which
accompanies the Capital Requirements Directive and sets out detailed rules for capital eligibility, the calculation of RWAs,
the measurement of leverage, the management of large exposures and minimum standards for liquidity. Between 27 June
2019 and 28 June 2023, this regulation will be amended in line with the requirements of amending Regulation (EU)
2019/876 (CRR II). CRR, as amended by CRR II, forms part of UK law pursuant to the European Union (Withdrawal) Act
2018, as amended and is subject to the temporary transitional powers available to UK regulators to delay or phase-in on-
shoring changes to UK regulatory requirements arising at the end of the transition period until 31 March 2022.
‘Capital Requirements Regulation II (CRR II)’ Regulation (EU) 2019/876, amending Regulation (EU) No 575/2013 (CRR).
This is a component of the EU Risk Reduction Measure package. The requirements set out in CRR II will be introduced
between 27 June 2019 and 28 June 2023. CRR, as amended by CRR II, forms part of UK law pursuant to the European
Union (Withdrawal) Act 2018, as amended and is subject to the temporary transitional powers available to UK regulators
to delay or phase-in on-shoring changes to UK regulatory requirements arising at the end of the transition period until 31
March 2022.
‘Capital requirements on the underlying exposures (KIRB)’ An approach available to banks when calculating RWAs for
securitisation exposures. This is based upon the RWA amounts that would be calculated under the IRB approach for the
underlying pool of securitised exposures in the program, had such exposures not been securitised.
‘Capital resources’ Common Equity Tier 1, Additional Tier 1 capital and Tier 2 capital that are eligible to satisfy capital
requirements under CRD. Referred to as ‘own funds’ within EU regulatory texts.
‘Capital risk’ The risk that the Barclays Group has an insufficient level or composition of capital to support its normal
business activities and to meet its regulatory capital requirements under normal operating environments or stressed
conditions (both actual and as defined for internal planning or regulatory testing purposes). This includes the risk from the
Barclays Group’s pension plans.
‘Central Counterparty’ or ‘Central Clearing Counterparties (CCPs)’ A clearing house mediating between the buyer and the
seller in a financial transaction, such as a derivative contract or repurchase agreement (repo). Where a central
counterparty is used, a single bi-lateral contract between the buyer and seller is replaced with two contracts, one between
the buyer and the CCP and one between the CCP and the seller. The use of CCPs allows for greater oversight and
improved credit risk mitigation in over-the-counter (OTC) markets.
‘Charge-off’ In the retail segment this refers to the point in time when collections activity changes from the collection of
arrears to the recovery of the full balance. This is normally when six payments are in arrears.
‘Client Assets’ Assets managed or administered by the Barclays Group on behalf of clients including assets under
management (AUM), custody assets, assets under administration and client deposits.
‘CLOs and Other insured assets’ Highly rated CLO positions wrapped by monolines, non-CLOs wrapped by monolines
and other assets wrapped with Credit Support Annex (CSA) protection.
‘Collateralised Debt Obligation (CDO)’ A security issued by a third party which references Asset Backed Securities and/or
certain other related assets purchased by the issuer. CDOs may feature exposure to sub-prime mortgage assets through
the underlying assets.
‘Collateralised Loan Obligation (CLO)’ A security backed by repayments from a pool of commercial loans. The payments
may be made to different classes of owners (in tranches).
‘Collateralised Mortgage Obligation (CMO)’ A security backed by mortgages. A special purpose entity receives income
from the mortgages and passes them on to investors in the security.
Glossary of Terms
104

-- 107 of 125 --

‘Combined Buffer Requirement (CBR)’ In the context of the CRD capital obligations, the total Common Equity Tier 1
capital required to meet the combined requirements of the Capital Conservation Buffer, the GSII Buffer or the OSII buffer
as applicable, the Systemic Risk buffer and an institution specific counter-cyclical buffer.
‘Commercial paper (CP)’ Short-term notes issued by entities, including banks, for funding purposes.
‘Commercial real estate (CRE)’ Commercial real estate includes office buildings, industrial property, medical centres,
hotels, retail stores, shopping centres, farm land, multifamily housing buildings, warehouses, garages, industrial
properties and other similar properties. Commercial real estate loans are loans backed by a package of commercial real
estate. Note: for the purposes of the Credit Risk section, the UK CRE portfolio includes property investment,
development, trading and housebuilders but excludes social housing contractors.
‘Commissions and other incentives’ Includes commission-based arrangements, guaranteed incentives and Long Term
Incentive Plan awards.
‘Committee of Sponsoring Organisations of the Treadway Commission Framework (COSO)’ A joint initiative of five private
sector organisations dedicated to the development of frameworks and providing guidance on enterprise risk management,
internal control and fraud deterrence.
‘Commodity derivatives’ Exchange traded and over-the-counter (OTC) derivatives based on an underlying commodity
(e.g. metals, precious metals, oil and oil related products, power and natural gas).
‘Commodity risk’ Measures the impact of changes in commodity prices and volatilities, including the basis between related
commodities (e.g. Brent vs. WTI crude prices).
‘Common Equity Tier 1 (CET1) capital’ The highest quality form of regulatory capital under CRR that comprises common
shares issued and related share premium, retained earnings and other reserves, less specified regulatory adjustments.
‘Common Equity Tier 1 (CET1) ratio’ A measure of Common Equity Tier 1 capital expressed as a percentage of RWAs.
‘Compensation: income ratio’ The ratio of compensation expense over total income. Compensation represents total staff
costs less non-compensation items consisting of outsourcing, staff training, redundancy costs and retirement costs.
‘Comprehensive Capital Analysis and Review (CCAR)’ An annual exercise, required by and evaluated by the Federal
Reserve, through which the largest bank holding companies operating in the US assess whether they have sufficient
capital to continue operations through periods of economic and financial stress and have robust capital-planning
processes that account for their unique risks.
‘Comprehensive Risk Capital Charge (CRCC)’ An estimate of all the material market risks, including rating migration and
default for the correlation trading portfolio.
‘Comprehensive Risk Measure (CRM)’ An estimate of all the material market risks, including rating migration and default
for the correlation trading portfolio. Also referred to as All Price Risk (APR) and Comprehensive Risk Capital Charge
(CRCC).
‘Conduct risk’ The risk of detriment to customers, clients, market integrity, competition or Barclays from the inappropriate
supply of financial services, including instances of wilful or negligent misconduct.
‘Constant Currency Basis’ Excluding the impact of foreign currency conversion to GBP when comparing financial results
in two different financial periods.
‘Consumer, Cards and Payments (CC&P)’ International Cards and Consumer Bank (including Barclays US Consumer
Bank and Barclaycard Germany), Unified Payments (including merchant acquiring and commercial payments) and Private
Bank.
‘Contingent Capital Notes (CCNs)’ Interest bearing debt securities issued by the Barclays Group or its subsidiaries that
are either permanently written off or converted into an equity instrument from the issuer's perspective in the event of the
Common Equity Tier 1 (CET1) ratio of the relevant Barclays Group entity falling below a specific level, or at the direction
of regulators.
‘Conversion Trigger’ Used in the context of Contingent Capital Notes and AT1 securities. A capital adequacy trigger event
occurs when the CET1 ratio of the bank falls below a certain level (the trigger) as defined in the Terms & Conditions of the
instruments issued. See ‘Contingent Capital Notes (CCNs)’.
‘Coronavirus Business Interruption Loan Scheme (CBILS)’ A loan scheme by the British Business Bank (BBB) to support
UK based small and medium-sized businesses (turnover of up to £45 million) adversely impacted by COVID-19. The
CBILS scheme provides loans up to £5 million which are backed by an 80% UK Government (BBB) guarantee. The UK
Government will pay interest and fees for the first 12 months on behalf of the borrowers, subject to terms and conditions.
Coronavirus Large Business Interruption Loan Scheme (CLBILS)’ A loan scheme by the British Business Bank (BBB) to
support UK based medium-sized businesses (turnover above £45 million, but with no access to CCFF) adversely
Glossary of Terms
105

-- 108 of 125 --

impacted by COVID-19, The CBILS scheme provides loans of up to £200 million which are backed by an 80% UK
Government (BBB) guarantee.
‘Corporate and Investment Bank (CIB)’ Barclays Corporate and Investment Bank businesses which form part of Barclays
International.
‘Correlation risk’ Refers to the change in marked to market value of a security when the correlation between the
underlying assets changes over time.
‘Cost of Equity’ The rate of return targeted by the equity holders of a company.
‘Cost: income jaws’ Relationship of the percentage change movement in operating expenses relative to total income.
‘Cost: income ratio’ Total operating expenses divided by total income.
‘Countercyclical Capital Buffer (CCyB)’ An additional buffer introduced as part of the CRD IV package that requires banks
to have an additional cushion of CET 1 capital with which to absorb potential losses, enhancing their resilience and
contributing to a stable financial system.
‘Countercyclical leverage ratio buffer (CCLB)’ A macroprudential buffer that has applied to specific PRA regulated
institutions since 2018 and is calculated at 35% of any risk weighted countercyclical capital buffer set by the Financial
Policy Committee (FPC). The CCLB applies in addition to the minimum of 3.25% and any G-SII additional leverage ratio
buffer that applies.
‘Counterparty credit risk (CCR)’ The risk that a counterparty to a transaction could default before the final settlement of a
transaction’s cash flows. In the context of RWAs, a component of RWAs that represents the risk of loss from derivatives,
repurchase agreements and similar transactions as a result of the default of the counterparty.
‘Coverage ratio’ This represents the percentage of impairment allowance reserve against the gross exposure.
‘Covered bonds’ Debt securities backed by a portfolio of mortgages that are segregated from the issuer’s other assets
solely for the benefit of the holders of the covered bonds.
‘Covid Corporate Finance Facility (CCFF)’: Bank of England (BOE) scheme to support liquidity among larger investment
grade firms which make a material UK contribution, helping to bridge coronavirus disruption to their cash flows. The Bank
of England provides liquidity by purchasing short-term debt in the form of commercial paper from corporates. Barclays
acts as dealer.
‘CRD IV’ The Fourth Capital Requirements Directive, comprising an EU Directive and an accompanying Regulation (CRR)
that together prescribe EU capital adequacy and liquidity requirements, and which implements Basel 3 in the European
Union.
‘CRD V’ The Fifth Capital Requirements Directive, comprising an EU amending Directive and an accompanying amending
Regulation (CRR II) that together prescribe EU capital adequacy and liquidity requirements, and which implements
enhanced Basel 3 proposals in the European Union.
‘Credit conversion factor (CCF)’ A factor used to estimate the risk from off-balance sheet commitments for the purpose of
calculating the total Exposure at Default (EAD) used to calculate RWAs.
‘Credit default swaps (CDS)’ A contract under which the protection seller receives premiums or interest-related payments
in return for contracting to make payments to the protection buyer in the event of a defined credit event. Credit events
normally include bankruptcy, payment default on a reference asset or assets, or downgrades by a rating agency.
‘Credit derivatives (CDs)’ An arrangement whereby the credit risk of an asset (the reference asset) is transferred from the
buyer to the seller of the protection.
‘Credit impairment charges’ Also known as ‘credit impairment’. Impairment charges on loans and advances to customers
and banks and impairment charges on fair value through other comprehensive income assets and reverse repurchase
agreements.
‘Credit market exposures’ Assets and other instruments relating to commercial real estate and leveraged finance
businesses that have been significantly impacted by the deterioration in the global credit markets. The exposures include
positions subject to fair value movements in the Income Statement, positions that are classified as loans and advances,
and available for sale and other assets.
‘Credit quality step’ In the context of the Standardised Approach to calculating credit risk RWAs, a “credit quality
assessment scale” maps the credit assessments of a recognised credit rating agency or export credit agency to credit
quality steps that determine the risk weight to be applied to an exposure.
‘Credit rating’ An evaluation of the creditworthiness of an entity seeking to enter into a credit agreement.
‘Credit risk’ The risk of loss to Barclays from the failure of clients, customers or counterparties, including sovereigns, to
fully honour their obligations to Barclays, including the whole and timely payment of principal, interest, collateral and other
Glossary of Terms
106

-- 109 of 125 --

receivables. In the context of RWAs, it is the component of RWAs that represents the risk of loss in loans and advances
and similar transactions resulting from the default of the counterparty.
‘Credit risk mitigation’ A range of techniques and strategies to actively mitigate credit risks to which the bank is exposed.
These can be broadly divided into three types: collateral, netting and set-off, and risk transfer.
‘Credit spread’ The premium over the benchmark or risk-free rate required by the market to accept a lower credit quality.
‘Credit Valuation Adjustment (CVA)’ The difference between the risk-free value of a portfolio of trades and the market
value which takes into account the counterparty’s risk of default. The CVA therefore represents an estimate of the
adjustment to fair value that a market participant would make to incorporate the credit risk of the counterparty due to any
failure to perform on contractual agreements.
‘CRR leverage exposure’ Calculated in accordance with Article 429 of the CRR.
‘CRR leverage ratio’ Calculated using the CRR definition of “Tier 1 capital” for the numerator and the CRR definition of
“leverage exposure” as the denominator.
‘Customer assets’ Represents loans and advances to customers. Average balances are calculated as the sum of all daily
balances for the year to date divided by number of days in the year to date.
‘Customer deposits’ In the context of the Liquidity Risk section, money deposited by all individuals and companies that are
not credit institutions. Such funds are recorded as liabilities in the Barclays Group’s balance sheet under “deposits at
amortised cost”.
‘Customer liabilities’ See ‘Customer deposits’.
‘Daily Value at Risk (DVaR)’ An estimate of the potential loss which might arise from market movements under normal
market conditions, if the current positions were to be held unchanged for one business day, measured to a specified
confidence level.
‘DBRS’ A credit rating agency.
‘Debit Valuation Adjustment (DVA)’ The opposite of Credit Valuation Adjustment (CVA). It is the difference between the
risk-free value of a portfolio of trades and the market value which takes into account the Barclays Group’s risk of default.
The DVA, therefore, represents an estimate of the adjustment to fair value that a market participant would make to
incorporate the credit risk of the Barclays Group due to any failure to perform on contractual obligations. The DVA
decreases the value of a liability to take into account a reduction in the remaining balance that would be settled should the
Barclays Group default or not perform any contractual obligations.
‘Debt buybacks’ Purchases of the Barclays Group’s issued debt securities, including equity accounted instruments,
leading to their de-recognition from the balance sheet.
‘Debt securities in issue’ Transferable securities evidencing indebtedness of the Barclays Group. These are liabilities of
the Barclays Group and include certificates of deposit and commercial paper.
‘Default grades’ The Barclays Group classifies ranges of default probabilities into a set of 21 intervals called default
grades, in order to distinguish differences in the probability of default risk.
‘Default fund contributions’ The amount of contribution made by members of a central counterparty (CCP). All members
are required to contribute to this fund in advance of using a CCP. The default fund can be used by the CCP to cover
losses incurred by the CCP where losses are greater than the margins provided by a defaulting member.
‘Derivatives netting’ Adjustments applied across asset and liability mark-to-market derivative positions pursuant to legally
enforceable bilateral netting agreements and eligible cash collateral received in derivative transactions that meet the
requirements of BCBS 270 (Basel III leverage ratio framework and disclosure requirements).
‘Diversification effect’ Reflects the fact the risk of a diversified portfolio is smaller than the sum of the risks of its
constituent parts. It is measured as the sum of the individual asset class DVaR estimates less the total DVaR.
‘Dodd-Frank Act (DFA)’ The US Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010.
‘Domestic Liquidity Sub-Group Arrangement (DoLSub)’ An intra-group capital and liquidity support agreement that secures
certain regulatory permissions authorised by the Prudential Regulation Authority (PRA).
‘Economic Value of Equity (EVE)’ A measure of the potential change in value of expected future cash flows due to an
adverse interest rate movement, based on existing balance sheet run-off profile.
'Effective Expected Positive Exposure (EEPE)' The weighted average over time of effective expected exposure. The
weights are the proportion that an individual exposure represents of the entire exposure horizon time interval.
‘Effective interest rate (EIR)’ As defined in IFRS 9 Financial Instruments, effective interest rate is the rate that exactly
discounts estimated future cash payments or receipts through the expected life of the financial asset or financial liability to
the gross carrying amount of a financial asset or to the amortised cost of a financial liability.
Glossary of Terms
107

-- 110 of 125 --

‘Eligible liabilities’ Liabilities and capital instruments that are eligible to meet MREL that do not already qualify as own
funds.
‘Encumbrance’ The use of assets to secure liabilities, such as by way of a lien or charge.
‘Enterprise Risk Management Framework (ERMF)’ The Barclays Group’s risk management responsibilities are laid out in
the Enterprise Risk Management Framework, which describes how Barclays identifies and manages risk. The framework
identifies the principal risks faced by the Barclays Group; sets out risk appetite requirements; sets out roles and
responsibilities for risk management; and sets out risk committee structure.
‘Equities’ Trading businesses encompassing Cash Equities, Equity Derivatives & Equity Financing
‘Equity and stock index derivatives’ Derivatives whose value is derived from equity securities. This category includes
equity and stock index swaps and options (including warrants, which are equity options listed on an exchange). The
Barclays Group also enters into fund-linked derivatives, being swaps and options whose underlyings include mutual
funds, hedge funds, indices and multi-asset portfolios. An equity swap is an agreement between two parties to exchange
periodic payments, based upon a notional principal amount, with one side paying fixed or floating interest and the other
side paying based on the actual return of the stock or stock index. An equity option provides the buyer with the right, but
not the obligation, either to purchase or sell a specified stock, basket of stocks or stock index at a specified price or level
on or before a specified date.
‘Equity risk’ In the context of trading book capital requirements, the risk of change in market value of an equity investment.
‘Equity structural hedge’ An interest rate hedge in place to reduce earnings volatility of the overnight / short term equity
investment and to smoothen the income over a medium/long term.
‘EU Risk Reduction Measure package’ A collection of amending Regulations and Directives that update core EU
regulatory texts and which came into force on 27 June 2019.
‘Euro Interbank Offered Rate (EURIBOR)’ A benchmark interest rate at which banks can borrow funds from other banks in
the European interbank market.
‘Europe’ Geographic segment comprising countries in which Barclays operates within the EU (excluding the UK), Northern
Continental and Eastern Europe.
‘European Banking Authority (EBA)’ The European Banking Authority (EBA) is an independent EU Authority which works
to ensure effective and consistent prudential regulation and supervision across the European banking sector. Its overall
objectives are to maintain financial stability in the EU and to safeguard the integrity, efficiency and orderly functioning of
the banking sector.
‘European Securities and Markets Authority (ESMA)’ An independent European Supervisory Authority with the remit of
enhancing the protection of investors and reinforcing stable and well-functioning financial markets in the European Union.
‘Eurozone’ Represents the 19 European Union countries that have adopted the Euro as their common currency. The 19
countries are Austria, Belgium, Cyprus, Estonia, Finland, France, Germany, Greece, Ireland, Italy, Latvia, Lithuania,
Luxembourg, Malta, Netherlands, Portugal, Slovakia, Slovenia and Spain.
‘Expected Credit Losses (ECL)’ A present value measure of the credit losses expected to result from default events that
may occur during a specified period of time. ECLs must reflect the present value of cash shortfalls, and the unbiased and
probability weighted assessment of a range of outcomes.
‘Expected Losses’ A regulatory measure of anticipated losses for exposures captured under an internal ratings based
credit risk approach for capital adequacy calculations. It is measured as the Barclays Group's modelled view of
anticipated losses based on Probability of Default (PD), Loss Given Default (LGD) and Exposure at Default (EAD), with a
one-year time horizon.
’Expert lender models’ Models of risk measures that are used for parts of the portfolio where the risk drivers are specific to
a particular counterparty, but where there is insufficient data to support the construction of a statistical model. These
models utilise the knowledge of credit experts that have in depth experience of the specific customer type being modelled.
‘Exposure’ Generally refers to positions or actions taken by a bank, or consequences thereof, that may put a certain
amount of a bank’s resources at risk.
‘Exposure at Default (EAD)’ The estimation of the extent to which the Barclays Group may be exposed to a customer or
counterparty in the event of, and at the time of, that counterparty’s default. At default, the customer may not have drawn
the loan fully or may already have repaid some of the principal, so that exposure may be less than the approved loan limit.
‘External Credit Assessment Institutions (ECAI)’ Institutions whose credit assessments may be used by credit institutions
for the determination of risk weight exposures according to CRR.
‘External ratings based approach / internal assessment approach (Sec ERBA / IAA)’ Under the SEC-ERBA approach,
regulatory capital is assigned to securitisation tranches on the basis of their external credit rating. SEC-ERBA approach
Glossary of Terms
108

-- 111 of 125 --

can also be used for unrated ABCP exposures where the institution has the regulatory permission to use the Internal
Assessment approach (IAA) to assign a credit rating to the unrated ABCP exposure.
‘Federal Housing Finance Agency (FHFA)’ An independent federal agency in the United States that oversees the
secondary mortgage market and regulates Fannie Mae and Freddie Mac, as well as 11 Federal Home Loan banks. The
FHFA also sets the Housing Price Index (HPI) in the United States.
‘Federal Reserve Board (FRB)’ The Board of Governors of the Federal Reserve System, commonly known as the Federal
Reserve Board, is responsible for- amongst other things – setting monetary policy in the US.
'FICC' Represents Macro (including rates and currency), Credit and Securitised products.
'Financial Policy Committee (FPC)' The Bank of England’s Financial Policy Committee identifies, monitors and takes
action to remove or reduce systemic risks with a view to protecting and enhancing the resilience of the UK financial
system. The FPC also has a secondary objective to support the economic policy of the UK Government.
'Foundation Internal Ratings Based (F-IRB)’ See ‘Internal Ratings Based (IRB)’.
‘Financial Conduct Authority (FCA)’ The statutory body responsible for conduct of business regulation and supervision of
UK authorised firms. The FCA also has responsibility for the prudential regulation of firms that do not fall within the PRA’s
scope.
‘Financial Services Compensation Scheme (FSCS)’ The UK’s fund for compensation of authorised financial services firms
that are unable to pay claims.
‘Financial collateral comprehensive method (FCCM)’ A counterparty credit risk exposure calculation approach which
applies volatility adjustments to the market value of exposure and collateral when calculating RWA values.
‘Financial Stability Board (FSB)’ An international body that monitors and makes recommendations about the global
financial system. It promotes international financial stability by coordinating national financial authorities and international
standard-setting bodies as they work toward developing strong regulatory, supervisory and other financial sector policies.
It fosters a level playing field by encouraging coherent implementation of these policies across sectors and jurisdictions.
‘Fitch’ A credit rating agency.
‘Forbearance Programmes’ Forbearance programmes to assist customers in financial difficulty through agreements to
accept less than contractual amounts due where financial distress would otherwise prevent satisfactory repayment within
the original terms and conditions of the contract. These agreements may be initiated by the customer, Barclays or a third
party and include approved debt counselling plans, minimum due reductions, interest rate concessions and switches from
capital and interest repayments to interest-only payments.
‘Foreclosures in Progress’ The process by which the bank initiates legal action against a customer with the intention of
terminating a loan agreement whereby the bank may repossess the property subject to local law and recover amounts it is
owed.
‘Foreign exchange derivatives’ The Barclays Group’s principal exchange rate-related contracts are forward foreign
exchange contracts, currency swaps and currency options. Forward foreign exchange contracts are agreements to buy or
sell a specified quantity of foreign currency, usually on a specified future date at an agreed rate. Currency swaps
generally involve the exchange, or notional exchange, of equivalent amounts of two currencies and a commitment to
exchange interest periodically until the principal amounts are re-exchanged on a future date. Currency options provide the
buyer with the right, but not the obligation, either to purchase or sell a fixed amount of a currency at a specified exchange
rate on or before a future date. As compensation for assuming the option risk, the option writer generally receives a
premium at the start of the option period.
‘Foreign exchange risk’ In the context of DVaR, the impact of changes in foreign exchange rates and volatilities.
‘Full time equivalent’ Full time equivalent units are the on-job hours paid for employee services divided by the number of
ordinary-time hours normally paid for a full-time staff member when on the job (or contract employees where applicable).
‘Fully loaded’ When a measure is presented or described as being on a fully loaded basis, it is calculated without applying
the transitional provisions set out in Part Ten of CRR.
‘Funded credit protection’ A technique of credit risk mitigation where the reduction of the credit risk on the exposure of an
institution derives from the right of that institution, in the event of the default of the counterparty or on the occurrence of
other specified credit events relating to the counterparty, to liquidate, or to obtain transfer or appropriation of, or to retain
certain assets or amounts, or to reduce the amount of the exposure to, or to replace it with, the amount of the difference
between the amount of the exposure and the amount of a claim on the institution.
‘Gains on acquisitions’ The amount by which the acquirer’s interest in the net fair value of the identifiable assets, liabilities
and contingent liabilities, recognised in a business combination, exceeds the cost of the combination.
‘General Data Protection Regulation (GDPR)’ GDPR (Regulation (EU) 2016/679) is a regulation by which the European
Parliament, the Council of the European Union and the European Commission intend to strengthen and unify data
Glossary of Terms
109

-- 112 of 125 --

protection for all individuals within the European Union. GDPR forms part of UK law pursuant to the European Union
(Withdrawal) Act 2018, as amended.
‘General market risk’ The risk of a price change in a financial instrument due to a change in the level of interest rates or
owing to a broad equity market movement unrelated to any specific attributes of individual securities.
‘Global-Systemically Important Banks (G-SIBs or G-SIIs)’ Global financial institutions whose size, complexity and systemic
interconnectedness, mean that their distress or failure would cause significant disruption to the wider financial system and
economic activity. The Financial Stability Board and the Basel Committee on Banking Supervision publish a list of global
systemically important banks.
‘G-SII additional leverage ratio buffer (G-SII ALRB)’ A macroprudential buffer that applies to G-SIBs and other major
domestic UK banks and building societies, including banks that are subject to ring-fencing requirements. The G-SII ALRB
will be calibrated as 35% (on a phased basis) of the combined Systemic Risk Buffers that apply to the bank.
‘GSII Buffer’ Common Equity Tier 1 capital required to be held under CRD to ensure that G-SIBs build up surplus capital
to compensate for the systemic risk that such institutions represent to the financial system.
’Grandfathering’ In the context of capital resources, the phasing in of the application of instrument eligibility rules which
allows CRR and CRR II non-compliant capital instruments to be included in regulatory capital subject to certain thresholds
which decrease over the transitional period.
‘Gross charge-off rates’ Represents the balances charged-off to recoveries in the reporting period, expressed as a
percentage of average outstanding balances excluding balances in recoveries. Charge-off to recoveries generally occurs
when the collections focus switches from the collection of arrears to the recovery of the entire outstanding balance, and
represents a fundamental change in the relationship between the bank and the customer. This is a measure of the
proportion of customers that have gone into default during the period.
‘Gross Domestic Product (GDP)’ Measures the total value of goods and services produced in a country within a specific
time period.
‘Gross write-off rates’ Expressed as a percentage and represent balances written off in the reporting period divided by
gross loans and advances held at amortised cost at the balance sheet date.
‘Gross new lending’ New lending advanced to customers during the period.
‘Guarantee’ Unless otherwise described, an undertaking by a third party to pay a creditor should a debtor fail to do so. It is
a form of credit substitution.
‘Head Office’ Comprises head office, Barclays Services FTE and legacy businesses.
‘High-Net-Worth’ Businesses within Barclays UK and Barclays International that provide banking and other services to
high net worth customers.
‘High quality liquidity assets (HQLA)’ It comprises eligible and unencumbered cash or assets that can be converted into
cash at little or no loss of value in private markets, to meet liquidity needs arising from a liquidity stress scenario or event.
Please refer to ‘Level 1 assets’ and ‘Level 2 assets’.
‘High Risk’ In retail banking, ‘High Risk’ is defined as the subset of up-to-date customers who, either through an event or
observed behaviour exhibit potential financial difficulty. Where appropriate, these customers are proactively contacted to
assess whether assistance is required.
‘Home loan’ A loan to purchase a residential property. The property is then used as collateral to guarantee repayment of
the loan. The borrower gives the lender a lien against the property and the lender can foreclose on the property if the
borrower does not repay the loan per the agreed terms. Also known as a residential mortgage.
‘IHC’ or ‘US IHC’ Barclays US LLC, the intermediate holding company established by Barclays in July 2016, which holds
most of Barclays’ subsidiaries and assets in the US.
'Internal Model Approach (IMA)’ In the context of RWAs, RWAs for which the exposure amount has been derived via the
use of a PRA approved internal market risk model.
'Internal Model Method (IMM)’ In the context of RWAs, RWAs for which the exposure amount has been derived via the
use of a PRA approved internal counterparty credit risk model.
‘Identified Impairment (II)’ Specific impairment allowances for financial assets, individually estimated.
‘IFRS 9 transitional arrangements’ Following the application of IFRS 9 as of 1 January 2018, Article 473a of CRR permits
institutions to phase-in the impact on capital and leverage ratios of the impairment requirements under the new
accounting standard.
Glossary of Terms
110

-- 113 of 125 --

‘Impairment Allowances’ A provision held on the balance sheet as a result of the raising of a charge against profit for
expected losses in the lending book. An impairment allowance may either be identified or unidentified and individual or
collective.
‘Income’ Total income, unless otherwise specified.
‘Incremental Risk Charge (IRC)’ An estimate of the incremental risk arising from rating migrations and defaults for traded
debt instruments beyond what is already captured in specific market risk VaR for the non-correlation trading portfolio.
‘Independent Validation Unit (IVU)’ The function within the bank responsible for independent review, challenge and
approval of all models.
‘Individual liquidity guidance (ILG)’ Guidance given to a bank about the amount, quality and funding profile of liquidity
resources that the PRA has asked the bank to maintain.
‘Inflation risk’ In the context of DVaR, the impact of changes in inflation rates and volatilities on cash instruments and
derivatives.
‘Insurance Risk’ The risk of the Barclays Group’s aggregate insurance premiums received from policyholders under a
portfolio of insurance contracts being inadequate to cover the claims arising from those policies.
‘Interchange’ Income paid to a credit card issuer for the clearing and settlement of a sale or cash advance transaction.
‘Interest-only home loans’ Under the terms of these loans, the customer makes payments of interest only for the entire
term of the mortgage, although customers may make early repayments of the principal within the terms of their
agreement. The customer is responsible for repaying the entire outstanding principal on maturity, which may require the
sale of the mortgaged property.
‘Interest rate derivatives’ Derivatives linked to interest rates. This category includes interest rate swaps, collars, floors
options and swaptions. An interest rate swap is an agreement between two parties to exchange fixed rate and floating
rate interest by means of periodic payments based upon a notional principal amount and the interest rates defined in the
contract. Certain agreements combine interest rate and foreign currency swap transactions, which may or may not include
the exchange of principal amounts. A basis swap is a form of interest rate swap, in which both parties exchange interest
payments based on floating rates, where the floating rates are based upon different underlying reference indices. In a
forward rate agreement, two parties agree a future settlement of the difference between an agreed rate and a future
interest rate, applied to a notional principal amount. The settlement, which generally occurs at the start of the contract
period, is the discounted present value of the payment that would otherwise be made at the end of that period.
‘Interest rate risk’ The risk of interest rate volatility adversely impacting the Barclays Group’s Net Interest Margin. In the
context of the calculation of market risk DVaR, measures the impact of changes in interest (swap) rates and volatilities on
cash instruments and derivatives.
‘Interest rate risk in the banking book (IRRBB)’ The risk that the Barclays Group is exposed to capital or income volatility
because of a mismatch between the interest rate exposures of its (non-traded) assets and liabilities.
‘Internal Assessment Approach (IAA)’ One of three types of calculation that a bank with permission to use the Internal
Ratings Based (IRB) approach may apply to securitisation exposures. It consists of mapping a bank's internal rating
methodology for credit exposures to those of an External Credit Assessment Institution (ECAI) to determine the
appropriate risk weight based on the ratings based approach. Its applicability is limited to ABCP programmes related to
liquidity facilities and credit enhancement.
‘Internal Capital Adequacy Assessment Process (ICAAP)’ It describes how the Group identifies, manages and qualifies
the risks it is exposed to, in pursuit of its business strategy. It assesses whether the quality and quantity of capital is
available to absorb capital losses for the risks the firm undertakes. The capital adequacy is assessed on a point of time
basis and on a forward looking basis taking into account baseline and stressed economic capital conditions.
‘Internal Ratings Based (IRB)’ An approach under the CRR framework that relies on the bank’s internal models to derive
the risk weights. The IRB approach is divided into two alternative applications, Advanced and Foundation:
– Advanced IRB (A-IRB): the bank uses its own estimates of Probability of Default (PD), Loss Given Default (LGD)
and credit conversion factor to model a given risk exposure.
– Foundation IRB (F-IRB): the bank applies its own PD as for Advanced, but it uses standard parameters for the
LGD and the credit conversion factor. The Foundation IRB approach is specifically designed for wholesale credit
exposures. Hence retail, equity, securitisation positions and non-credit obligations asset exposures are treated
under standardised or A-IRB.
‘Internal Ratings Based approach (SEC-IRBA)’ This is a method to calculate risk-weighted exposure amounts for
securitisation positions. Under this method, an institution must be able to model regulatory capital requirements for
Glossary of Terms
111

-- 114 of 125 --

underlying exposures in the securitisation as if these had not been securitised (‘KIRB’), subject to certain other inputs and
criteria.
‘Investment Bank’ The Barclays Group’s investment bank which consists of origination led and returns focused Global
Markets and Investment Banking businesses, which forms part of the Corporate and Investment Bank segment of
Barclays International.
‘Investment Banking Fees’ In the context of Investment Bank analysis of Total Income, fees generated from origination
activity businesses – including financial advisory, debt and equity underwriting.
‘Investment grade’ A debt security, treasury bill or similar instrument with a credit rating of AAA to BBB as measured by
external credit rating agencies.
‘ISDA Master Agreement’ The most commonly used master contract for OTC derivative transactions internationally. It is
part of a framework of documents, designed to enable OTC derivatives to be documented fully and flexibly. The
framework consists of a master agreement, a schedule, confirmations, definitions booklets, and a credit support annex.
The ISDA Master Agreement is published by the International Swaps and Derivatives Association, commonly known as
“ISDA”.
‘Key Risk Scenarios (KRS)’ Key Risk Scenarios are a summary of the extreme potential risk exposure for each Key Risk
in each business and function, including an assessment of the potential frequency of risk events, the average size of
losses and three extreme scenarios. The Key Risk Scenario assessments are a key input to the Advanced Measurement
Approach calculation of regulatory and economic capital requirements.
‘Large exposure’ A large exposure is defined as the total exposure of a bank to a counterparty or group of connected
clients, whether in the banking book or trading book or both, which in aggregate equals or exceeds 10% of the bank's
eligible capital.
‘Legal risk’ The risk of loss or imposition of penalties, damages or fines from the failure of the Barclays Group to meet its
legal obligations including regulatory or contractual requirements.
‘Lending’ In the context of Investment Bank analysis of Total Income, lending income includes Net Interest Income (NII),
gains or losses on loan sale activity, and risk management activity relating to the loan portfolio.
‘Letters of credit’ A letter typically used for the purposes of international trade guaranteeing that a debtor’s payment to a
creditor will be made on time and in full. In the event that the debtor is unable to make payment, the bank will be required
to cover the full or remaining amount of the purchase.
‘Level 1 assets’ High quality liquid assets under the Basel Committee’s Liquidity Coverage Ratio (LCR), including cash,
central bank reserves and higher quality government securities.
‘Level 2 assets’ High quality liquid assets under the Basel Committee’s Liquidity Coverage Ratio (LCR), Level 2A assets,
including, e.g. lower quality government securities, covered bonds and corporate debt securities, and Level 2B assets,
including, e.g. lower rated corporate bonds, residential mortgage backed securities and equities that meet certain
conditions.
‘Lifetime expected credit losses’ An assessment of expected losses associated with default events that may occur during
the life of an exposure, reflecting the present value of cash shortfalls over the remaining expected life of the asset.
‘Lifetime Probability’ The likelihood of accounts entering default during the expected remaining life of the asset.
‘Liquidity Coverage Ratio (LCR)’ The ratio of the stock of high quality liquid assets to expected net cash outflows over the
next 30 days. High-quality liquid assets should be unencumbered, liquid in markets during a time of stress and, ideally, be
central bank eligible. These include, e.g. cash and claims on central governments and central banks.
‘Liquidity Pool’ The Barclays Group liquidity pool comprises cash at central banks and highly liquid collateral specifically
held by the Barclays Group as a contingency to enable the bank to meet cash outflows in the event of stressed market
conditions.
‘Liquidity Risk’ The risk that the Barclays Group is unable to meet its contractual or contingent obligations or that it does
not have the appropriate amount, tenor and composition of funding and liquidity to support its assets.
‘Liquidity risk appetite (LRA)’ The level of liquidity risk that the Barclays Group chooses to take in pursuit of its business
objectives and in meeting its regulatory obligations.
‘Liquidity Risk Management Framework (the Liquidity Framework)’ The Liquidity Risk Management Framework, which is
sanctioned by the Board Risk Committee, incorporates liquidity policies, systems and controls that the Barclays Group
has implemented to manage liquidity risk within tolerances approved by the Board and regulatory agencies.
‘Litigation and conduct charges’ or ‘Litigation and conduct’ Litigation and conduct charges include regulatory fines,
litigation settlements and conduct-related customer redress.
Glossary of Terms
112

-- 115 of 125 --

‘Loan loss rate’ Quoted in basis points and represents total impairment charges divided by gross loans and advances held
at amortised cost at the balance sheet date.
‘Loan to deposit ratio’ or ‘Loan: deposit ratio’ Loans and advances at amortised costs divided by deposits at amortised
cost.
‘Loan to value (LTV) ratio’ Expresses the amount borrowed against an asset (i.e. a mortgage) as a percentage of the
appraised value of the asset. The ratios are used in determining the appropriate level of risk for the loan and are generally
reported as an average for new mortgages or an entire portfolio. Also see ‘Marked to market (MTM) LTV ratio’.
‘London Interbank Offered Rate (LIBOR)’ A benchmark interest rate at which banks can borrow funds from other banks in
the London interbank market.
‘Loss Given Default (LGD)’ The percentage of Exposure at Default (EAD) that will not be recovered following default. LGD
comprises the actual loss (the part that is not expected to be recovered), together with the economic costs associated
with the recovery process.
‘Management VaR’ A measure of the potential loss of value arising from unfavourable market movements at a specific
confidence level, if current positions were to be held unchanged for predefined period. Corporate and Investment Bank
uses Management VaR with a two-year equally weighted historical period, at a 95% confidence level, with a one day
holding period.
‘Mandatory break clause’ In the context of counterparty credit risk, a contract clause that means a trade will be ended on
a particular date.
‘Marked to market approach’ A counterparty credit risk exposure calculation approach which uses the current marked to
market value of derivative positions as well as a potential future exposure add-on to calculate an exposure to which a risk
weight can be applied. This is also known as the Current Exposure Method.
‘Marked to market (MTM) LTV ratio’ The loan amount as a percentage of the current value of the asset used to secure the
loan. Also see ‘Balance weighted Loan to Value (LTV) ratio’ and ‘Valuation weighted Loan to Value (LTV) ratio.’
‘Market risk’ The risk of loss arising from potential adverse changes in the value of the Barclays Group’s assets and
liabilities from fluctuation in market variables including, but not limited to, interest rates, foreign exchange, equity prices,
commodity prices, credit spreads, implied volatilities and asset correlations.
‘Master netting agreement’ An agreement that provides for a single net settlement of all financial instruments and
collateral covered by the agreement in the event of the counterparty’s default or bankruptcy or insolvency, resulting in a
reduced exposure.
‘Master trust securitisation programme’ A securitisation structure where a trust is set up for the purpose of acquiring a pool
of receivables. The trust issues multiple series of securities backed by these receivables.
‘Material Risk Takers (MRTs)’ Categories of staff whose professional activities have or are deemed to have a material
impact on Barclays’ risk profile, as determined in accordance with the European Banking Authority regulatory technical
standard on the identification of such staff.
‘Maximum Distributable Amount (MDA)’ The MDA is a factor representing the available distributable profit whilst remaining
in excess of its combined buffer requirement. CRD IV places restrictions on a bank’s dividend decisions depending on its
proximity to meeting the buffer.
‘Medium-Term Notes’ Corporate notes (or debt securities) continuously offered by a company to investors through a
dealer. Investors can choose from differing maturities, ranging from nine months to 30 years. They can be issued on a
fixed or floating coupon basis or with an exotic coupon; with a fixed maturity date (non-callable) or with embedded call or
put options or early repayment triggers. MTNs are most generally issued as senior, unsecured debt.
‘Methodology and policy’ In the context of the Capital Risk section of the Barclays PLC Annual Report, the effect on RWAs
of methodology changes driven by regulatory policy changes.
‘MiFID II’ The Markets in Financial Instruments Directive 2004/39/EC (known as "MiFID I”) as subsequently amended to
MiFID II is a European Union law that provides harmonised regulation for investment services across the member states
of the European Economic Area.
‘Minimum requirement for own funds and eligible liabilities (MREL)’ A European Union wide requirement under the Bank
Recovery and Resolution Directive for all European banks and investment banks to hold a minimum level of equity and/or
loss absorbing eligible liabilities to ensure the operation of the bail-in tool to absorb losses and recapitalise an institution in
resolution. An institution’s MREL requirement is set by its resolution authority. Amendments in the EU Risk Reduction
Measure package are designed to align MREL and TLAC for EU G-SIBs.
‘Model risk’ The risk of the potential adverse consequences from financial assessments or decisions based on incorrect or
misused model outputs and reports.
Glossary of Terms
113

-- 116 of 125 --

‘Model updates’ In the context of the Capital Risk section of the Barclays PLC Annual Report, changes in RWAs caused
by model implementation, changes in model scope or any changes required to address model malfunctions.
‘Model validation’ Process through which models are independently challenged, tested and verified to prove that they
have been built, implemented and used correctly, and that they continue to be fit-for-purpose.
‘ModelledVaR’ In the context of RWAs, market risk calculated using Value at Risk models laid down by the CRR and
supervised by the PRA.
‘Money market funds’ Investment funds typically invested in short-term debt securities.
‘Monoline derivatives’ Derivatives with a monoline insurer such as credit default swaps referencing the underlying
exposures held.
‘Moody’s’ A credit rating agency.
‘Mortgage Servicing Rights (MSR)’ A contractual agreement in which the right to service an existing mortgage is sold by
the original lender to another party that specialises in the various functions involved with servicing mortgages.
‘Multilateral development banks’ Financial institutions created for the purposes of development, where membership
transcends national boundaries.
‘National discretion’ Discretions in CRD given to member states to allow the local regulator additional powers in the
application of certain CRD rules in its jurisdiction.
‘Net asset value per share’ Calculated by dividing shareholders’ equity, excluding non-controlling interests and other
equity instruments, by the number of issued ordinary shares.
‘Net Interest Income (NII)’ The difference between interest income on assets and interest expense on liabilities.
‘Net Interest Margin (NIM)’ Net interest Income (NII) divided by the sum of average customer assets.
‘Net investment income’ Changes in the fair value of financial instruments designated at fair value, dividend income and
the net result on disposal of available for sale assets.
‘Net Stable Funding Ratio (NSFR)’ The ratio of available stable funding to required stable funding over a one-year time
horizon, assuming a stressed scenario. The ratio is required to be over 100%. Available stable funding would include such
items as equity capital, preferred stock with a maturity of over one year, or liabilities with a maturity of over one year. The
required amount of stable funding is calculated as the sum of the value of the assets held and funded by the institution,
multiplied by a specific required stable funding factor assigned to each particular asset type, added to the amount of
potential liquidity exposure multiplied by its associated required stable funding factor.
‘Net trading income’ Gains and losses arising from trading positions which are held at fair value, in respect of both market-
making and customer business, together with interest, dividends and funding costs relating to trading activities.
‘Net write-off rate’ Expressed as a percentage and represents balances written off in the reporting period less any post
write-off recoveries divided by gross loans and advances held at amortised cost at the balance sheet date.
‘Net written credit protection’ In the context of leverage exposure, the net notional value of credit derivatives protection
sold and credit derivatives protection bought.
‘New bookings’ The total of the original balance on accounts opened in the reporting period, including any applicable fees
and charges included in the loan amount.
‘Non-asset backed debt instruments’ Debt instruments not backed by collateral, including government bonds; US agency
bonds; corporate bonds; commercial paper; certificates of deposit; convertible bonds; corporate bonds and issued notes.
‘Non-Model Method (NMM)’ In the context of RWAs, counterparty credit risk, RWAs where the exposure amount has been
derived through the use of CRR norms, as opposed to an internal model.
‘Non-Traded Market Risk’ The risk that the current or future exposure in the banking book (i.e. non-traded book) will
impact the bank's capital and/or earnings due to adverse movements in Interest or foreign exchange rates.
‘Non-Traded VaR’ Reflects the volatility in the value of the fair value through other comprehensive income (FVOCI)
investments in the liquidity pool which flow directly through capital via the FVOCI reserve. The underlying methodology to
calculate non-traded VaR is similar to Traded Management VaR, but the two measures are not directly comparable. The
Non-Traded VaR represents the volatility to capital driven by the FVOCI exposures. These exposures are in the banking
book and do not meet the criteria for trading book treatment.
‘Notch’ A single unit of measurement in a credit rating scale.
‘Notional amount’ The nominal or face amount of a financial instrument, such as a loan or a derivative, that is used to
calculate payments made on that instrument.
Glossary of Terms
114

-- 117 of 125 --

‘Open Banking’ The Payment Services Directive (PSD2) and the Open API standards and data sharing remedy imposed
by the UK Competition and Markets Authority following its Retail Banking Market Investigation Order.
‘Operating leverage’ Operating expenses compared to total income less credit impairment charges and other provisions.
‘Operational risk’ The risk of loss to the bank from inadequate or failed processes or systems, human factors or due to
external events (e.g. fraud) where the root cause is not due to credit or market risks.
‘Operational Riskdata eXchange Association (ORX)’ The Operational Riskdata eXchange Association (ORX) is a not-for-
profit industry association dedicated to advancing the measurement and management of operational risk in the global
financial services industry. Barclays is a member of ORX.
‘Origination led’ Focus on high margin, low capital fee based activities and related hedging opportunities.
‘Other systemically important institutions (OSII)’ Other systemically important institutions are institutions that are deemed
to create risk to financial stability due to their systemic importance.
‘Over-the-counter (OTC) derivatives’ Derivative contracts that are traded (and privately negotiated) directly between two
parties. They offer flexibility because, unlike standardised exchange-traded products, they can be tailored to fit specific
needs.
‘Overall capital requirement’ The overall capital requirement is the sum of capital required to meet the total of a Pillar 1
requirement, a Pillar 2A requirement, a Global Systemically Important Institution (G-SII) buffer, a Capital Conservation
Buffer (CCB) and a Countercyclical Capital Buffer (CCyB).
‘Own credit’ The effect of changes in the Barclays Group’s own credit standing on the fair value of financial liabilities.
‘Owner occupied mortgage’ A mortgage where the intention of the customer was to occupy the property at origination.
‘Own funds’ The sum of Tier 1 and Tier 2 capital.
‘Own funds and eligible liabilities ratio’ A risk-based ratio representing the own funds and eligible liabilities of the
institution expressed as a percentage of total RWAs.
‘Past due items’ Refers to loans where the borrower has failed to make a payment when due under the terms of the loan
contract.
‘Payment Protection Insurance (PPI) redress’ Provision for the settlement of PPI mis-selling claims and related claims
management costs.
‘Pension Risk’ The risk of the Barclays Group’s earnings and capital being adversely impacted by the Barclays Group’s
defined benefit obligations increasing or the value of the assets backing these defined benefit obligations decreasing due
to changes in both the level and volatility of prices.
‘Performance costs’ The accounting charge recognised in the period for performance awards. For deferred incentives and
long-term incentives, the accounting charge is spread over the relevant periods in which the employee delivers service.
‘Personal Banking’ offers retail solutions to help customers with their day-to-day banking needs.
‘Period end allocated tangible equity’ Allocated tangible equity is calculated as 13.5% (2020: 13.0%) of RWAs for each
business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting assumptions the Barclays
Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the
Barclays Group’s tangible shareholders’ equity and the amounts allocated to businesses.
‘Pillar 1 requirements’ The minimum regulatory capital requirements to meet the sum of credit (including counterparty
credit), market risk and operational risk.
‘Pillar 2A requirements’ The additional regulatory capital requirement to meet risks not captured under Pillar 1
requirements. These requirements are the outcome of the bank’s Internal Capital Adequacy Assessment Process (ICAAP)
and the complementary supervisory review and evaluation carried out by the PRA.
‘Post-Model Adjustment (PMA)’ In the context of Basel models, a PMA is a short term increase in regulatory capital
applied at portfolio level to account for model input data deficiencies, inadequate model performance or changes to
regulatory definitions (e.g. definition of default) to ensure the model output is accurate, complete and appropriate.
‘Potential Future Exposure (PFE) on derivatives’ A regulatory calculation in respect of the Barclays Group’s potential
future credit exposure on both exchange traded and OTC derivative contracts, calculated by assigning a standardised
percentage (based on the underlying risk category and residual trade maturity) to the gross notional value of each
contract.
‘PRA waivers’ PRA approvals that specifically give permission to the bank to either modify or waive existing rules. Waivers
are specific to an organisation and require applications being submitted to and approved by the PRA.
‘Primary securitisations’ The issuance of securities (bonds and commercial papers) for fund-raising.
Glossary of Terms
115

-- 118 of 125 --

‘Primary Stress Tests’ In the context of Traded Market Risk, Stress Testing provides an estimate of potentially significant
future losses that might arise from extreme market moves or scenarios. Primary Stress Tests apply stress moves to key
liquid risk factors for each of the major trading asset classes.
‘Prime Services’ Involves financing of fixed income and equity positions using Repo and stock lending facilities. The Prime
Services business also provides brokerage facilitation services for hedge fund clients offering execution and clearance
facilities for a variety of asset classes.
‘Principal’ In the context of a loan, the amount borrowed, or the part of the amount borrowed which remains unpaid
(excluding interest).
‘Private equity investments’ Investments in equity securities in operating companies not quoted on a public exchange.
Investment in private equity often involves the investment of capital in private companies or the acquisition of a public
company that results in the delisting of public equity. Capital for private equity investment is raised by retail or institutional
investors and used to fund investment strategies such as leveraged buyouts, venture capital, growth capital, distressed
investments and mezzanine capital.
‘Principal Risks’ The principal risks affecting the Barclays Group, as described in the Risk Review section of the Barclays
PLC Annual Report.
‘Pro-cyclicality’ Movements in financial variables (including capital requirements) following natural fluctuations in the
economic cycle, where the subsequent impact on lending or other market behaviours acts as an amplification of the
economic cycle by the financial sector.
‘Probability of Default (PD)’ The likelihood that a loan will not be repaid and will fall into default. PD may be calculated for
each client who has a loan (normally applicable to wholesale customers/clients) or for a portfolio of clients with similar
attributes (normally applicable to retail customers). To calculate PD, Barclays assesses the credit quality of borrowers and
other counterparties and assigns them an internal risk rating. Multiple rating methodologies may be used to inform the
rating decision on individual large credits, such as internal and external models, rating agency ratings, and for wholesale
assets market information such as credit spreads. For smaller credits, a single source may suffice such as the result from
an internal rating model.
‘Product structural hedge’ An interest rate hedge put in place to reduce earnings volatility on product balances with instant
access (such as non-interest bearing current accounts and managed rate deposits) and to smoothen the income over a
medium/long term.
‘Properties in Possession held as ‘Loans and Advances to Customers’’ Properties in the UK and Italy where the customer
continues to retain legal title but where the bank has enforced the possession order as part of the foreclosure process to
allow for the disposal of the asset or the court has ordered the auction of the property.
‘Properties in Possession held as ‘Other Real Estate Owned’’ Properties in South Africa where the bank has taken legal
ownership of the title as a result of purchase at an auction or similar and treated as ‘Other Real Estate Owned’ within
other assets on the bank’s balance sheet.
‘Proprietary trading’ When a bank, brokerage or other financial institution trades on its own account, at its own risk, rather
than on behalf of customers, so as to make a profit for itself.
‘Prudential Regulation Authority (PRA)’ The statutory body responsible for the prudential supervision of banks, building
societies, insurers and a small number of significant investment banks in the UK. The PRA is a subsidiary of the Bank of
England.
‘Prudential Valuation Adjustment (PVA)’ A calculation which adjusts the accounting values of positions held on balance
sheet at fair value to comply with regulatory valuation standards, which place greater emphasis on the inherent
uncertainty around the value at which a trading book position could be exited.
‘Public benchmark’ Unsecured medium term notes issued in public syndicated transactions.
‘Qualifying central bank claims’ An amount calculated in line with the PRA policy statement allowing banks to exclude
claims on the central bank from the calculation of the leverage exposure measure, as long as these are matched by
deposits denominated in the same currency and of identical or longer maturity.
‘Qualifying Revolving Retail Exposure (QRRE)’ In the context of the IRB approach to credit risk RWA calculations, an
exposure meeting the criteria set out in Capital Requirements Regulation (CRR Article 154.4). It includes most types of
credit card exposure.
‘Rates’ In the context of Investment Bank income analysis, trading revenue relating to government bonds and interest rate
derivatives.
‘Re-aging’ The returning of a delinquent account to up-to-date status without collecting the full arrears (principal, interest
and fees).
Glossary of Terms
116

-- 119 of 125 --

‘Real Estate Mortgage Investment Conduits (REMICs)’ An entity that holds a fixed pool of mortgages and that is
separated into multiple classes of interests for issuance to investors.
‘Recovery book’ Represents the total amount of exposure which has been transferred to recovery units who set and
implement strategies to recover the Group’s exposure.
‘Recovery book Impairment Coverage Ratio’ Impairment allowance held against recoveries balances expressed as a
percentage of balance in recoveries.
‘Recovery book proportion of outstanding balances’ Represents the amount of recoveries (gross month-end customer
balances of all accounts that have charged-off) as at the period end compared to total outstanding balances. The size of
the recoveries book would ultimately have an impact on the overall impairment requirement on the portfolio. Balances in
recovery will decrease if: assets are written-off; amounts are collected; or assets are sold to a third party (i.e. debt sale).
‘Regulatory capital’ The amount of capital that a bank holds to satisfy regulatory requirements.
‘Renegotiated loans’ Loans are generally renegotiated either as part of an ongoing customer relationship or in response to
an adverse change in the circumstances of the borrower. In the latter case, renegotiation can result in an extension of the
due date of payment or repayment plans under which the Barclays Group offers a concessionary rate of interest to
genuinely distressed borrowers. This will result in the asset continuing to be overdue, and individually impaired if the
renegotiated payments of interest and principal will not recover the original carrying amount of the asset. In other cases,
renegotiation will lead to a new agreement, which is treated as a new loan.
‘Repurchase agreement (Repo)’ or ‘Reverse repurchase agreement (Reverse repo)’ Arrangements that allow
counterparties to use financial securities as collateral for an interest bearing cash loan. The borrower agrees to sell a
security to the lender subject to a commitment to repurchase the asset at a specified price on a given date. For the party
selling the security (and agreeing to repurchase it in the future), it is a Repurchase agreement or Repo; for the
counterparty to the transaction (buying the security and agreeing to sell in the future), it is a Reverse repurchase
agreement or Reverse repo.
‘Reputation risk’ The risk that an action, transaction, investment or event will reduce trust in the Barclays Group’s integrity
and competence by clients, counterparties, investors, regulators, employees or the public.
‘Re-securitisations’ The repackaging of securitised products into securities. The resulting securities are therefore
securitisation positions where the underlying assets are also predominantly securitisation positions.
‘Reserve Capital Instruments (RCIs)’ Hybrid issued capital securities which may be debt or equity accounted, depending
on the terms.
‘Residential Mortgage-Backed Securities (RMBS)’ Securities that represent interests in a group of residential mortgages.
Investors in these securities have the right to cash received from future mortgage payments (interest and/or principal).
‘Residual maturity’ The remaining contractual term of a credit obligation associated with a credit exposure.
‘Restructured loans’ Comprises loans where, for economic or legal reasons related to the debtor’s financial difficulties, a
concession has been granted to the debtor that would not otherwise be considered. Where the concession results in the
expected cash flows discounted at the original effective interest rate being less than the loan’s carrying value, an
impairment allowance will be raised.
‘Retail Loans’ Loans to individuals or small and medium sized enterprises rather than to financial institutions and larger
businesses. It includes both secured and unsecured loans such as mortgages and credit card balances, as well as loans
to certain smaller business customers, typically with exposures up to £3m or with a turnover of up to £5m.
‘Return on average Risk Weighted Assets’ Statutory profit after tax as a proportion of average RWAs.
‘Return on average tangible shareholders’ equity (RoTE)’ Profit after tax attributable to ordinary equity holders of the
parent, as a proportion of average shareholders’ equity excluding non-controlling interests and other equity instruments
adjusted for the deduction of intangible assets and goodwill.
‘Return on average allocated tangible equity’ Profit after tax attributable to ordinary equity holders of the parent, as a
proportion of average allocated tangible equity.
‘Risk appetite’ The level of risk that Barclays is prepared to accept whilst pursuing its business strategy, recognising a
range of possible outcomes as business plans are implemented.
‘Risk weighted assets (RWAs)’ A measure of a bank’s assets adjusted for their associated risks. Risk weightings are
established in accordance with the Basel rules as implemented by CRR and local regulators.
‘Risks not in VaR (RNIVS)’ Refers to all the key market risks which are not captured or not well captured within the VaR
model framework.
Glossary of Terms
117

-- 120 of 125 --

‘Sarbanes-Oxley requirements’ The Sarbanes-Oxley Act 2002 (SOX), which was introduced by the US Government to
safeguard against corporate governance scandals such as Enron, WorldCom and Tyco. All US-listed companies must
comply with SOX.
‘Second Lien’ Debt that is issued against the same collateral as higher lien debt but that is subordinate to it. In the case of
default, compensation for this debt will only be received after the first lien has been repaid and thus represents a riskier
investment than the first lien.
‘Secondary Stress Tests’ Secondary stress tests are used in measuring potential losses arising from illiquid market risks
that cannot be hedged or reduced within the time period covered in Primary Stress Tests.
‘Secured Overnight Financing Rate (SOFR)’ A broad measure of the cost of borrowing cash overnight collateralized by
U.S. Treasury securities in the repurchase agreement (repo) market.
‘Securities Financing Transactions (SFT)’ In the context of RWAs, any of the following transactions: a repurchase
transaction, a securities or commodities lending or borrowing transaction, or a margin lending transaction whereby cash
collateral is received or paid in respect of the transfer of a related asset.
‘Securities Financing Transactions adjustments’ In the context of leverage ratio, a regulatory add-on calculated as
exposure less collateral, taking into account master netting agreements.
‘Securities lending arrangements’ Arrangements whereby securities are legally transferred to a third party subject to an
agreement to return them at a future date. The counterparty generally provides collateral against non-performance in the
form of cash or other assets.
‘Securitisation’ Typically, a process by which debt instruments such as mortgage loans or credit card balances are
aggregated into a pool, which is used to back new securities. A company sells assets to a special purpose vehicle (SPV)
which then issues securities backed by the assets. This allows the credit quality of the assets to be separated from the
credit rating of the original borrower and transfers risk to external investors.
‘Set-off clauses’ In the context of counterparty credit risk, contract clauses that allow Barclays to set off amounts owed to
us by a counterparty against amounts owed by us to the counterparty.
‘Settlement balances’ Receivables or payables recorded between the date (the trade date) a financial instrument (such as
a bond) is sold, purchased or otherwise closed out, and the date the asset is delivered by or to the entity (the settlement
date) and cash is received or paid.
‘Settlement Netting’ Netting approach used in the calculation of the leverage exposure measure whereby firms may
calculate their exposure value of regular way purchases and sales awaiting settlement in accordance with Article 429g of
CRR, as amended by Regulation (EU) 2019/876 (CRR 2).
‘Settlement risk’ The risk that settlement in a transfer system will not take place as expected, usually owing to a party
defaulting on one or more settlement obligations.
‘Significant Increase in Credit Risk (SICR)’ Barclays assesses when a significant increase in credit risk has occurred
based on quantitative and qualitative assessments.
‘Small and Medium-Sized Enterprises (SME)’ An enterprise which employs fewer than 250 persons and which has an
annual turnover which does not exceed EUR 50 million, and / or an annual balance sheet total not exceeding EUR 43
million. Within the SME category, a small enterprise is defined as an enterprise which employs fewer than 50 persons and
whose annual turnover and/or annual balance sheet total does not exceed EUR 10 million. This is defined in accordance
with Commission Recommendation 2003/361/EC of 6 May 2003 concerning the definition of micro, small and medium
sized enterprises.
‘Slotting’ Slotting is an internal Barclays terminology for what is known as “Specialised Lending” in the IRB approach as
described in Capital Requirements Regulation (CRR Article 147.8). A standard set of rules are required to be used in
credit risk RWA calculations, based upon an assessment of factors such as the financial strength of the counterparty. The
requirements for the application of the Specialised Lending approach are detailed in CRR Article 153.5.
‘Sovereign exposure(s)’ Exposures to central governments, including holdings in government bonds and local government
bonds.
‘Specific market risk’ A risk that is due to the individual nature of an asset and can potentially be diversified or the risk of a
price change in an investment due to factors related to the issuer or, in the case of a derivative, the issuer of the
underlying investment.
‘Spread risk’ Measures the impact of changes to the swap spread, i.e. the difference between swap rates and government
bond yields.
Glossary of Terms
118

-- 121 of 125 --

‘SRB ALRB’ The Systemic Risk Buffer (SRB) Additional Leverage Ratio Buffer is firm specific requirement set by the PRA
using its powers under section 55M of the Financial Services and Markets Act 2000. Barclays is required to hold an
amount of CET1 capital that is equal to or greater than its Additional Leverage Ratio Buffer.
‘Stage 1’ This represents financial instruments where the credit risk of the financial instrument has not increased
significantly since initial recognition. Stage 1 financial instruments are required to recognise a 12 month expected credit
loss allowance.
‘Stage 2’ This represents financial instruments where the credit risk of the financial instrument has increased significantly
since initial recognition. Stage 2 financial instruments are required to recognise a lifetime expected credit loss allowance.
‘Stage 3’ This represents financial instruments where the financial instrument is considered impaired. Stage 3 financial
instruments are required to recognise a lifetime expected credit loss allowance.
‘Standard & Poor’s’ A credit rating agency.
‘Standardised approach (SEC-SA)’ This is a method to calculate risk-weighted exposure amounts for securitisation
positions. Under this method, an institution must be able calculate regulatory capital requirements per standardized
approach for underlying exposures in the securitisation as if these had not been securitised (‘KSA’), subject to certain other
inputs and criteria.
‘Standby facilities, credit lines and other commitments’ Agreements to lend to a customer in the future, subject to certain
conditions. Such commitments are either made for a fixed period, or have no specific maturity but are cancellable by the
lender subject to notice requirements.
‘Statutory’ Line items of income, expense, profit or loss, assets, liabilities or equity stated in accordance with the
requirements of the UK Companies Act 2006 and the requirements of International Financial Reporting Standards (IFRS).
‘Statutory return on average shareholders’ equity’ Statutory profit after tax attributable to ordinary shareholders as a
proportion of average shareholders’ equity.
‘STD’ / ‘Standardised Approach’ A method of calculating RWAs that relies on a mandatory framework set by the regulator
to derive risk weights based on counterparty type and a credit rating provided by an External Credit Assessment Institute.
‘Sterling Over Night Index Average (SONIA)’ Reflects bank and building societies’ wholesale overnight funding rates in the
sterling unsecured market administrated and calculated by the Bank of England.
‘Stress Testing’ A process which involves identifying possible future adverse events or changes in economic conditions
that could have unfavourable effects on the Barclays Group (either financial or non-financial), assessing the Barclays
Group’s ability to withstand such changes, and identifying management actions to mitigate the impact.
‘Stressed Value at Risk (SVaR)’ An estimate of the potential loss arising from a 12-month period of significant financial
stress calibrated to 99% confidence level over a 10-day holding period.
‘Structured entity’ An entity in which voting or similar rights are not the dominant factor in deciding control. Structured
entities are generally created to achieve a narrow and well defined objective with restrictions around their ongoing
activities.
‘Structural hedge’ or ‘hedging’ An interest rate hedge in place to reduce earnings volatility and to smoothen the income
over a medium/long term on positions that exist within the balance sheet and do not re-price in line with market rates. See
also ‘Equity structural hedge’ and ‘Product structural hedge’.
‘Structural model of default’ A model based on the assumption that an obligor will default when its assets are insufficient to
cover its liabilities.
‘Structured credit’ Includes the legacy structured credit portfolio primarily comprising derivative exposures and financing
exposures to structured credit vehicles.
‘Structured finance or structured notes’ A structured note is an investment tool that pays a return linked to the value or
level of a specified asset or index and sometimes offers capital protection if the value declines. Structured notes can be
linked to equities, interest rates, funds, commodities and foreign currency.
‘Sub-prime’ Sub-prime is defined as loans to borrowers typically having weakened credit histories that include payment
delinquencies and potentially more severe problems such as court judgments and bankruptcies. They may also display
reduced repayment capacity as measured by credit scores, high debt-to-income ratios, or other criteria indicating
heightened risk of default.
‘Subordinated liabilities’ Liabilities which, in the event of insolvency or liquidation of the issuer, are subordinated to the
claims of depositors and other creditors of the issuer.
‘Supranational bonds’ Bonds issued by an international organisation, where membership transcends national boundaries
(e.g. the European Union or World Trade Organisation).
‘Synthetic Securitisation Transactions’ Securitisation transactions effected through the use of derivatives.
Glossary of Terms
119

-- 122 of 125 --

‘Systemic Risk Buffer’ CET1 capital that may be required to be held as part of the Combined Buffer Requirement
increasing the capacity of UK banks to absorb stress and limiting the damage to the economy as a result of restricted
lending.
‘Tangible Net Asset Value (TNAV)’ Shareholders’ equity excluding non-controlling interests adjusted for the deduction of
intangible assets and goodwill.
‘Tangible Net Asset Value per share’ Calculated by dividing shareholders’ equity, excluding non-controlling interests and
other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares.
‘Tangible shareholders’ equity’ Shareholders’ equity excluding non-controlling interests and other equity instruments
adjusted for the deduction of intangible assets and goodwill.
‘Term premium’ Additional interest required by investors to hold assets with a longer period to maturity.
‘The Fundamental Review of the Trading Book (FRTB)’ A comprehensive suite of capital rules developed by the Basel
Committee on Banking Supervision as part of Basel III and applicable to banks’ wholesale trading activities.
‘The Standardised Approach (TSA)’ Under TSA, banks are required to hold regulatory capital for operational risk equal to
the annual average, calculated over a rolling three-year period, of the relevant income indicator (across all business
lines), multiplied by a supervisory defined percentage factor by business lines.
‘The three lines of defence’ The three lines of defence operating model enables Barclays to separate risk management
activities between those client facing areas of the Barclays Group and associated support functions responsible for
identifying risk, operating within applicable limits and escalating risk events (first line); colleagues in Risk and Compliance
who establish the limits, rules and constraints under which the first line operates and monitor their performance against
those limits and constraints (second line); and, colleagues in Internal Audit who provide assurance to the Board and
Executive Management over the effectiveness of governance, risk management and control over risks (third line). The
Legal function does not sit in any of the three lines, but supports them all. The Legal function is, however, subject to
oversight from Risk and Compliance with respect to operational and conduct risks.
‘Tier 1 capital’ The sum of the Common Equity Tier 1 capital and Additional Tier 1 capital.
‘Tier 1 capital ratio’ The ratio which expresses Tier 1 capital as a percentage of RWAs under CRR.
‘Tier 2 (T2) capital’ A type of capital as defined in the CRR principally composed of capital instruments, subordinated loans
and share premium accounts where qualifying conditions have been met.
‘Tier 2 (T2) securities’ Securities that are treated as Tier 2 (T2) capital in the context of CRR.
‘Total balances on forbearance programmes coverage ratio’ Impairment allowance held against Forbearance balances
expressed as a percentage of balance in forbearance.
‘Total capital ratio’ Total regulatory capital as a percentage of RWAs.
‘Total Loss Absorbing Capacity (TLAC)’ A standard published by the FSB which is applicable to G-SIBs and requires a G-
SIB to hold a prescriptive minimum level of instruments and liabilities that should be readily available for bail-in within
resolution to absorb losses and recapitalise the institution.
‘Total outstanding balance’ In retail banking, total outstanding balance is defined as the gross month-end customer
balances on all accounts including accounts charged off to recoveries.
‘Total return swap’ An instrument whereby the seller of protection receives the full return of the asset, including both the
income and change in the capital value of the asset. The buyer of the protection in return receives a predetermined
amount.
‘Traded Market Risk’ The risk of a reduction to earnings or capital due to volatility of trading book positions.
‘Trading book’ All positions in financial instruments and commodities held by an institution either with trading intent, or in
order to hedge positions held with trading intent.
‘Traditional Securitisation Transactions’ Securitisation transactions in which an underlying pool of assets generates cash
flows to service payments to investors.
‘Transitional’ When a measure is presented or described as being on a transitional basis, it is calculated in accordance
with the transitional provisions set out in Part Ten of CRR.
‘Treasury and Capital Risk’ This comprises of Liquidity Risk, Capital Risk and Interest Rate Risk in the banking book.
‘Twelve month expected credit losses’ The portion of the lifetime ECL arising if default occurs within 12 months of the
reporting date (or shorter period if the expected life is less than 12 months), weighted by the probability of said default
occurring.
‘Twelve month PD’ The likelihood of accounts entering default within 12 months of the reporting date.
Glossary of Terms
120

-- 123 of 125 --

‘Unencumbered’ Assets not used to secure liabilities or otherwise pledged.
‘United Kingdom (UK)’ Geographic segment where Barclays operates comprising the UK. Also see ‘Europe’.
‘UK Bank Levy’ A levy that applies to UK banks, building societies and the UK operations of foreign banks. The levy is
payable based on a percentage of the chargeable equity and liabilities of the bank on its balance sheet date.
‘UK leverage exposure’ Calculated as per the PRA rulebook, where the exposure calculation also includes the FPC’s
recommendation to allow banks to exclude claims on the central bank from the calculation of the leverage exposure
measure, as long as these are matched by deposits denominated in the same currency and of identical or longer maturity.
‘UK leverage ratio’ As per the PRA rulebook, means a bank’s Tier 1 capital divided by its total exposure measure, with this
ratio expressed as a percentage.
‘Unfunded credit protection’ A technique of credit risk mitigation where the reduction of the credit risk on the exposure of
an institution derives from the obligation of a third party to pay an amount in the event of the default of the borrower or the
occurrence of other specified credit events.
‘US Partner Portfolio’ Co-branded credit card programs with companies across various sectors including travel,
entertainment and retail.
‘US Residential Mortgages’ Securities that represent interests in a group of US residential mortgages.
‘Valuation weighted Loan to Value (LTV) ratio’ In the context of credit risk disclosures on secured home loans, a means of
calculating marked to market LTVs derived by comparing total outstanding balance and the value of total collateral we
hold against these balances. Valuation weighted Loan to Value ratio is calculated using the following formula: LTV = total
outstandings in portfolio/total property values of total outstandings in portfolio.
‘Value at Risk (VaR)’ A measure of the potential loss of value arising from unfavourable market movements at a specific
confidence level and within a specific timeframe.
‘Weighted off balance sheet commitments’ Regulatory add-ons to the leverage exposure measure based on credit
conversion factors used in the Standardised Approach to credit risk.
‘Wholesale loans’ or ‘wholesale lending’ Lending to larger businesses, financial institutions and sovereign entities.
‘Working Group on Sterling Risk-Free Reference Rates (RFRWG)’ A group mandated with catalysing a broad-based
transition to using SONIA (‘Sterling Overnight Index Average’) as the primary sterling interest rate benchmark in bond,
loan and derivatives markets.
‘Write-off (gross)’ The point where it is determined that an asset is irrecoverable, or it is no longer considered
economically viable to try to recover the asset or it is deemed immaterial or full and final settlement is reached and the
shortfall written off. In the event of write-off, the customer balance is removed from the balance sheet and the impairment
allowance held against the asset is released. Net write-offs represent gross write-offs less post write-off recoveries.
‘Wrong-way risk’ Arises in a trading exposure when there is significant correlation between the underlying asset and the
counterparty, which in the event of default would lead to a significant mark to market loss. When assessing the credit
exposure of a wrong-way trade, analysts take into account the correlation between the counterparty and the underlying
asset as part of the sanctioning process.
Glossary of Terms
121

-- 124 of 125 --

The following table sets out the Group’s capitalisation, indebtedness and contingent liabilities on a consolidated basis, in
accordance with IFRS, as at 30 June 2021.
As at
30.06.21
m
Share Capital of Barclays PLC
Ordinary shares - issued and fully paid shares of £0.25 each 16,998
£m
Group equity
Called up share capital and share premium 4,568
Other equity instruments 11,167
Other reserves 2,856
Retained earnings 48,461
Total equity excluding non-controlling interests 67,052
Non-controlling interests 1,064
Total equity 68,116
Group indebtedness
Subordinated liabilities 12,839
Debt securities in issue 90,733
Total indebtedness 103,572
Total capitalisation and indebtedness 171,688
Group contingent liabilities and commitments
Guarantees and letters of credit pledged as collateral security 13,519
Performance guarantees, acceptances and endorsements 5,679
Total contingent liabilities 19,198
Documentary credits and other short-term trade related transactions 1,017
Standby facilities, credit lines and other commitments 345,281
Total commitments 346,298
Exhibit 99.2 – Capitalisation and Indebtedness
122

-- 125 of 125 --